
<html lang="en"     class="pb-page"  data-request-id="14072656-8b93-41ca-b938-b4e0b78c2ea7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-12;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.9b01074;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability" /></meta><meta name="dc.Creator" content="Phillip R.  Lazzara" /></meta><meta name="dc.Creator" content="Brian P.  David" /></meta><meta name="dc.Creator" content="Aparna  Ankireddy" /></meta><meta name="dc.Creator" content="Benjamin G.  Richardson" /></meta><meta name="dc.Creator" content="Katherine  Dye" /></meta><meta name="dc.Creator" content="Kiira M.  Ratia" /></meta><meta name="dc.Creator" content="Sekhar P.  Reddy" /></meta><meta name="dc.Creator" content="Terry W.  Moore" /></meta><meta name="dc.Description" content="Pharmacological activation of NRF2 (nuclear factor erythroid 2-related factor 2) arises from blocking the interaction of NRF2 with its negative regulator, KEAP1 (Kelch-like ECH-associated protein 1..." /></meta><meta name="Description" content="Pharmacological activation of NRF2 (nuclear factor erythroid 2-related factor 2) arises from blocking the interaction of NRF2 with its negative regulator, KEAP1 (Kelch-like ECH-associated protein 1..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 4, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01074" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01074" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01074" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01074" /></link>
        
    
    

<title>Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01074" /></meta><meta property="og:title" content="Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0008.jpeg" /></meta><meta property="og:description" content="Pharmacological activation of NRF2 (nuclear factor erythroid 2-related factor 2) arises from blocking the interaction of NRF2 with its negative regulator, KEAP1 (Kelch-like ECH-associated protein 1). We previously reported an isoquinoline-based NRF2 activator, but this compound showed negative logD7.4 and a −2 charge at physiological pH, which may have limited its membrane permeability. In this work, we report potent, metabolically stable analogs that result from replacing a carboxymethyl group at the 4-position with a fluoroalkyl group." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01074"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01074">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01074&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01074&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01074&amp;href=/doi/10.1021/acs.jmedchem.9b01074" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 6547-6560</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01483" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01990" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Phillip R. Lazzara</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Phillip R. Lazzara</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Phillip+R.++Lazzara">Phillip R. Lazzara</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3709-2749" title="Orcid link">http://orcid.org/0000-0003-3709-2749</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brian P. David</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian P. David</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian+P.++David">Brian P. David</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5328-5394" title="Orcid link">http://orcid.org/0000-0001-5328-5394</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Aparna Ankireddy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aparna Ankireddy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pediatrics, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aparna++Ankireddy">Aparna Ankireddy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Benjamin G. Richardson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Benjamin G. Richardson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin+G.++Richardson">Benjamin G. Richardson</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6003-3021" title="Orcid link">http://orcid.org/0000-0001-6003-3021</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katherine Dye</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katherine Dye</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UI Centre for Drug Discovery, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katherine++Dye">Katherine Dye</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kiira M. Ratia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kiira M. Ratia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences,  UI Centre for Drug Discovery, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kiira+M.++Ratia">Kiira M. Ratia</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sekhar P. Reddy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sekhar P. Reddy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pediatrics,  University of Illinois Cancer Center, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sekhar+P.++Reddy">Sekhar P. Reddy</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Terry W. Moore</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Terry W. Moore</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences,  University of Illinois Cancer Center, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#d7a3a0bab8b8a5b297a2beb4f9b2b3a2"><span class="__cf_email__" data-cfemail="c8bcbfa5a7a7baad88bda1abe6adacbd">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Terry+W.++Moore">Terry W. Moore</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5410-306X" title="Orcid link">http://orcid.org/0000-0002-5410-306X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01074&amp;href=/doi/10.1021%2Facs.jmedchem.9b01074" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 6547–6560</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 4, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 July 2019</li><li><span class="item_label"><b>Published</b> online</span>4 November 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 June 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01074" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01074</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6547%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPhillip%2BR.%2BLazzara%252C%2BBrian%2BP.%2BDavid%252C%2BAparna%2BAnkireddy%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D12%26contentID%3Dacs.jmedchem.9b01074%26title%3DIsoquinoline%2BKelch-like%2BECH-Associated%2BProtein%2B1-Nuclear%2BFactor%2B%2528Erythroid-Derived%2B2%2529-like%2B2%2B%2528KEAP1-NRF2%2529%2BInhibitors%2Bwith%2BHigh%2BMetabolic%2BStability%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6560%26publicationDate%3DJune%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01074"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1804</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01074" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Phillip&quot;,&quot;last_name&quot;:&quot;R. Lazzara&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;P. David&quot;},{&quot;first_name&quot;:&quot;Aparna&quot;,&quot;last_name&quot;:&quot;Ankireddy&quot;},{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;G. Richardson&quot;},{&quot;first_name&quot;:&quot;Katherine&quot;,&quot;last_name&quot;:&quot;Dye&quot;},{&quot;first_name&quot;:&quot;Kiira&quot;,&quot;last_name&quot;:&quot;M. Ratia&quot;},{&quot;first_name&quot;:&quot;Sekhar&quot;,&quot;last_name&quot;:&quot;P. Reddy&quot;},{&quot;first_name&quot;:&quot;Terry&quot;,&quot;last_name&quot;:&quot;W. Moore&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;6547-6560&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01074&quot;},&quot;abstract&quot;:&quot;Pharmacological activation of NRF2 (nuclear factor erythroid 2-related factor 2) arises from blocking the interaction of NRF2 with its negative regulator, KEAP1 (Kelch-like ECH-associated protein 1). We previously reported an isoquinoline-based NRF2 activator, but this compound showed negative logD7.4 and a −2 charge at physiological pH, which may have limited its membrane permeability. In this work, we report potent, metabolically stable analogs that result from replacing a carboxymethyl group at the 4-position with a fluoroalkyl group.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01074&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01074" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01074&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01074" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01074&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01074" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01074&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01074&amp;href=/doi/10.1021/acs.jmedchem.9b01074" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01074" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01074" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01074%26sid%3Dliteratum%253Aachs%26pmid%3D31682434%26genre%3Darticle%26aulast%3DLazzara%26date%3D2020%26atitle%3DIsoquinoline%2BKelch-like%2BECH-Associated%2BProtein%2B1-Nuclear%2BFactor%2B%2528Erythroid-Derived%2B2%2529-like%2B2%2B%2528KEAP1-NRF2%2529%2BInhibitors%2Bwith%2BHigh%2BMetabolic%2BStability%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D12%26spage%3D6547%26epage%3D6560%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=290716" title="Sulfones">Sulfones</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/jmcmar.2020.63.issue-12/20200625/jmcmar.2020.63.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/medium/jm9b01074_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01074&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Pharmacological activation of NRF2 (nuclear factor erythroid 2-related factor 2) arises from blocking the interaction of NRF2 with its negative regulator, KEAP1 (Kelch-like ECH-associated protein 1). We previously reported an isoquinoline-based NRF2 activator, but this compound showed negative logD<sub>7.4</sub> and a −2 charge at physiological pH, which may have limited its membrane permeability. In this work, we report potent, metabolically stable analogs that result from replacing a carboxymethyl group at the 4-position with a fluoroalkyl group.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/63/12"><issue-title>Drug Metabolism and Toxicology</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35331" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35331" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Regulation of the oxidative stress response is crucial for attenuating tissue and DNA damage from reactive molecules, such as reactive oxygen species (ROS), reactive nitrogen species (RNS), and electrophiles. The cellular antioxidant response is primarily governed by the KEAP1–NRF2 protein–protein interaction (PPI).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> KEAP1 (Kelch-like ECH-associated protein 1) negatively regulates NRF2 (nuclear factor (erythroid-derived 2)-like 2) in the absence of oxidative or electrophilic stressors (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In the presence of ROS, RNS, and electrophilic species, one or more of 27 cysteine residues on KEAP1 become covalently modified, inducing a conformation that no longer allows for NRF2 to be sequestered.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> This dissociation increases cellular levels of NRF2, which translocates to the nucleus and promotes the transcription of genes coding for antioxidant enzymes such as NADPH quinone oxidoreductase 1 (NQO1), heme oxygenase (HO-1), and glutathione-<i>S</i>-transferase (GST).<a onclick="showRef(event, 'ref1 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref4 ref5">(1,4,5)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/medium/jm9b01074_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Under basal conditions, NRF2 is bound to KEAP1, ubiquitinated by CUL3, and degraded by the proteasome (top). In the presence of an electrophile (middle) or a noncovalent inhibitor (bottom), NRF2 translocates to the nucleus and transcribes cytoprotective genes, like NADPH quinone oxidoreductase 1 (NQO1), heme oxygenase-1 (HO-1), and glutathione <i>S</i>-transferase (GST).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01074&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Misregulation of the KEAP1–NRF2 axis has been implicated in several disease states,<a onclick="showRef(event, 'ref1 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref6">(1,6)</a> including rheumatoid arthritis,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> chronic kidney disease,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> multiple sclerosis,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and diabetic wound healing.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> Several therapies, such as dimethyl fumarate (<b>1</b>), sulforaphane (<b>2</b>), and bardoxolone methyl (<b>3</b>), that pharmacologically activate NRF2 in patients with chronic inflammatory diseases rely on electrophilic activation of NRF2 through covalent modification of KEAP1 (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Electrophilic therapies may have nontrivial off-target effects due to their reactive nature.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Furthermore, the lack of specificity in a pharmacologically active molecule may complicate the understanding of the compound’s mechanism of action.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> To more thoroughly understand the role NRF2 plays in chronic inflammatory diseases, selective and nonelectrophilic inhibitors are being developed and investigated.</div><figure id="cht1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/medium/jm9b01074_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Electrophilic Activators of NRF2<a onclick="showRef(event, 'ref9 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref9 ref15 ref16 ref17">(9,15−17)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01074&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">There are several known nonelectrophilic inhibitors that block the binding of NRF2 to KEAP1 (<a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>), several of which have been validated recently.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Our lab has been interested in the aryl bicyclic sulfonamide-based inhibitors (<b>4a</b>, <b>4b</b>, and <b>5a</b>).<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> Other nonelectrophilic NRF2 activators have been reported by groups at Sanofi (<b>6</b>)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and GlaxoSmithKline/Astex (<b>7</b>)<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> and are shown in <a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>. For further examples of nonelectrophilic NRF2 activators, see recent reviews.<a onclick="showRef(event, 'ref6 ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref6 ref24 ref25 ref26 ref27">(6,24−27)</a></div><figure id="cht2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/medium/jm9b01074_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Non-electrophilic Inhibitors of KEAP1<a onclick="showRef(event, 'ref19 ref21 ref22 ref28'); return false;" href="javascript:void(0);" class="ref ref19 ref21 ref22 ref28">(19,21,22,28)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01074&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The premise of developing nonelectrophilic NRF2 activators is based upon avoiding covalent reaction with cysteine nucleophiles from KEAP1, so it is important to also avoid activation to reactive metabolites. The 1,4-diaminonaphthalene scaffold, exemplified by unsubstituted <b>4a</b>, may be oxidatively metabolized to quinone-type reactive metabolites. For this reason, we have invested substantial efforts in developing analogs of 1,4-bis-sulfonamide <b>4a</b> and its bis-acid analog <b>4b</b> that have electron-poor heterocyclic cores but that afford a similar display of substituents. Recently, we disclosed an isoquinoline-based inhibitor <b>5a</b> that possessed an improved safety profile over the previously known naphthalene-based inhibitors <b>4</b>;<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> however, isoquinoline <b>5a</b> was rather hydrophilic and, at physiological pH, possessed two negatively charged carboxylate groups, which may limit its membrane permeability. The work in this report describes modifications to isoquinoline <b>5a</b> to impart more desirable physicochemical properties while maintaining potency and metabolic stability.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81818" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81818" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our investigation began with a brief survey of sulfonamides to determine whether 4-methoxybenzenesulfonamide was a suitable substitution for further modification. Symmetrically substituted isoquinoline bis-sulfonamides <b>5b</b> and <b>5c</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) were obtained through our previously reported procedure starting with 1-hydroxyisoquinoline.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Synthesis of unsymmetrically substituted isoquinolines <b>5d</b> and <b>5e</b> called for the development of a new synthetic procedure in which 4-aminoisoquinoline (<b>8</b>) was sulfonylated, Boc-protected, and oxidized with <i>m-</i>chloroperoxybenzoic acid (<i>m</i>CPBA) to the isoquinoline-<i>N</i>-oxides <b>9a</b> and <b>9b</b>. The <i>N</i>-oxides underwent a hypervalent iodine-mediated formal [3 + 3] addition with the appropriate sulfonamide to provide unsymmetrically substituted isoquinoline bis-sulfonamides <b>10d</b> and <b>10e</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> From these intermediates, <b>5d</b> and <b>5e</b> were easily accessed, and these compounds were analyzed in a fluorescence anisotropy (FA) assay.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Compound <b>5a</b> maintained the highest binding affinity among the series of analogs (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and was selected for further optimization.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/medium/jm9b01074_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 1,4-Substituted Isoquinolines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01074&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) 4-methoxybenzenesulfonyl chloride, pyridine, rt, 1 h; (b) Boc<sub>2</sub>O, <i>N</i>,<i>N</i>-dimethylaminopyridine, MeCN, rt, 2 h; (c) <i>m</i>CPBA, CHCl<sub>3</sub>, rt, 24 h; (d) 4-methoxybenzenesulfonamide or 4-fluorobenzenesulfonamide, PPh<sub>3</sub>, PhI(OAc)<sub>2</sub>, MeCN, 80 °C, 1 h; (e) CF<sub>3</sub>CO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 2 h; (f) BrCH<sub>2</sub>CO<sub>2</sub>Et, K<sub>2</sub>CO<sub>3</sub>, Me<sub>2</sub>NCHO, rt, 48 h; (g) 15% NaOH, MeOH, rt, 4 h; (h) alkyl-X or alkyl-OTf, K<sub>2</sub>CO<sub>3</sub>, Me<sub>2</sub>NCHO or MeCN, rt, 18–48 h.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub>, logD<sub>7.4</sub>, and Metabolic <i>t</i><sub>1/2</sub> of Isoquinoline NRF2 Activators</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/medium/jm9b01074_0005.gif" alt="" id="gr5" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="(" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">R<sup>4</sup></th><th class="colsep0 rowsep0" align="center" char="(">IC<sub>50</sub>,<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> nM (95% CI)</th><th class="colsep0 rowsep0" align="center" char=".">logD<sub>7.4</sub><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a> (min)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="(">63<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a> (54–82)</td><td class="colsep0 rowsep0" align="char" char=".">–1.5</td><td class="colsep0 rowsep0" align="char" char=".">104</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="(">430 (233–566)</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="char" char="(">350 (291–380)</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="(">280 (251–352)</td><td class="colsep0 rowsep0" align="char" char=".">–1.9</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"><b>5e</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="(">240 (204–267)</td><td class="colsep0 rowsep0" align="char" char=".">–1.8</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="(">1100 (807–1343)</td><td class="colsep0 rowsep0" align="char" char=".">–0.5</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="(">230 (210–280)</td><td class="colsep0 rowsep0" align="char" char=".">–1.6</td><td class="colsep0 rowsep0" align="char" char=".">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left"><b>11c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH(CH<sub>3</sub>)COOH</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="(">2300 (1600–2500)</td><td class="colsep0 rowsep0" align="char" char=".">–1.1</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="(">1000 (770–1300)</td><td class="colsep0 rowsep0" align="char" char=".">0.0</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left"><b>13a</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="(">73 (66–91)</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">136</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left"><b>13b</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="(">130 (110–170)</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">>180</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left"><b>13c</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="(">120 (100–160)</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">>180</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left"><b>13d</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="(">420 (250–490)</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">>180</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CHF<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="(">55 (50–70)</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>F</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="(">210 (190–240)</td><td class="colsep0 rowsep0" align="char" char=".">–0.1</td><td class="colsep0 rowsep0" align="char" char=".">58</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values, shown in nM units with 95% confidence intervals, were determined by fluorescence anisotropy.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">LogD values at pH 7.4 represent the log of the partition coefficient between <i>n</i>-octanol and pH 7.4 buffer and were determined by HPLC.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Half-lives (<i>t</i><sub>1/2</sub>) in human liver microsomes in the presence of NADPH are given in minutes and were determined by LC-MS/MS.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">IC<sub>50</sub> value reported in Richardson et al.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Not determined.</p></div></div></div><div class="NLM_p">Next we set out to address the −2 charge of these bis-acid inhibitors by synthesizing monoacidic analogs of bis-acid <b>5a</b>. Small molecules possessing significant anionic character at physiological pH typically require active transport to cross cellular membranes.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Previously, we described that monoacid analogs of naphthalene <b>4</b> maintained good potency <i>in vitro</i>. Due to the reduction in symmetry in the isoquinoline core, both constitutional isomers, one where the acid is substituted off the 4-position sulfonamide (<b>11a</b>) and the other where the acid is substituted off the 1-position sulfonamide (<b>11b</b>), were needed to determine whether there was a preference for the placement of the acidic moiety relative to the isoquinoline ring nitrogen. Modifying our syntheses in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> allowed us to easily access <b>11a</b> and <b>11b</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01074/suppl_file/jm9b01074_si_001.pdf" class="ext-link">SI</a>). Comparison of these two compounds in a FA assay indicated that <b>11b</b> (IC<sub>50</sub> = 230 nM) was a more potent inhibitor of KEAP1 than <b>11a</b> (IC<sub>50</sub> = 1.1 μM). While these compounds now only had one negatively charged group, they were still rather hydrophilic, possessing logD<sub>7.4</sub> values of −1.6 and −0.5, respectively.</div><div class="NLM_p">With monoacid <b>11b</b> suggesting the 1-position as the proper site for the carboxylate group, we turned our attention to increasing the lipophilicity of these compounds. Lipophilicity is a major factor in determining the membrane permeability of small molecules.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Compounds with logP values below 1 may be resistant to crossing the amphipathic cell membrane through passive transport due to their significant water solubility.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> Due to the acidic carboxylate group that would be ionized at physiological pH, we found it fitting to measure the partition coefficient as logD<sub>7.4</sub>.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> We hypothesized that the addition of more aliphatic character (propionate <b>11c</b>) or alkylation of the free sulfonamide (<i>N</i>-methyl sulfonamide <b>12</b>) would likely increase the logD<sub>7.4</sub>. We saw a 5-fold loss of inhibitory activity with each of these modifications (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entries 8 and 9), even though methylated sulfonamide <b>12</b> showed an increase in the logD<sub>7.4</sub> to 0.0. Furthermore, it appeared that compounds of structure <b>12</b> were less metabolically stable than their bis-acid analogs.</div><div class="NLM_p">To address the issues of potency, lipophilicity, and metabolic stability, we sought to replace the carboxylate in <b>5a</b> with an electron-withdrawing yet lipophilic moiety. We installed small variably fluorinated alkyl chains, such as 2,2,2-trifluoroethyl <b>13a</b>, 2,2-difluoroethyl <b>14</b>, and 2-fluoroethyl <b>15</b>. While all of these fluoroalkyl compounds showed nanomolar potency in the FA assay, <b>13a</b> showed the greatest lipophilicity with a logD<sub>7.4</sub> of 0.5 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 6). Gratifyingly, <b>13a</b> also showed a significant improvement in metabolic stability compared to <b>11b</b>. In an attempt to further increase the lipophilicity and metabolic stability of these inhibitors, we replaced one or both of the <i>p</i>-methoxybenzenesulfonamides with <i>p</i>-fluorobenzenesulfonamides, yielding compounds <b>13b</b>, <b>13c</b>, and <b>13d</b> (entries 11–13, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). These compounds were found to be much more metabolically stable than <b>13a</b>, each possessing a <i>t</i><sub>1/2</sub> > 180 min; however, there were negligible gains in lipophilicity and a slight decrease in binding affinity associated with these modifications.</div><div class="NLM_p">We obtained a crystal structure of <b>13a</b> bound to the Kelch domain of KEAP1 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). We previously reported<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> a docking experiment with monoacidic 1,4-diamoninaphthalene-based inhibitors, in which we hypothesized that the carboxylate would bind near R483 of the Kelch domain pocket, rather than near R380. Interestingly, we observe in the crystal structure that the carboxylate of <b>13a</b> interacts with R380, N414, and R415. The sulfonamide oxygens engage S508, S555, and S602 through hydrogen bonding. The distances from the pendant phenyl rings to Y334 and Y525 are 4.99 and 5.66 Å, respectively. These distances are outside the range typically seen for π-stacking interactions.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/medium/jm9b01074_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UF0">6UF0</a>) of compound <b>13a</b> bound to human Keap1 Kelch domain. (A, B) Interactions of <b>13a</b> (orange) with the NRF-2 binding site of Keap1 (cyan ribbon). Polar interactions within 3 Å are denoted by dashed lines in panel A. An <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density omit map, with <b>13a</b> removed from map calculations, is shown as blue mesh and contoured at 2.7σ in panel B. (C) Superposition of Keap1 structures bound to <b>13a</b> (cyan) and compound <b>7</b> from pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FNU">5FNU</a> (wheat).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01074&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Lastly, we determined the ability of these compounds to activate NRF2 in cultured keratinocytes. An inhibitor of the KEAP1/NRF2 interaction should lead to increased NRF2 protein levels, and this has been demonstrated by us and others.<a onclick="showRef(event, 'ref21 ref22 ref28'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref28">(21,22,28)</a> To assess this, we measured the protein levels of NRF2 by Western blot in keratinocytes treated with compound or vehicle control (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). While <b>5a</b>, <b>11b</b>, and <b>13a</b> have similar IC<sub>50</sub> values in the fluorescence anisotropy assay, there was a notable increase in cellular levels of NRF2, which correlated with the decrease in negative charge from −2 to −1 and an increase in logD<sub>7.4</sub> of −1.5 to 0.5 (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). NQO1 expression was not substantially different among compounds <b>5a</b>, <b>11b</b>, and <b>13a</b>; however, we observed a dose-related increase in NQO1 levels when HaCaT cells were treated with increasing concentrations of <b>13a</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). These data support the hypothesis that the modifications made to <b>5a</b>, resulting in compound <b>13a</b>, enhanced cell membrane permeability and cellular activity.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/medium/jm9b01074_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) HaCaT cells were treated with vehicle control DMSO, 10 μM compound (<b>5e</b>, <b>12</b>, <b>5a</b>, <b>11b</b>, <b>11c</b>, <b>13a</b>), or positive control <b>3</b> (1 μM) for 16 h. Cell lysates were prepared, equal amounts of protein were probed with antibodies specific for NRF2 or NQO1. Actin was used as a reference. Image was cropped at the dotted line to remove an unrelated compound. See the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01074/suppl_file/jm9b01074_si_001.pdf" class="ext-link">Supporting Information</a> for the uncropped images. NRF2 and NQO1 band intensities were quantified using NIH ImageJ software and were normalized to that of the respective actin band intensity. The normalized values of NRF2 and NQO1 of DMSO-treated samples were taken as one unit. The fold increase in NRF2 and NQO1 expression of two independent sets is presented relative to DMSO controls independently or combined. (B) HaCaT cells were treated with DMSO, 0.1, 1, or 10 μM <b>13a</b>, or 250 nM <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01074&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Quantification of Western Blot Data in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">DMSO</th><th class="colsep0 rowsep0" align="center"><b>5c</b></th><th class="colsep0 rowsep0" align="center"><b>12</b></th><th class="colsep0 rowsep0" align="center"><b>5a</b></th><th class="colsep0 rowsep0" align="center"><b>11b</b></th><th class="colsep0 rowsep0" align="center"><b>11c</b></th><th class="colsep0 rowsep0" align="center"><b>13a</b></th><th class="colsep0 rowsep0" align="center"><b>3</b> (1 μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">fold change NRF2</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1.60</td><td class="colsep0 rowsep0" align="left">1.46</td><td class="colsep0 rowsep0" align="left">2.88</td><td class="colsep0 rowsep0" align="left">3.77</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">7.30</td><td class="colsep0 rowsep0" align="left">8.93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">fold change NQO1</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1.06</td><td class="colsep0 rowsep0" align="left">1.27</td><td class="colsep0 rowsep0" align="left">1.62</td><td class="colsep0 rowsep0" align="left">1.61</td><td class="colsep0 rowsep0" align="left">1.18</td><td class="colsep0 rowsep0" align="left">1.60</td><td class="colsep0 rowsep0" align="left">1.31</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Data represent the average fold change, relative to DMSO control, of two biological replicates for immunoblots for NRF2 and NQO1 (see <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). Bardoxolone methyl (<b>3</b>) was used as positive control. β-actin was used as loading control.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Quantification of Western Blot Data in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">DMSO</th><th class="colsep0 rowsep0" align="center"><b>3</b> (0.25 μM)</th><th class="colsep0 rowsep0" align="center"><b>13a</b> (0.1 μM)</th><th class="colsep0 rowsep0" align="center"><b>13a</b> (1.0 μM)</th><th class="colsep0 rowsep0" align="center"><b>13a</b> (10 μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">fold change NRF2</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">3.34</td><td class="colsep0 rowsep0" align="left">1.19</td><td class="colsep0 rowsep0" align="left">2.02</td><td class="colsep0 rowsep0" align="left">3.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">fold change NQO1</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1.43</td><td class="colsep0 rowsep0" align="left">1.15</td><td class="colsep0 rowsep0" align="left">1.36</td><td class="colsep0 rowsep0" align="left">1.59</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Data represent the average fold change, relative to DMSO control, of two biological replicates for immunoblots for NRF2 and NQO1 (see <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). HaCaT cells were treated with 0.1, 1.0, or 10 μM <b>13a</b> for 14 h (see <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). Bardoxolone methyl (<b>3</b>) was used as positive control. β-actin was used as loading control.</p></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45836" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45836" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this report, we have described monoacidic inhibitors of the KEAP1/NRF2 interaction. The molecules are potent and have high metabolic stability, which is an important consideration because of the mechanistically undesirable NRF2 activation that may arise by reaction of reactive metabolites with sensor cysteines on KEAP1.</div><div class="NLM_p">You and co-workers first described diacidic naphthalene <b>4b</b>, which showed good in vitro activity.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Diacid <b>4b</b> was designed so that the carboxylic acids made contact with two subpockets present where NRF2’s ETGE motif binds to KEAP1. We previously developed diacid isoquinoline <b>5a</b>, but we wanted to reduce the number of negative charges, as a way to increase cellular potency of NRF2 activators. Our studies reveal that monoacidic NRF2 activators based on the isoquinoline scaffold can be developed. There is a slight preference for the negatively charged group to be placed at the 1-position of the isoquinoline, rather than the 4-position. Our studies also demonstrate that a fluoroalkyl group can be placed at the 4-position to increase lipophilicity, enhance cellular potency, and reduce metabolic liabilities.</div><div class="NLM_p">The trends seen with the fluoroalkyl analogs in the metabolic studies follow a logical progression and can be readily explained. First, stability in human liver microsomes increases as more electronegative atoms are installed at the 4-position (i.e., CH<sub>2</sub>CF<sub>3</sub> > CH<sub>2</sub>CHF<sub>2</sub> ≈ CH<sub>2</sub>CO<sub>2</sub>H > CH<sub>2</sub>CH<sub>2</sub>F > H > CH<sub>3</sub>). Additionally, the CH<sub>2</sub>CF<sub>3</sub> group also shows increased lipophilicity, which may account for increased cell permeability. Second, converting either or both of the <i>para</i>-methoxy groups to <i>para</i>-fluoro groups shuts down metabolism altogether, implying O-dealkylation as a contributor to the metabolic profile. The <i>p</i>-methoxy groups may provide an attractive position for installing a metabolic soft spot if it is necessary to redirect metabolism away from a reactive metabolite. Third, converting the <i>para</i>-methoxy groups to <i>para-</i>hydroxy groups provides an opportunity for conjugative metabolism and causes rapid loss of the parent.</div><div class="NLM_p">The crystal structure of isoquinoline <b>13a</b>, which is also known as PRL-295, adds much to our understanding of the binding surface of the Kelch domain. It is instructive to first consider the binding of GSK compound <b>7</b> to the Kelch domain. In addition to interactions with S555, Q530, and Y525, GSK compound <b>7</b> engages R483 and S508 though the carboxylate moiety (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>c). These same interactions are not apparent in the structure of <b>13a</b>. Rather, the carboxylate binds on the opposite side of the binding pocket, relative to the carboxylate of compound <b>7</b>. The carboxylate of isoquinoline <b>13a</b> forms hydrogen bonds with the side chains of R415, R380, and N414. To accommodate these new interactions, two amino acids move: R415 and R380 shift substantially between the structures of <b>7</b> and <b>13a</b>. Another observation from the structure is that the trifluoroethyl group of <b>13a</b> occupies a hydrophobic pocket made up of residues I461, F478, and G462. This hydrophobic pocket might dictate the orientation of isoquinoline <b>13a</b> in the binding pocket. Overall, the structure of <b>13a</b> suggests there is significant plasticity in the Kelch domain binding site, which can give rise to different small molecule-binding orientations.</div><div class="NLM_p last">In conclusion, we have addressed molecular properties that support the ability of 2,2,2-trifluoroethyl monoacid isoquinoline <b>13a</b> to cross cellular membranes while maintaining potency and metabolic stability. Specifically, we decreased the negative charge of bis-acid isoquinoline <b>5a</b> at physiological pH and increased the overall lipophilicity through the incorporation of a 2,2,2-trifluoroethyl group as a replacement for a carboxymethyl group. This modification led to the synthesis of a collection of molecules, which will be used in lead optimization for the treatment of diabetic wounds and other chronic inflammatory diseases.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44266" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44266" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Considerations</h3><div class="NLM_p last">All starting materials and solvents were purchased from Sigma-Aldrich, Acros Organics, Fischer Scientific, ArkPharm, TCI America, or Matrix Scientific and used without further purification. Reactions were run without taking precautions to exclude air or moisture, unless otherwise noted. Compound <b>5a</b> was synthesized as previously reported.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> 4-Methoxybenzenesulfonamide and 4-fluorobenzenesulfonamide were synthesized from the corresponding sulfonyl chlorides according to reported procedures.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> Compound identities were confirmed by <sup>1</sup>H and <sup>13</sup>C nuclear magnetic resonance (NMR) spectroscopy and high resolution mass spectrometry (HRMS). <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker 400 MHz or Bruker 900 MHz spectrometer using the corresponding residual solvent peak (CDCl<sub>3</sub>, <sup>1</sup>H δ = 7.26 and <sup>13</sup>C δ = 77.2; CD<sub>3</sub>COCD<sub>3</sub>, <sup>1</sup>H δ = 2.05 and <sup>13</sup>C δ = 29.2; CD<sub>3</sub>OD, <sup>1</sup>H δ = 3.31 and <sup>13</sup>C = 49.2; CD<sub>3</sub>CN, <sup>1</sup>H δ = 1.96 and <sup>13</sup>C δ = 118.3; DMSO-<i>d</i><sub>6</sub>, <sup>1</sup>H δ = 2.50 and <sup>13</sup>C δ = 39.5) as an internal standard. HRMS spectra were recorded on a Shimadzu LCMS-IT-TOF, and the molecular weight of the compounds was within 0.05% of calculated values. Purity of each of the final, tested compounds was determined by HPLC on a Shimadzu LC-20AB (Solvent system: gradient from 30% MeCN/70% H<sub>2</sub>O to 95% MeCN/5% H<sub>2</sub>O (+0.1% formic acid) over 13 min. Column: Shimadzu C<sub>18</sub>, 50 μm, 50 mm × 4.6 mm). Purity of each compound was ≥95% (UV, 254 nm) unless otherwise noted. Flash chromatography was performed using silica gel (230–400 mesh). Reactions were monitored by thin-layer chromatography (TLC) on silica gel GHLF plates (250 μm, Macherey–Nagel, Inc., Bethlehem, PA).</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 2,2′-(Isoquinoline-1,4-diylbis(((4-fluorophenyl)sulfonyl)azanediyl))diacetic Acid (<b>5b</b>)</h3><div class="NLM_p last">Diethyl 2,2′-(isoquinoline-1,4-diylbis(((4-fluorophenyl)sulfonyl)azanediyl))diacetate (<b>16</b>) (0.072 g, 0.11 mmol, 1 equiv) was added to a flask and dissolved in THF (0.5 mL). NaOH, 15% in H<sub>2</sub>O (w/w) (0.05 mL), was added, and the reaction mixture was stirred at room temperature for 18 h. Upon completion, the mixture was diluted with H<sub>2</sub>O (10 mL), and the pH was adjusted to 4 using HCl (2 N). The aqueous mixture was extracted with EtOAc (3 × 10 mL), and the organic extract was washed with brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated. The crude product was purified using a C18 semipreparative HPLC column (CH<sub>3</sub>CN/H<sub>2</sub>O with 0.1% formic acid; 0–17.5 min, 50% CH<sub>3</sub>CN; 17.5–19.5 min, 50–95% CH<sub>3</sub>CN; 19.5–26.5 min, 95% CH<sub>3</sub>CN; 26.5–29 min, 95–50% CH<sub>3</sub>CN; 29–36 min, 50% CH<sub>3</sub>CN). The combined fractions were concentrated to remove CH<sub>3</sub>CN and frozen. The product was then subjected to lyophilization to yield 0.016 g (25% yield) of <b>5b</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>CN) δ 8.71 (d, <i>J</i> = 8.4 Hz, 1H), 8.18 (d, <i>J</i> = 8.4 Hz, 1H), 7.95–7.73 (m, 5H), 7.67 (dd, <i>J</i> = 8.8, 5.1 Hz, 2H), 7.30 (q, <i>J</i> = 8.6 Hz, 4H), 4.70–4.43 (m, 4H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>CN) δ 169.2, 168.4, 165.6 (d, <i>J</i> = 253.8 Hz, 1 C), 165.6 (d, <i>J</i> = 253.5 Hz), 152.4, 142.0, 137.1, 134.4, 132.7, 132.4, 131.7, 131.4 (d, <i>J</i> = 9.7 Hz), 130.9 (d, <i>J</i> = 9.5 Hz), 128.6, 128.1, 127.8, 123.0, 116.4 (d, <i>J</i> = 22.7 Hz), 116.3 (d, <i>J</i> = 23.3 Hz), 52.6, 51.2 HRMS-ESI (+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>19</sub>F<sub>2</sub>N<sub>3</sub>O<sub>8</sub>S<sub>2</sub>, 592.060; found, 592.0659.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 2,2′-(Isoquinoline-1,4-diylbis(((4-hydroxyphenyl)sulfonyl)azanediyl))diacetic Acid (<b>5c</b>)</h3><div class="NLM_p last">A solution of diethyl 2,2′-(isoquinoline-1,4-diylbis(((4-methoxyphenyl)sulfonyl)azanediyl))diacetate<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (0.100 g, 0.148 mmol, 1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL) was stirred at −78 °C for 0.5 h. BBr<sub>3</sub>, 1 M in CH<sub>2</sub>Cl<sub>2</sub> (1.0 mL), was added dropwise to the flask. The reaction mixture was allowed to warm to room temperature and was stirred for 24 h. EtOH (5 mL) was added to quench the reaction, and the reaction mixture was diluted with EtOAc (10 mL) and washed with H<sub>2</sub>O (20 mL) and brine (20 mL). The crude mixture was purified by semipreparative HPLC column: 0–35 min, 30% CH<sub>3</sub>CN; 35–36 min, 30–95% CH<sub>3</sub>CN; 36–43 min, 95% CH<sub>3</sub>CN; 43–45 min, 95–30% CH<sub>3</sub>CN; 45–50 min, 30% CH<sub>3</sub>CN). The combined fractions were concentrated to remove CH<sub>3</sub>CN and frozen. The product was then subjected to lyophilization to yield 0.030 g (24% yield) of (<b>5c</b>) as a white powder. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.78 (d, <i>J</i> = 8.7 Hz, 1 H), 8.11 (d, <i>J</i> = 8.7 Hz, 1 H), 8.00–7.92 (m, 1 H), 7.83–7.72 (m, 1 H), 7.73–7.67 (m, 1 H), 7.61–7.51 (m, 2 H), 7.45–7.34 (m, 2 H), 6.99–6.85 (m, 4 H), 4.63–4.50 (m, 1 H), 4.49–4.40 (m, 2 H), 4.38–4.28 (m, 1 H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.2, 169.5, 162.5, 162.4, 152.6, 141.4, 137.3, 132.6, 131.2, 131.0, 130.5, 128.7, 128.2, 127.7, 126.0, 123.8, 116.0, 116.0, 114.3. HRMS-ESI (+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>21</sub>N<sub>3</sub>O<sub>10</sub>S<sub>2</sub>, 588.0747; found, 588.0742.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> <i>N</i>-(1-((<i>N</i>-(Carboxymethyl)-4-fluorophenyl)sulfonamido)isoquinolin-4-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycine (<b>5d</b>)</h3><div class="NLM_p last">In a 20 mL screw-cap vial, ethyl <i>N</i>-(1-((<i>N</i>-(2-ethoxy-2-oxoethyl)-4-fluorophenyl)sulfonamido)isoquinolin-4-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (<b>17</b>) (0.025 mg, 0.037 mmol) was dissolved in tetrahydrofuran (1.0 mL), and 15% NaOH in H<sub>2</sub>O (w/w) (0.20 mL) was added. The reaction was stirred at room temperature for 2 h. Upon completion, as judged by TLC, the reaction was diluted with H<sub>2</sub>O (10 mL). The solution was adjusted to pH 4 with 2 N HCl, and a white precipitate formed. The suspension was extracted with EtOAc (3 × 10 mL). The combined organic extracts were washed with H<sub>2</sub>O (2 × 15 mL) and brine (2 × 15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to yield an off-white solid. The crude product was purified by semipreparative HPLC (C18; CH<sub>3</sub>CN/H<sub>2</sub>O with 1% formic acid: 0–18.5 min, 50% CH<sub>3</sub>CN; 18.5–20.5 min, 50–95% CH<sub>3</sub>CN; 20.5–27.5 min, 95% CH<sub>3</sub>CN; 27.5–30 min, 95–50% CH<sub>3</sub>CN; 30–37 min, 50% CH<sub>3</sub>CN). The combined fractions were concentrated to remove CH<sub>3</sub>CN and frozen. The product was then subjected to lyophilization to yield 12 mg (54% yield) of <b>5d</b> as an off-white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>CN) δ 8.75–8.64 (m, 1H), 8.30–8.18 (m, 1H), 7.90–7.83 (m, 1H), 7.79 (s, 2H), 7.72–7.59 (m, 4H), 7.31 (s, 2H), 7.05 (d, <i>J</i> = 9.0 Hz, 2H), 4.48 (s, 4H), 3.90 (s, 3H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>CN) δ 169.3, 168.5, 165.6 (d, <i>J</i> = 253.4 Hz), 163.7, 152.2, 141.8, 137.3, 132.8, 132.7 (d, <i>J</i> = 2.7 Hz), 131.5, 131.4 (d, <i>J</i> = 9.8 Hz), 130.1, 129.5, 128.5, 128.0, 127.7, 123.3, 116.2 (d, <i>J</i> = 23.0 Hz), 114.3, 55.6, 52.6, 51.3; HRMS-ESI (+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>9</sub>S<sub>2</sub>, 604.0860; found, 604.0855.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>N</i>-(4-((<i>N</i>-(Carboxymethyl)-4-fluorophenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycine (<b>5e</b>)</h3><div class="NLM_p last">In a 4 mL screw-cap vial, 4-fluoro-<i>N</i>-(1-((4-methoxyphenyl)sulfonamide)isoquinolin-4-yl)benzenesulfonamide (<b>18</b>) (45 mg, 0.092 mmol) and potassium carbonate (30 mg, 0.22 mmol) were placed, and dimethylformamide (0.75 mL) was added. Ethyl bromoacetate (30 μL, 0.27 mmol) was added to the stirred suspension, and the resulting mixture was allowed to stir for 72 h. Upon complete consumption of starting material, as determined by LC-MS, the reaction was diluted with EtOAc (10 mL), washed with H<sub>2</sub>O (20 mL) and brine (20 mL) and dried over Na<sub>2</sub>SO<sub>4.</sub> Solvent was removed under reduced pressure to yield 44 mg (73% yield) of a yellow solid. The isolated intermediate, ethyl <i>N</i>-(4-((<i>N</i>-2(-ethoxy-2-oxoethyl)-4-fluorophenyl)sulfonamide)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (44 mg, 0.066 mmol), was placed in a 20 mL screw-cap vial and dissolved in tetrahydrofuran (2 mL), and 15% NaOH in H<sub>2</sub>O (w/w) (0.35 mL) was added. The reaction was stirred at room temperature for 2 h. The reaction was diluted with H<sub>2</sub>O (10 mL). The solution was adjusted to pH 4 with 2 N HCl, and a white precipitate formed. The suspension was extracted with EtOAc (3 × 10 mL). The combined organic extracts were washed with H<sub>2</sub>O (2 × 15 mL) and brine (2 × 15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to yield an off-white solid. The crude product was purified by semipreparative HPLC (C18; CH<sub>3</sub>CN/H<sub>2</sub>O with 1% formic acid: 0–18.5 min, 47% CH<sub>3</sub>CN; 18.5–20.5 min, 47–95% CH<sub>3</sub>CN; 20.5–27.5 min, 95% CH<sub>3</sub>CN; 27.5–30 min, 95–47% CH<sub>3</sub>CN; 30–37 min, 47% CH<sub>3</sub>CN). The combined fractions were concentrated to remove CH<sub>3</sub>CN and frozen. The product was then subjected to lyophilization to yield 12 mg (30% yield) of <b>5e</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.74–8.64 (m, 1H), 8.23–8.10 (m, 1H), 7.86 (s, 2H), 7.78 (d, <i>J</i> = 3.9 Hz, 3H), 7.53 (d, <i>J</i> = 9.0 Hz, 2H), 7.29 (s, 2H), 7.06 (d, <i>J</i> = 8.9 Hz, 2H), 4.65–4.53 (m, 1H), 4.45 (d, <i>J</i> = 6.4 Hz, 3H), 3.92 (s, 3H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>CN) δ 169.3, 168.7, 165.5 (d, <i>J</i> = 252.0 Hz), 163.8, 152.7, 141.9, 137.0, 134.4 (d, <i>J</i> = 3.0 Hz), 132.2, 131.6, 130.9 (d, <i>J</i> = 9.8 Hz), 130.6, 128.7, 128.0, 127.9, 127.8, 122.9, 116.3 (d, <i>J</i> = 22.0 Hz), 114.2, 55.6, 52.7, 51.1. HRMS-ESI (+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>9</sub>S<sub>2</sub>, 604.0860; found, 604.0855.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Procedure for the Synthesis of Intermediates <b>9a</b> and <b>9b</b></h3><div class="NLM_p">The appropriate compound, either <b>19a</b> or <b>19b</b> (1 equiv, 4.8 mmol), was dissolved in chloroform (15 mL), and a solution of <i>m</i>CPBA (4 equiv, 3.33 g, 19.3 mmol) in 45 mL of chloroform was added dropwise. After the addition was complete, the reaction was stirred at room temperature for 18 h. NaOH (25 mL of 1 N) was added to the reaction and stirred for 10 min. The layers were separated, and the organic layer was washed again with 1 N NaOH (25 mL), dried over MgSO<sub>4</sub>, and concentrated under reduced pressure to yield an off-white solid. The crude product was purified by column chromatography (silica gel; MeOH/EtOAc 0:100 to 10:90). Pure fractions were combined to yield isoquinoline <i>N</i>-oxide <b>9a</b> or <b>9b</b> as an off-white solid.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 4-((<i>N</i>-(<i>tert</i>-Butoxycarbonyl)-4-methoxyphenyl)sulfonamido)isoquinoline 2-Oxide (<b>9a</b>)</h4><div class="NLM_p last">Off-white solid; yield 78% (1.63 g, 3.8 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.84 (s, 1H), 8.13–8.10 (m, 1H), 8.07–7.96 (m, 2H), 7.85 (dd, <i>J</i> = 6.1, 3.4 Hz, 1H), 7.81–7.75 (m, 1H), 7.71–7.63 (m, 2H), 7.08–7.00 (m, 2H), 3.91 (s, 3H), 1.29 (s, 9H).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 4-((<i>N</i>-<i>tert</i>-Butoxylcarbonyl)-4-fluorophenyl)sulfonamide)isoquinoline 2-Oxide (<b>9b</b>)</h4><div class="NLM_p last">Off-white solid; yield 70% (0.363 g, 0.87 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.86 (s, 1H), 8.19–8.11 (m, 3H), 7.88–7.79 (m, 2H), 7.76–7.65 (m, 2H), 7.31 (dd, <i>J</i> = 8.9, 8.2 Hz, 2H), 1.32 (s, 9H).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure for the Synthesis of Intermediates <b>10a</b>–<b>c</b></h3><div class="NLM_p">Compound <b>9a</b> or <b>9b</b> (1 equiv, 1.16 mmol), the appropriate sulfonamide (2 equiv, 2.3 mmol), diacetoxy iodobenzene (2 equiv, 2.3 mmol), and triphenylphosphine (2 equiv, 2.3 mmol) were placed in a flame-dried single-necked round-bottom flask. The flask was purged with argon, and acetonitrile (2.3 mL) was added. The resulting suspension was heated to 80 °C. After 18 h, the flask was removed from heat and allowed to cool to room temperature. H<sub>2</sub>O (20 mL) was added to the flask, and the mixture was extracted with EtOAc (2 × 25 mL). The combined organic layers were washed with brine (25 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>. Solvent was removed under reduced pressure to yield an orange oil. The crude material was purified by column chromatography (silica gel; EtOAc/Hexanes 0:100 to 50:50), which yielded a mixture of the product and residual sulfonamide. Pure product was obtained by a second column (silica gel; EtOAc/DCM 0:100 to 10:90) to yield <b>10a</b>–<b>c</b> as off-white solids.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>tert</i>-Butyl (1-((4-methoxyphenyl)sulfonamido)isoquinolin-4-yl)((4-methoxyphenyl)sulfonyl)carbamate (<b>10a</b>)</h4><div class="NLM_p last">Off-white solid; yield 37% (0.26 g, 0.43 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.06 (d, <i>J</i> = 6.1 Hz, 1H), 8.60 (d, <i>J</i> = 7.6 Hz, 1H), 8.04–7.99 (m, 2H), 7.99–7.93 (m, 2H), 7.75 (ddd, <i>J</i> = 8.2, 7.1, 1.3 Hz, 1H), 7.56 (ddd, <i>J</i> = 8.2, 7.2, 1.2 Hz, 1H), 7.51 (d, <i>J</i> = 8.1 Hz, 1H), 7.38 (d, <i>J</i> = 6.1 Hz, 1H), 7.05–7.00 (m, 2H), 7.00–6.95 (m, 2H), 3.92 (s, 3H), 3.85 (s, 3H), 1.33 (s, 9H).</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>tert</i>-Butyl (1-((4-fluorophenyl)sulfonamido)isoquinolin-4-yl)((4-methoxyphenyl)sulfonyl)carbamate (<b>10b</b>)</h4><div class="NLM_p last">Off-white solid; yield 54% (0.190 g, 0.32 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.04–11.91 (m, 1H), 8.59 (d, <i>J</i> = 8.3 Hz, 1H), 8.13–8.03 (m, 2H), 7.97 (d, <i>J</i> = 8.8 Hz, 2H), 7.81–7.72 (m, 1H), 7.60 (t, <i>J</i> = 7.7 Hz, 1H), 7.47 (d, <i>J</i> = 8.2 Hz, 1H), 7.30 (br. s., 1H), 7.21 (q, <i>J</i> = 8.5 Hz, 2H), 7.05 (d, <i>J</i> = 9.0 Hz, 2H), 3.95 (s, 3H), 1.36 (s, 9H).</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>tert</i>-Butyl ((4-fluorophenyl)sulfonyl)(1-((4-methoxyphenyl)sulfonamide)isoquinolin-4-yl)carbamate (<b>10c</b>)</h4><div class="NLM_p last">Off-white solid; yield 50% (0.135 g, 0.23 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.09–11.91 (m, 1H), 8.60 (d, <i>J</i> = 8.4 Hz, 1H), 8.11–8.05 (m, 2H), 8.04–7.97 (m, 2H), 7.77–7.69 (m, 1H), 7.59 (d, <i>J</i> = 7.3 Hz, 1H), 7.36 (d, <i>J</i> = 8.0 Hz, 1H), 7.28–7.22 (m, 3H), 7.05–6.96 (m, 2H), 3.88 (s, 3H), 1.35 (s, 9H).</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure for the Synthesis of Compounds <b>11a</b>–<b>c</b>, <b>12</b>, <b>13a</b>, <b>14</b>, and <b>15</b></h3><div class="NLM_p">In a 20 mL screw-cap vial, the appropriate ester <b>20a</b>–<b>20c</b>, <b>21</b>, <b>22a</b>, <b>24</b>, or <b>25</b> (0.10 mmol) was dissolved in methanol (2 mL), and 15% aqueous NaOH (0.25 mL) was added. The reaction was stirred at room temperature for 4 h. Upon completion, the methanol was removed under reduced pressure, and the residual liquid was diluted with H<sub>2</sub>O (10 mL). The solution was adjusted to pH 4 with 2 N HCl, and a white precipitate formed. The suspension was extracted with EtOAc (3 × 10 mL), washed with H<sub>2</sub>O (2 × 15 mL) and brine (2 × 15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to yield an off-white solid.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-(1-((4-Methoxyphenyl)sulfonamido)isoquinolin-4-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycine (<b>11a</b>)</h4><div class="NLM_p last">The crude product was purified by HPLC (C18; CH<sub>3</sub>CN/H<sub>2</sub>O 60%:40%, isocratic) to yield <b>11a</b> as an off-white solid. Yield 55% (31 mg, 0.056 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.88 (br. s., 1H), 11.89 (br. s., 1H), 8.35 (d, <i>J</i> = 7.8 Hz, 1H), 7.92 (d, <i>J</i> = 8.6 Hz, 2H), 7.82–7.73 (m, 1H), 7.69 (d, <i>J</i> = 8.1 Hz, 3H), 7.60 (t, <i>J</i> = 7.7 Hz, 1H), 7.46 (br. s., 1H), 7.08 (d, <i>J</i> = 8.8 Hz, 4H), 4.52 (d, <i>J</i> = 18.1 Hz, 1H), 4.21 (d, <i>J</i> = 17.6 Hz, 1H), 3.86 (s, 3H), 3.82 (s, 3H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.6, 163.3, 162.4, 151.8, 136.1, 135.1, 134.0, 131.9, 130.4, 130.2, 128.7, 128.4, 127.5, 124.9, 123.3, 121.1, 114.9, 114.6, 56.2, 56.0, 52.6. HRMS-ESI (+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>23</sub>N<sub>3</sub>O<sub>8</sub>S<sub>2</sub>, 558.0999; found, 558.1006.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-(4-((4-Methoxyphenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycine (<b>11b</b>)</h4><div class="NLM_p last">The crude product was purified by HPLC (C18; CH<sub>3</sub>CN/H<sub>2</sub>O 60%:40%, isocratic) to yield <b>11b</b> as an off-white solid. Yield 80% (38 mg, 0.068 mmol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.61–8.53 (m, 1H), 8.04 (s, 1H), 7.94–7.83 (m, 1H), 7.77–7.64 (m, 4H), 7.60–7.48 (m, 3H), 7.00–6.93 (m, 2H), 6.92–6.85 (m, 2H), 4.47 (br. s., 2H), 3.89 (s, 3H), 3.82 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.0, 164.0, 163.6, 150.2, 134.2, 133.7, 132.4, 130.5, 129.9, 129.5, 129.1, 128.9, 127.9, 127.9, 120.9, 114.5, 114.5, 55.7, 52.3. HRMS-ESI (+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>23</sub>N<sub>3</sub>O<sub>8</sub>S<sub>2</sub>, 558.0960; found, 558.1011.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>-(4-((4-Methoxyphenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)alanine (<b>11c</b>)</h4><div class="NLM_p last">Crude product was purified by HPLC (C18; CH<sub>3</sub>CN/H<sub>2</sub>O 60%:40%, isocratic) to yield <b>11c</b> as a white solid. Yield 70% (2.4 mg, 0.0042 mmol). <sup>1</sup>H NMR (900 MHz, CDCl<sub>3</sub>) δ 8.53 (d, <i>J</i> = 8.23 Hz, 1H), 8.15 (br. s., 1H), 8.04 (dd, <i>J</i> = 8.78, 2.20 Hz, 1H), 7.91 (t, <i>J</i> = 7.68 Hz, 1H), 7.84 (t, <i>J</i> = 7.41 Hz, 1H), 7.77 (d, <i>J</i> = 8.78 Hz, 2H), 7.57 (d, <i>J</i> = 8.23 Hz, 2H), 6.98 (d, <i>J</i> = 8.23 Hz, 2H), 6.94 (d, <i>J</i> = 8.78 Hz, 2H), 5.12 (q, <i>J</i> = 7.32 Hz, 1H), 3.90 (s, 3H), 3.85 (s, 3H), 1.16 (d, <i>J</i> = 7.68 Hz, 3H); <sup>13</sup>C NMR (226 MHz, CDCl<sub>3</sub>) δ 172.3, 164.1, 163.8, 147.7, 133.7, 133.2, 132.5, 130.4, 130.0, 129.8, 129.7, 129.7, 129.6, 128.2, 128.0, 121.1, 114.6, 114.6, 59.3, 55.7, 55.7, 16.8. HRMS-ESI (+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>25</sub>N<sub>3</sub>O<sub>8</sub>S<sub>2</sub>, 572.1117; found, 572.1216. HPLC Purity: 93.3%.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-(4-((4-Methoxy-<i>N</i>-methylphenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycine (<b>12</b>)</h4><div class="NLM_p last">The crude product was purified by HPLC (C18; CH<sub>3</sub>CN/H<sub>2</sub>O 60%:40%, isocratic) to yield <b>12</b> as an off-white solid. Yield 52% (7 mg, 0.012 mmol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.57 (d, <i>J</i> = 8.1 Hz, 1H), 8.24 (d, <i>J</i> = 8.3 Hz, 1H), 7.9 (ddd, <i>J</i> = 8.4, 6.9, 1.3 Hz, 1H), 7.85–7.78 (m, 1H), 7.74–7.66 (m, 3H), 7.65–7.58 (m, 2H), 7.13–6.91 (m, 4H), 4.40–4.63 (m, 2H), 3.91 (s, 3H), 3.89 (s, 3H), 3.33 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 169.5, 164.0, 163.6, 152.1, 138.0, 137.8, 135.9, 133.0, 130.5, 130.1, 129.4, 128.4, 128.4, 128.3, 127.6, 123.4, 114.5, 55.7, 55.7, 52.7, 39.7. HRMS-ESI (+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>25</sub>N<sub>3</sub>O<sub>8</sub>S<sub>2</sub>, 572.1117; found, 572.1142.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-(4-((4-Methoxy-<i>N</i>-(2,2,2-trifluoroethyl)phenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycine (<b>13a</b>)</h4><div class="NLM_p last">The crude product was purified by HPLC (C18; MeCN/H<sub>2</sub>O 60:40 to 75:25) to yield <b>13a</b> as an off-white solid. Yield 81% (21 mg, 0.033 mmol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.70 (d, <i>J</i> = 8.3 Hz, 1H), 8.01–7.96 (m, 1H), 7.92–7.86 (m, 1H), 7.86–7.78 (m, 1H), 7.75 (s, 1H), 7.68–7.58 (m, 2H), 7.55–7.45 (m, 2H), 7.01–6.90 (m, 4H), 4.63–4.42 (m, 3H), 4.36–4.21 (m, 1H), 3.90 (s, 6H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.3, 164.0, 163.9, 153.0, 140.8, 137.2, 133.1, 132.6, 130.5, 130.1, 129.2, 129.1, 128.6, 128.4, 127.8, 122.4 (q, <i>J</i> = 272 Hz), 123.7, 55.8, 55.7, 52.2 (q, <i>J</i> = 39.6 Hz), 52.4. HRMS-ESI (+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>27</sub>H<sub>24</sub>F<sub>3</sub>N<sub>3</sub>O<sub>8</sub>S<sub>2</sub>, 640.0990; found, 640.1037.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-((4-Fluorophenyl)sulfonyl)-<i>N</i>-(4-((4-methoxy-<i>N</i>-(2,2,2-trifluoroethyl)phenyl)sulfonamido)isoquinolin-1-yl)glycine (<b>13b</b>)</h4><div class="NLM_p last">In a 20 mL screw-cap vial, ethyl <i>N</i>-((4-fluorophenyl)sulfonyl)-<i>N</i>-(4-((4-methoxy-<i>N</i>-(2,2,2-trifluoroethyl)phenyl)sulfonamido)isoquinolin-1-yl)glycinate (<b>22b</b>) (44 mg, 0.067 mmol) was dissolved in tetrahydrofuran (1.5 mL), and 15% NaOH in H<sub>2</sub>O (w/w) (0.35 mL) was added. The reaction was stirred at room temperature for 6 h. Upon completion, as judged by TLC, the reaction was diluted with H<sub>2</sub>O (10 mL). The solution was adjusted to pH 4 with 2 N HCl, and a white precipitate formed. The suspension was extracted with EtOAc (3 × 10 mL). The combined organic extracts were washed with H<sub>2</sub>O (2 × 15 mL) and brine (2 × 15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to yield an off-white solid. The crude product was purified by semipreparative HPLC (C18; CH<sub>3</sub>CN/H<sub>2</sub>O with 1% formic acid: 0–18.5 min, 60% CH<sub>3</sub>CN; 18.5–20.5 min, 60–95% CH<sub>3</sub>CN; 20.5—27.5 min, 95% CH<sub>3</sub>CN; 27.5–30 min, 95–60% CH<sub>3</sub>CN; 30–37 min, 60% CH<sub>3</sub>CN). The combined fractions were concentrated to remove CH<sub>3</sub>CN and frozen. The product was then subjected to lyophilization to yield 10 mg (23% yield) of <b>13b</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>CN) δ 8.74 (d, <i>J</i> = 8.4 Hz, 1H), 8.11 (d, <i>J</i> = 8.4 Hz, 1H), 7.91 (t, <i>J</i> = 7.6 Hz, 1H), 7.86–7.77 (m, 1H), 7.68–7.56 (m, 5H), 7.32 (t, <i>J</i> = 8.7 Hz, 2H), 7.07 (d, <i>J</i> = 8.9 Hz, 2H), 4.74–4.57 (m, 1H), 4.49 (d, <i>J</i> = 2.7 Hz, 2H), 4.40–4.23 (m, 1H), 3.91 (s, 3H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>CN) δ 168.4, 165.6 (d, <i>J</i> = 252.0 Hz), 164.1, 152.6, 141.4, 137.2, 132.5 (d, <i>J</i> = 2.9 Hz, 132.4, 132.0, 131.4 (d, <i>J</i> = 8.8 Hz), 130.3, 128.6, 128.35, 128.2, 128.0, 124.2 (d, <i>J</i> = 279.0 Hz), 122.7, 116.3 (d, <i>J</i> = 22.0 Hz), 114.6, 55.7, 52.6 (q, <i>J</i> = 33.0 Hz), 51.2. HRMS-ESI (+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>21</sub>F<sub>4</sub>N<sub>3</sub>O<sub>7</sub>S<sub>2</sub>, 628.07835; found, 628.0833.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-(4-((4-Fluoro-<i>N</i>-(2,2,2-trifluoroethyl)phenyl)sulfonamide)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycine (<b>13c</b>)</h4><div class="NLM_p last">In a 4 mL screw-cap vial, ethyl <i>N</i>-(4-((4-fluorophenyl)sulfonamide)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (<b>23</b>) (40 mg, 0.069 mmol) and potassium carbonate (12 mg, 0.083 mmol) were dissolved in DMF (1 mL), and 2,2,2-trifluoroethyl trifluoromethanesulfonate (13 μL, 0.082 mmol) was added. The reaction was stirred overnight. The reaction was diluted with H<sub>2</sub>O and extracted with EtOAc (3 × 7 mL). The combined organic layers were washed with H<sub>2</sub>O (2 × 20 mL) and brine (20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to afford 35 mg (79% yield) of a white solid that did not require further purification. In a 20 mL screw-cap vial, ethyl <i>N</i>-(4-((4-fluoro-<i>N</i>-(2,2,2-trifluoroethyl)phenyl)sulfonamide)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (<b>22c</b>) (35 mg, 0.053 mmol) was dissolved in tetrahydrofuran (2 mL), and 15% NaOH in H<sub>2</sub>O (w/w) (0.35 mL) was added. The reaction was stirred at room temperature for 5 h. Upon completion, as judged by TLC, the reaction was diluted with H<sub>2</sub>O (10 mL). The solution was adjusted to pH 4 with 2 N HCl acid, and a white precipitate formed. The suspension was extracted with EtOAc (3 × 10 mL). The combined organic extracts were washed with H<sub>2</sub>O (2 × 15 mL) and brine (2 × 15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to yield an off-white solid. The crude product was purified by semipreparative HPLC (C18; CH<sub>3</sub>CN/H<sub>2</sub>O with 1% formic acid: 0–18.5 min, 60% CH<sub>3</sub>CN; 18.5–20.5 min, 60–95% CH<sub>3</sub>CN; 20.5–27.5 min, 95% CH<sub>3</sub>CN; 27.5–30 min, 95–60% CH<sub>3</sub>CN; 30—37 min, 60% CH<sub>3</sub>CN). The combined fractions were concentrated to remove CH<sub>3</sub>CN and frozen. The product was then subjected to lyophilization to yield 15 mg (35% yield) of <b>13c</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.75 (d, <i>J</i> = 8.4 Hz, 1H), 8.05 (s, 1H), 7.94–7.87 (m, 1H), 7.87–7.80 (m, 1H), 7.76 (dd, <i>J</i> = 8.8, 5.0 Hz, 2H), 7.67 (s, 1H), 7.52 (d, <i>J</i> = 8.9 Hz, 2H), 7.32 (t, <i>J</i> = 8.8 Hz, 2H), 7.07 (d, <i>J</i> = 8.9 Hz, 2H), 4.74–4.59; <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>CN) δ 168.6, 165.8 (d, <i>J</i> = 252.0 Hz), 163.8, 153.3, 141.5, 136.8, 133.2 (d, <i>J</i> = 2.9 Hz), 132.0, 131.7, 131.1 (d, <i>J</i> = 10.3 Hz,), 130.6, 128.7, 128.3, 128.1, 127.7, 124.1 (d, <i>J</i> = 277.0 Hz), 122.4, 116.7 (d, <i>J</i> = 24.0 Hz), 114.2, 55.6, 52.6 (q, <i>J</i> = 33.3 Hz), 51.1. HRMS-ESI (+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>21</sub>F<sub>4</sub>N<sub>3</sub>O<sub>7</sub>S<sub>2</sub>, 628.0835; found, 628.0833.</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>N</i>-(4-((4-Fluoro-<i>N</i>-(2,2,2-trifluoroethyl)phenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-fluorophenyl)sulfonyl)glycine (<b>13d</b>)</h4><div class="NLM_p last">In a 4 mL screw-cap vial, ethyl <i>N</i>-(4-((4-fluoro-<i>N</i>-(2,2,2-trifluoroethyl)phenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-fluorophenyl)sulfonyl)glycinate (<b>22d</b>) (0.014 mg, 0.021 mmol) was dissolved in tetrahydrofuran (0.5 mL), and 15% NaOH in H<sub>2</sub>O (w/w) (0.20 mL) was added. The reaction was stirred at room temperature for 6 h. Upon completion, as judged by TLC, the reaction was diluted with H<sub>2</sub>O (10 mL). The solution was adjusted to pH 4 with 2 N HCl, and a white precipitate formed. The precipitate was filtered and dissolved in CH<sub>2</sub>Cl<sub>2</sub> (5 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to yield a yellow solid. The crude product was purified by semipreparative HPLC: 0–18.5 min, 60% CH<sub>3</sub>CN; 18.5–20.5 min, 60–95% CH<sub>3</sub>CN; 20.5–27.5 min, 95% CH<sub>3</sub>CN; 27.5–30 min, 95–60% CH<sub>3</sub>CN; 30–37 min, 60% CH<sub>3</sub>CN). The combined fractions were concentrated to remove CH<sub>3</sub>CN and frozen. The product was then subjected to lyophilization to yield 6 mg (46% yield) of <b>13d</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>CN) δ 8.83–8.69 (m, 1H), 8.10–7.99 (m, 1H), 7.95–7.86 (m, 1H), 7.86–7.78 (m, 1H), 7.75 (dd, <i>J</i> = 8.9, 5.0 Hz, 2H), 7.69–7.60 (m, 3H), 7.31 (td, <i>J</i> = 8.8, 5.6 Hz, 5H), 4.73–4.58 (m, 1H), 4.43 (d, <i>J</i> = 1.2 Hz, 2H), 4.41–4.30 (m, 1H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>CN) δ 169.1, 165.8 (d, <i>J</i> = 253.0 Hz), 165.6 (d, <i>J</i> = 252.0 Hz), 153.22, 141.5, 136.8, 133.2 (d, <i>J</i> = 3.0 Hz), 132.7 (d, <i>J</i> = 3.0 Hz), 131.9, 131.8, 131.4 (d, <i>J</i> = 9.8 Hz), 131.1 (d, <i>J</i> = 9.8 Hz), 128.8, 128.3, 128.1, 124.1 (d, <i>J</i> = 278.0 Hz), 122.3, 116.6 (d, <i>J</i> = 23.0 Hz), 116.2 (d, <i>J</i> = 23.0 Hz), 52.6 (q, <i>J</i> = 34.0 Hz), 51.7. HRMS-ESI (+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>18</sub>F<sub>5</sub>N<sub>3</sub>O<sub>6</sub>S<sub>2</sub>, 616.0635; found, 616.0630.</div></div><div id="sec4_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-(4-((4-Methoxy-<i>N</i>-(2,2-difluoroethyl)phenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycine (<b>14</b>)</h4><div class="NLM_p last">The crude product was purified by HPLC (C18; MeCN/H<sub>2</sub>O + 0.1% formic acid 60:40 to 75:25) to yield <b>14</b> as an off-white solid. Yield 59% (10.2 mg, 0.016 mmol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.66 (d, <i>J</i> = 8.1 Hz, 1H), 7.91–7.76 (m, 4H), 7.61 (d, <i>J</i> = 9.1 Hz, 2H), 7.54 (d, <i>J</i> = 9.1 Hz, 2H), 6.97 (d, <i>J</i> = 8.8 Hz, 4H), 6.09 (tt, <i>J</i> = 56, 4.0 Hz, 1H), 4.52 (br. s., 2H), 3.99 (dt, <i>J</i> = 13, 4.4 Hz, 2H), 3.89 (s, 6H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 169.9, 164.0, 163.9, 152.7, 140.5, 137.3, 130.5, 130.0, 129.1, 128.9, 128.5, 128.2, 127.9, 122.5, 114.1, 114.4, 114.6, 55.8, 55.7, 54.0, 52.4. HRMS-ESI (+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>27</sub>H<sub>26</sub>F<sub>2</sub>N<sub>3</sub>O<sub>8</sub>S<sub>2</sub>, 622.1129; found, 622.1132.</div></div><div id="sec4_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-(4-((<i>N</i>-(2-Fluoroethyl)-4-methoxyphenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycine (<b>15</b>)</h4><div class="NLM_p last">The crude product was purified by HPLC (C18; CH<sub>3</sub>CN/H<sub>2</sub>O + 0.1% formic acid 60:40 to 75:25) to yield <b>15</b> as an off-white solid. Yield 38% (3.8 mg, 0.0063 mmol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.62 (d, <i>J</i> = 7.8 Hz, 1H), 8.11 (d, <i>J</i> = 8.3 Hz, 1H), 7.93–7.86 (m, 1H), 7.86–7.80 (m, 1H), 7.77 (s, 1H), 7.69–7.63 (m, 2H), 7.62–7.54 (m, 2H), 7.02–6.94 (m, 4H), 4.64–4.45 (m, 4H), 4.16–3.92 (m, 2H), 3.90 (s, 6H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 169.1, 164.0, 163.6, 152.5, 139.7, 138.4, 133.8, 133.2, 130.5, 129.9, 129.6, 129.4, 128.4, 128.1, 127.9, 123.1, 114.5, 81.5 (d, <i>J</i> = 172 Hz), 55.7, 55.7, 52.7, 52.5 (d, <i>J</i> = 22 Hz). HRMS-ESI (+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>27</sub>H<sub>27</sub>FN<sub>3</sub>O<sub>8</sub>S<sub>2</sub>, 604.1223; found, 604.1224.</div></div></div><div id="sec4_4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Diethyl 2,2′-(Isoquinoline-1,4-diylbis(((4-fluorophenyl)sulfonyl)azanediyl))diacetate (<b>16</b>)</h3><div class="NLM_p last"><i>N</i>,<i>N</i>′-(Isoquinoline-1,4-diyl)bis(4-fluorobenzenesulfonamide) (<b>26</b>), K<sub>2</sub>CO<sub>3</sub> (0.11 g, 0.85 mmol), and 18-crown-6 ether (0.019 g, 0.074 mmol) were added to a flask. DMF (1.5 mL) was added, and the mixture was stirred at room temperature for 0.5 h. Ethyl bromoacetate (0.13 mL, 1.18 mmol) was added, and the mixture was stirred for 24 h at room temperature. The mixture was diluted with EtOAc (40 mL), washed with H<sub>2</sub>O (30 mL) and brine (30 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated to yield a crude product, which was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) and purified by column chromatography (silica gel; EtOAc/Hexanes, 10:90 to 100:0). The fractions were combined and concentrated <i>in vacuo</i> to yield 0.077 g (32% yield) of <b>16</b> as a tan solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.90–8.77 (m, 1H), 8.07 (s, 1H), 8.00–7.86 (m, 1H), 7.86–7.73 (m, 4H), 7.73–7.58 (m, 2H), 7.26–7.09 (m, 4H), 4.80 (d, <i>J</i> = 18 Hz, 1H), 4.49 (d, <i>J</i> = 2.7 Hz, 2H), 4.29–3.94 (m, 5H), 1.24 (t, <i>J</i> = 7.2 Hz, 3H), 1.11 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Ethyl <i>N</i>-(1-((<i>N</i>-(2-Ethoxy-2-oxoethyl)-4-fluorophenyl)sulfonamido)isoquinolin-4-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (<b>17</b>)</h3><div class="NLM_p last">In a 4 mL screw-cap vial, 4-fluoro-<i>N</i>-(4-((4-methoxyphenyl)sulfonamido)isoquinolin-1-yl)benzenesulfonamide (<b>27</b>) (19 mg, 0.038 mmol), potassium carbonate (12 mg, 0.090 mmol), and 18-crown-6 ether (6 mg, 0.023 mmol) were placed, and dimethylformamide (0.50 mL) was added. Ethyl bromoacetate (12 μL, 0.10 mmol) was added to the stirred suspension, and the resulting mixture was allowed to stir for 48 h. Upon complete consumption of starting material, as determined by LC-MS, the reaction was diluted with EtOAc (10 mL), washed with H<sub>2</sub>O (20 mL) and brine (20 mL), and dried over Na<sub>2</sub>SO<sub>4.</sub> Solvent was removed under reduced pressure to yield 25 mg (99% yield) of a yellow solid, <b>17</b>. The product did not require further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.90–8.76 (m, 1H), 8.08–7.98 (m, 2H), 7.84–7.74 (m, 2H), 7.72–7.66 (m, 2H), 7.66–7.58 (m, 2H), 7.24–7.13 (m, 2H), 7.00–6.91 (m, 2H), 4.79–4.65 (m, 1H), 4.49 (d, <i>J</i> = 6.5 Hz, 2H), 4.29 (d, <i>J</i> = 16.3 Hz, 1H), 4.15 (dd, <i>J</i> = 7.1, 5.4 Hz, 2H), 4.06 (qd, <i>J</i> = 7.1, 1.7 Hz, 2H), 3.90 (s, 3H).</div></div><div id="sec4_4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4-Fluoro-<i>N</i>-(1-((4-methoxyphenyl)sulfonamide)isoquinolin-4-yl)benzenesulfonamide (<b>18</b>)</h3><div class="NLM_p last">In a 20 mL screw-cap vial, <i>tert</i>-butyl ((4-fluorophenyl)sulfonyl)(1-((4-methoxyphenyl)sulfonamide)isoquinolin-4-yl)carbamate (<b>10c</b>) (65 mg, 0.11 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (2 mL), and the resulting solution was cooled to 0–5 °C in an ice/water bath. Once cooled, trifluoroacetic acid (0.3 mL, 0.022 mmol) was added to the isoquinoline solution, and the reaction was allowed to slowly warm to room temperature. After 4 h, the reaction was quenched with sat. aq. NaHCO<sub>3</sub> (4 mL), and the resulting mixture was allowed to stir for 30 min. The layers were separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (6 mL). The combined organics were washed with brine (5 mL) and dried over Na<sub>2</sub>SO<sub>4</sub> to yield 45 mg (85%) of <b>18</b> as a light yellow solid. The product did not require further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.57 (br. s., 1H), 8.37 (d, <i>J</i> = 8.1 Hz, 1H), 7.97–7.91 (m, 3H), 7.81 (dd, <i>J</i> = 8.8, 5.0 Hz, 2H), 7.65–7.52 (m, 2H), 7.48–7.38 (m, 1H), 7.14–7.02 (m, 3H), 6.97 (d, <i>J</i> = 8.9 Hz, 2H).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> General Procedure for the Synthesis of Intermediates <b>19a</b> and <b>19b</b></h3><div class="NLM_p">In a single-necked flask, <b>28a</b> or <b>28b</b> (1 equiv, 7.79 mmol) and DMAP (0.1 equiv, 0.78 mmol) were dissolved in CH<sub>3</sub>CN (105 mL). A solution of Boc<sub>2</sub>O (1.5 equiv, 11.9 mmol) in CH<sub>3</sub>CN (20 mL) was added in one portion, and the resulting mixture was stirred at room temperature for 2 h. The reaction mixture was concentrated under reduced pressure to give an orange oil (<b>19a</b>) or a yellow oil (<b>19b</b>).</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>tert</i>-Butyl Isoquinolin-4-yl((4-methoxyphenyl)sulfonyl)carbamate (<b>19a</b>)</h4><div class="NLM_p last">The crude product mixture was purified by column chromatography (silica gel; EtOAc/Hexanes 0:100 to 50:50). Pure fractions were combined to yield <b>19a</b> as a yellow solid. Yield 66% (2.14 g, 5.16 mmol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.28 (s, 1H), 8.39 (s, 1H), 8.06–7.99 (m, 3H), 7.90 (d, <i>J</i> = 8.31 Hz, 1H), 7.78 (t, <i>J</i> = 7.70 Hz, 1H), 7.66 (t, <i>J</i> = 7.70 Hz, 1H), 7.03 (d, <i>J</i> = 9.05 Hz, 2H), 3.91 (s, 3H), 1.28 (s, 9H).</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>tert</i>-Butyl ((4-Fluorophenyl)sulfonyl)(isoquinolin-4-yl)carbamate (<b>19b</b>)</h4><div class="NLM_p last">The crude product mixture was purified by column chromatography (silica gel; EtOAc/Hexanes 0:100 to 65:35). Pure fractions were combined to yield <b>19b</b> as a yellow solid. Yield 90% (0.720 g, 1.79 mmol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.32 (s, 1H), 8.41 (s, 1H), 8.20–8.11 (m, 2H), 8.09 (d, <i>J</i> = 8.1 Hz, 1H), 7.94–7.85 (m, 1H), 7.82 (dd, <i>J</i> = 6.8, 1.2 Hz, 1H), 7.71 (dd, <i>J</i> = 8.1, 1.0 Hz, 1H), 7.29 (t, <i>J</i> = 8.6 Hz, 2H), 1.30 (s, 9H).</div></div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Ethyl <i>N</i>-(1-((4-Methoxyphenyl)sulfonamido)isoquinolin-4-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (<b>20a</b>)</h3><div class="NLM_p last">In a 4 mL screw-cap vial, <i>N</i>,<i>N</i>′-(isoquinoline-1,4-diyl)bis(4-methoxybenzenesulfonamide)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (200 mg, 0.40 mmol) and K<sub>2</sub>CO<sub>3</sub> (66 mg, 0.48 mmol) were dissolved in DMF and cooled to 0 °C, and ethyl bromoacetate (48 μL, 0.44 mmol) was added to the cold solution. The reaction was stirred for 6 h, maintaining a temperature of 0–5 °C the entire time. After 6 h, the reaction was diluted with H<sub>2</sub>O and extracted with ethyl acetate (3 × 10 mL). The combined organic fractions were washed with H<sub>2</sub>O (2 × 20 mL) and brine (2 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to yield an orange oil. The crude product was purified by column chromatography (silica gel; EtOAc/Hexanes, 0:100 to 40:60) to afford 59.6 mg (25% yield) of <b>20a</b> as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.73 (d, <i>J</i> = 6.1 Hz, 1H), 8.55 (d, <i>J</i> = 8.1 Hz, 1H), 7.99–7.93 (m, 2H), 7.78–7.72 (m, 4H), 7.55 (ddd, <i>J</i> = 8.3, 6.4, 1.7 Hz, 1H), 7.22 (d, <i>J</i> = 6.1 Hz, 1H), 7.01–6.94 (m, 4H), 4.86 (d, <i>J</i> = 18.1 Hz, 1H), 4.22–4.11 (m, 2H), 4.04 (d, <i>J</i> = 18.1 Hz, 1H), 3.92 (s, 3H), 3.87 (s, 3H), 1.25 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Ethyl <i>N</i>-(4-((4-Methoxyphenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (20b)</h3><div class="NLM_p last">In a 20 mL screw-cap vial, ethyl <i>N</i>-(4-((N-(<i>tert</i>-butoxycarbonyl)-4-methoxyphenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (<b>29a</b>) (75 mg, 0.11 mmol) was dissolved in dichloromethane (3 mL), and the resulting solution was cooled to 0–5 °C in an ice/water bath. Once cooled, trifluoroacetic acid (0.50 mL, 6.5 mmol) was added to the isoquinoline solution, and the reaction was allowed to slowly warm to room temperature. After 4 h, the reaction was quenched with sat. aq. NaHCO<sub>3</sub> (3 mL), and the resulting mixture was allowed to stir for 30 min. The layers were separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (5 mL). The combined organics were washed with brine (5 mL) and dried over MgSO<sub>4</sub> to yield 62 mg (97%) of <b>20b</b> as a light yellow solid. The product did not require further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.81–8.76 (m, 3H), 8.04 (s, 1H), 7.95–7.86 (m, 1H), 7.76–7.61 (m, 4H), 7.53–7.39 (m, 3H), 6.97–6.91 (m, 2H), 6.88–6.83 (m, 2H), 4.45 (s, 2H), 3.99 (q, <i>J</i> = 7.09 Hz, 2H), 3.88 (s, 3H), 3.85–3.70 (m, 3H), 1.03 (t, <i>J</i> = 7.09 Hz, 3H).</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Ethyl <i>N</i>-(4-((4-Methoxyphenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)alaninate (<b>20c</b>)</h3><div class="NLM_p last">In a 20 mL screw-cap vial, ethyl <i>N</i>-(4-((<i>N</i>-(<i>tert</i>-butoxycarbonyl)-4-methoxyphenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)alaninate (<b>29b</b>) (13 mg, 0.019 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL). The resulting solution was cooled to 0–5 °C in an ice/water bath. Once cooled, trifluoroacetic acid (0.25 mL, 3.3 mmol) was added to the isoquinoline solution, and the reaction was allowed to slowly warm to room temperature. After 2 h, the reaction was quenched with sat. aq. NaHCO<sub>3</sub> (3 mL), and the resulting mixture was stirred for 30 min. The layers were separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (5 mL). The combined organics were washed with brine (5 mL) and dried over MgSO<sub>4</sub> to yield a brown residue. The crude product was purified by column chromatography (silica gel; EtOAc/hexanes, 0/100 to 30/70) to give 3.6 mg (32% yield) of <b>20c</b> as a light brown residue. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.74 (br. s., 1H), 8.11 (s, 1H), 7.91–7.84 (m, 1H), 7.77–7.61 (m, 6H), 6.96 (d, <i>J</i> = 9.05 Hz, 2H), 6.90–6.81 (m, 3H), 4.63 (d, <i>J</i> = 7.34 Hz, 1H), 4.10 (br. s., 2H), 3.90 (s, 3H), 3.81 (s, 3H), 1.27–0.98 (m, 6H).</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Ethyl <i>N</i>-(4-((4-Methoxy-<i>N</i>-methylphenyl)sulfonamido)isoquinolin-1-yl)-N-((4-methoxyphenyl)sulfonyl)glycinate (<b>21</b>)</h3><div class="NLM_p last">In a screw-cap vial, ethyl <i>N</i>-(4-((4-methoxyphenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (<b>20b</b>) (18.5 mg, 0.032 mmol) and potassium carbonate (6.5 mg, 0.05 mmol) were dissolved in CH<sub>3</sub>CN (0.2 mL), and iodomethane (2.94 μL, 0.05 mmol) was added. The reaction was stirred overnight. The reaction was diluted with ethyl acetate and filtered through a short pad of Celite. The filtrate was concentrated under reduced pressure to yield a yellow oil. The crude product was purified by column chromatography (silica gel; EtOAc/Hexanes, 0:100 to 30:70) afford 14 mg (74%) of <b>21</b> an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.86–8.79 (m, 1H), 8.13–8.07 (m, 1H), 7.84–7.73 (m, 2H), 7.70–7.63 (m, 3H), 7.57–7.50 (m, 2H), 7.02–6.93 (m, 4H), 4.48 (br. s., 2H), 4.04 (q, <i>J</i> = 7.09 Hz, 2H), 3.90 (s, 3H), 3.89 (s, 3H), 3.32 (s, 3H), 1.07 (t, <i>J</i> = 7.09 Hz, 3H).</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Ethyl <i>N</i>-(4-((4-Methoxy-<i>N</i>-(2,2,2-trifluoroethyl)phenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (<b>22a</b>)</h3><div class="NLM_p last">In a 4 mL screw-cap vial, ethyl <i>N</i>-(4-((4-methoxyphenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (<b>20b</b>) (30 mg, 0.051 mmol) and potassium carbonate (28.4 mg, 0.21 mmol) were dissolved in DMF, and 2,2,2-trifluoroethyl trifluoromethanesulfonate (27 μL, 0.18 mmol) was added. The reaction was stirred overnight. The reaction was diluted with water and extracted with ethyl acetate (3 × 10 mL). The combined organics were washed with water (2 × 20 mL) and brine (2 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to yield an orange oil. The crude product was purified by column chromatography (silica gel; EtOAc/Hexanes, 0:100 to 30:70) to afford 27.3 mg (80% yield) of <b>22a</b> as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.90–8.83 (m, 1H), 7.87–7.81 (m, 1H), 7.81–7.72 (m, 3H), 7.63–7.57 (m, 2H), 7.48–7.41 (m, 2H), 6.97–6.89 (m, 4H), 4.58–4.45 (m, 3H), 4.29–4.16 (m, 1H), 4.03 (q, <i>J</i> = 7.2 Hz, 2H), 3.88 (d, <i>J</i> = 5.1 Hz, 6H), 1.04 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Ethyl <i>N</i>-((4-Fluorophenyl)sulfonyl)-<i>N</i>-(4-((4-methoxy-<i>N</i>-(2,2,2-trifluoroethyl)phenyl)sulfonamido)isoquinolin-1-yl)glycinate (<b>22b</b>)</h3><div class="NLM_p last">In a 4 mL screw-cap vial, ethyl <i>N</i>-((4-fluorophenyl)sulfonyl)-<i>N</i>-(4-((4-methoxyphenyl)sulfonamido)isoquinolin-1-yl)glycinate (<b>30</b>) (60 mg, 0.10 mmol) and potassium carbonate (17 mg, 0.12 mmol) were dissolved in DMF (0.5 mL), and 2,2,2-trifluoroethyl trifluoromethanesulfonate (23 μL, 0.15 mmol) was added. The reaction was stirred overnight. The reaction was diluted with H<sub>2</sub>O and extracted with EtOAc (3 × 10 mL). The combined organics were washed with H<sub>2</sub>O (2 × 20 mL) and brine (20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to afford 47 mg (69% yield) of white solid <b>22b</b> that did not require further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.86 (dd, <i>J</i> = 7.0, 2.2 Hz, 1H), 7.91–7.86 (m, 1H), 7.81 (tt, <i>J</i> = 7.3, 5.1 Hz, 2H), 7.75 (s, 1H), 7.63 (d, <i>J</i> = 8.9 Hz, 2H), 7.59–7.46 (m, 2H), 7.18 (t, <i>J</i> = 8.5 Hz, 2H), 6.95 (d, <i>J</i> = 8.9 Hz, 2H), 4.62–4.44 (m, 3H), 4.25 (dd, <i>J</i> = 15.7, 8.3 Hz, 2H), 4.06 (q, <i>J</i> = 7.1 Hz, 2H), 3.90 (s, 3H), 1.07 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Ethyl <i>N</i>-(4-((4-Fluoro-<i>N</i>-(2,2,2-trifluoroethyl)phenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-fluorophenyl)sulfonyl)glycinate (<b>22d</b>)</h3><div class="NLM_p last">In a 4 mL screw-cap vial, 4-fluoro-<i>N</i>-(1-((4-fluorophenyl)sulfonamido)isoquinolin-4-yl)-<i>N</i>-(2,2,2-trifluoroethyl)benzenesulfonamide (<b>31</b>) (37 mg, 0.063 mmol) and potassium carbonate (10 mg, 0.075 mmol) were placed, and dimethylformamide (0.75 mL) was added. Ethyl bromoacetate (17 μL, 0.11 mmol) was added to the stirred suspension, and the resulting mixture was allowed to stir for 48 h. Upon complete consumption of starting material, as determined by LC-MS, the reaction was diluted with EtOAc (10 mL), washed with H<sub>2</sub>O (20 mL) and brine (20 mL), and dried over Na<sub>2</sub>SO<sub>4.</sub> Solvent was removed under reduced pressure to yield a crude product, which was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (0.8 mL) and purified by column chromatography (silica gel; EtOAc/Hexanes, 0:100 to 60:40). The fractions were combined and concentrated <i>in vacuo</i> to yield 0.014 g (35% yield) of <b>22d</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.92–8.83 (m, 1H), 7.87–7.76 (m, 4H), 7.75–7.68 (m, 2H), 7.62–7.49 (m, 2H), 7.18 (t, <i>J</i> = 8.5 Hz, 4H), 4.69–4.56 (m, 1H), 4.55–4.47 (m, 2H), 4.29–4.14 (m, 1H), 4.07 (q, <i>J</i> = 7.1 Hz, 2H), 1.09 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Ethyl <i>N</i>-(4-((4-Fluorophenyl)sulfonamide)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (<b>23</b>)</h3><div class="NLM_p last">In a 20 mL screw-cap vial, ethyl <i>N</i>-(4-((<i>N</i>-<i>tert</i>-butoxycarbonyl)-4-fluorophenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (<b>32</b>) (45 mg, 0.074 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (2 mL), and the resulting solution was cooled to 0–5 °C in an ice/water bath. Once cooled, trifluoroacetic acid (0.10 mL, 1.4 mmol) was added to the isoquinoline solution, and the reaction was allowed to slowly warm to room temperature. After 4 h, the reaction was quenched with sat. aq. NaHCO<sub>3</sub> (3 mL), and the resulting mixture was allowed to stir for 30 min. The layers were separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (5 mL). The combined organics were washed with brine (5 mL) and dried over Na<sub>2</sub>SO<sub>4</sub> to yield 42 mg (99%) of <b>23</b> as a light yellow solid. The product did not require further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.85–8.75 (m, 1H), 8.03 (s, 1H), 7.86–7.73 (m, 3H), 7.72–7.63 (m, 2H), 7.52 (d, <i>J</i> = 8.8 Hz, 2H), 7.30 (s, 1H), 7.09 (t, <i>J</i> = 8.5 Hz, 2H), 6.97 (d, <i>J</i> = 8.9 Hz, 2H), 4.47 (s, 2H), 4.02 (q, <i>J</i> = 7.1 Hz, 2H), 3.91 (s, 3H), 1.06 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Ethyl <i>N</i>-(4-((4-Methoxy-<i>N</i>-(2,2-difluoroethyl)phenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (<b>24</b>)</h3><div class="NLM_p last">In a 4 mL screw-cap vial, ethyl <i>N</i>-(4-((4-methoxyphenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (<b>20b</b>) (20 mg, 0.034 mmol) and potassium carbonate (18.9 mg, 0.14 mmol) were dissolved in DMF (0.2 mL), and 2,2-difluoroethyl trifluoromethanesulfonate (16.2 μL, 0.12 mmol) was added. The reaction was stirred overnight. The reaction was diluted with H<sub>2</sub>O and extracted with ethyl acetate (3 × 10 mL). The combined organic layers were washed with H<sub>2</sub>O (2 × 20 mL) and brine (2 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to yield an orange oil. The crude product was purified by column chromatography (silica gel; EtOAc/Hexanes, 0:100 to 30:70) to afford 18 mg (81%) of <b>24</b> as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.93–8.78 (m, 1H), 7.80 (s, 1H), 7.78–7.71 (m, 3H), 7.67–7.57 (m, 2H), 7.54–7.45 (m, 2H), 7.01–6.88 (m, 4H), 6.08 (tt, <i>J</i> = 56, 4.0 Hz, 1H), 4.51 (s, 2H), 4.08–3.92 (m, 4H), 3.89 (d, <i>J</i> = 4.7 Hz, 6H), 1.06 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Ethyl <i>N</i>-(4-((4-Methoxy-<i>N</i>-(2-fluoroethyl)phenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (<b>25</b>)</h3><div class="NLM_p last">In a 4 mL screw-cap vial, ethyl <i>N</i>-(4-((4-methoxyphenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (<b>20b</b>) (20 mg, 0.034 mmol) and potassium carbonate (18.9 mg, 0.14 mmol) were dissolved in DMF, and 1-iodo-2-fluoroethane (10 μL, 0.12 mmol) was added. The reaction was stirred overnight. The reaction was diluted with H<sub>2</sub>O and extracted with ethyl acetate (3 × 10 mL). The combined organics were washed with H<sub>2</sub>O (2 × 20 mL) and brine (2 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to yield a yellow oil. The crude product was purified by column chromatography (silica gel; EtOAc/Hexanes, 0:100 to 30:70) to afford 10.5 mg (49% yield) of <b>25</b> as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.89–8.83 (m, 1H), 8.00–7.94 (m, 1H), 7.82–7.74 (m, 3H), 7.68–7.62 (m, 2H), 7.54–7.48 (m, 2H), 7.00–6.93 (m, 4H), 4.51 (d, <i>J</i> = 2.9 Hz, 2H), 4.63–4.40 (m, 2H), 4.10–3.97 (m, 4H), 3.91 (s, 3H), 3.90 (s, 3H), 1.08 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>N</i>,<i>N</i>′-(Isoquinoline-1,4-diyl)bis(4-fluorobenzenesulfonamide) (<b>26</b>)</h3><div class="NLM_p last">Compound <b>26</b> was prepared from 1,4-dibromoisoquinoline analogously to our previously reported procedure.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Pink solid; Yield 68% (0.570 g, 1.2 mmol); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.39–8.31 (m, 1H), 8.07–7.95 (m, 1H), 7.89 (dd, <i>J</i> = 8.7, 5.3 Hz, 3H), 7.81–7.66 (m, 3H), 7.64–7.55 (m, 1H), 7.49–7.29 (m, 5H), 7.22–7.13 (m, 1H).</div></div><div id="sec4_5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 4-Fluoro-<i>N</i>-(4-((4-methoxyphenyl)sulfonamido)isoquinolin-1-yl)benzenesulfonamide (<b>27</b>)</h3><div class="NLM_p last">Compound <b>27</b> was isolated as a minor product during the formation of <b>10b</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.73 (br. s., 1H), 8.51 (d, <i>J</i> = 8.3 Hz, 1H), 7.84–8.18 (m, 2H), 7.79–7.69 (m, 3H), 7.70–7.62 (m, 1H), 7.59–7.49 (m, 1H), 7.23–7.12 (m, 2H), 7.07 (s, 1H), 6.99–6.86 (m, 2H), 6.40 (br. s., 1H), 3.87 (s, 3H).</div></div><div id="sec4_5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>N</i>-(Isoquinolin-4-yl)-4-methoxybenzenesulfonamide (<b>28a</b>)</h3><div class="NLM_p last">In a single-necked round-bottom flask, isoquinoline-4-amine <b>(8)</b> (1.50 g, 10.4 mmol) and 4-methoxybenzenesulfonyl chloride (2.47 g, 11.96 mmol) were dissolved in anhydrous pyridine (18 mL) and stirred at room temperature overnight. Upon completion of the reaction, determined by TLC, the reaction was diluted with H<sub>2</sub>O (50 mL) and extracted with EtOAc (25 mL). The layers were separated, and the aqueous layer was extracted with EtOAc (2 × 25 mL). The combined organics were washed with H<sub>2</sub>O (50 mL) and brine (2 × 50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to give a brown oil. Toluene (50 mL) was added to the oil and removed under reduced pressure to yield an orange solid. The crude product was purified by recrystallization from toluene to give 2.50 g (77% yield) of <b>28a</b> as an orange solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.17 (s, 1H), 8.23 (s, 1H), 8.13 (d, <i>J</i> = 8.8 Hz, 1H), 8.03 (d, <i>J</i> = 8.1 Hz, 1H), 7.79 (ddd, <i>J</i> = 8.4, 7.0, 1.2 Hz, 1H), 7.74–7.66 (m, 3H), 6.92–6.86 (m, 2H), 3.83 (s, 3H).</div></div><div id="sec4_5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 4-Fluoro-<i>N</i>-(isoquinolin-4-yl)benzenesulfonamide (<b>28b</b>)</h3><div class="NLM_p last">In a single-necked round-bottom flask, isoquinoline-4-amine (<b>8</b>) (0.560 g, 3.88 mmol) and 4-fluorobenzenesulfonyl chloride (0.90 g, 4.65 mmol) were dissolved in anhydrous pyridine (10 mL) and stirred at room temperature overnight. Upon completion of the reaction, determined by TLC, the reaction was diluted with H<sub>2</sub>O (35 mL) and extracted with EtOAc (25 mL). The layers were separated, and the aqueous layer was extracted with EtOAc (2 × 25 mL). The combined organic layers were washed with H<sub>2</sub>O (40 mL) and brine (2 × 50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to give a brown oil. Toluene (50 mL) was added to the oil and removed under reduced pressure to yield an off-white solid. The crude product was purified by filtration and washing with CH<sub>2</sub>Cl<sub>2</sub> (20 mL) to give 0.795 g (68% yield) of <b>28b</b> as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.48 (br. s., 1H), 9.19 (s, 1H), 8.15–8.07 (m, 2H), 7.95 (d, <i>J</i> = 8.1 Hz, 1H), 7.76–7.60 (m, 4H), 7.40–7.28 (m, 2H).</div></div><div id="sec4_5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Ethyl <i>N</i>-(4-((<i>N</i>-(<i>tert</i>-Butoxycarbonyl)-4-methoxyphenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (<b>29a</b>)</h3><div class="NLM_p last">In a 4 mL screw-cap vial, <i>tert</i>-butyl (1-((4-methoxyphenyl)sulfonamido)isoquinolin-4-yl)((4-methoxyphenyl)sulfonyl)carbamate (<b>10a</b>) (100 mg, 0.17 mmol) and potassium carbonate (58 mg, 0.42 mmol) were placed, and acetonitrile (1.3 mL) was added. Ethyl bromoacetate (37 μL, 0.33 mmol) was added to the stirred suspension, and the resulting mixture was allowed to stir for 36 h. Upon complete consumption of starting material as determined by LC-MS, the reaction was diluted with EtOAc (2 mL) and filtered through a small pad of Celite, which was washed with EtOAc. The filtrate was concentrated under reduced pressure to yield an orange oil. The crude product was purified by column chromatography (silica gel; EtOAc/Hexanes 0:100 to 30:70). Pure fractions were combined and concentrated under reduced pressure to yield 75 mg (66% yield) of <b>29a</b> as a light yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.96–8.88 (m, 1H), 8.14 (s, 1H), 8.04–7.89 (m, 2H), 7.83–7.73 (m, 2H), 7.72–7.62 (m, 1H), 7.55–7.47 (m, 2H), 7.07–7.01 (m, 2H), 7.00–6.94 (m, 2H), 4.58 (s, 2H), 4.15–3.99 (m, 2H), 3.94 (s, 3H), 3.90 (s, 3H), 1.30 (s, 9H), 1.06 (t, <i>J</i> = 7.09 Hz, 3H).</div></div><div id="sec4_5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Ethyl <i>N</i>-(4-((<i>N</i>-(<i>tert</i>-Butoxycarbonyl)-4-methoxyphenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)alaninate (<b>29b</b>)</h3><div class="NLM_p last">In a 4 mL screw-cap vial, <i>tert</i>-butyl (1-((4-methoxyphenyl)sulfonamido)isoquinolin-4-yl)((4-methoxyphenyl)sulfonyl)carbamate (<b>10a</b>) (190 mg, 0.32 mmol) and potassium carbonate (66 mg, 0.47 mmol) were placed, and CH<sub>3</sub>CN (1 mL) was added. Ethyl 2-bromopropionate (123 μL, 1.11 mmol) was added to the stirred suspension, and the resulting mixture was allowed to stir for 36 h. Upon complete consumption of starting material as determined by LC-MS, the reaction was diluted with EtOAc (2 mL) and filtered through a small pad of Celite, washing with EtOAc. The filtrate was concentrated under reduced pressure to yield a yellow oil. The crude product was purified by column chromatography (silica gel; EtOAc/Hexanes 0:100 to 30:70). Pure fractions were combined and concentrated under reduced pressure to yield 12 mg (5% yield) of <b>29b</b> as a light yellow residue. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.85 (br. s., 1H), 8.23 (d, <i>J</i> = 1.2 Hz, 1H), 8.01 (dd, <i>J</i> = 8.9, 3.1 Hz, 2H), 7.81–7.65 (m, 5H), 7.04 (dd, <i>J</i> = 9.1, 2.7 Hz, 2H), 7.00–6.94 (m, 2H), 4.77–4.63 (m, 1H), 4.17 (q, <i>J</i> = 6.8 Hz, 2H), 3.95 (d, <i>J</i> = 1.2 Hz, 3H), 3.90 (s, 3H), 1.34–1.18 (m, 15H).</div></div><div id="sec4_5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Ethyl <i>N</i>-((4-Fluorophenyl)sulfonyl)-<i>N</i>-(4-((4-methoxyphenyl)sulfonamido)isoquinolin-1-yl)glycinate (<b>30</b>)</h3><div class="NLM_p last">In a 20 mL screw-cap vial, ethyl <i>N</i>-(4-((<i>N</i>-(<i>tert</i>-butoxycarbonyl)-4-methoxyphenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-fluorophenyl)sulfonyl)glycinate (<b>33</b>) (0.10 mg, 0.15 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (2 mL), and the resulting solution was cooled to 0–5 °C in an ice/water bath. Once cooled, trifluoroacetic acid (0.4 mL, 0.031 mmol) was added to the isoquinoline solution, and the reaction was allowed to slowly warm to room temperature. After 4 h, the reaction was quenched with sat. aq. NaHCO<sub>3</sub> (4 mL), and the resulting mixture was allowed to stir for 30 min. The layers were separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (10 mL). The combined organics were washed with brine (5 mL) and dried over Na<sub>2</sub>SO<sub>4</sub> to yield 84 mg (95% yield) of <b>30</b> as a light yellow solid. The product did not require further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.87–8.75 (m, 1H), 8.04 (s, 1H), 7.93–7.82 (m, 1H), 7.82–7.66 (m, 4H), 7.65–7.53 (m, 2H), 7.24–7.13 (m, 2H), 6.96–6.86 (m, 2H), 6.82 (s, 1H), 4.47 (s, 2H), 4.03 (q, <i>J</i> = 7.2 Hz, 2H), 3.85 (s, 3H), 1.08 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 4-Fluoro-<i>N</i>-(1-((4-fluorophenyl)sulfonamido)isoquinolin-4-yl)-<i>N</i>-(2,2,2-trifluoroethyl)benzenesulfonamide (<b>31</b>)</h3><div class="NLM_p last">In a 4 mL screw-cap vial, <i>N</i>,<i>N</i>′-(isoquinoline-1,4-diyl)bis(4-fluorobenzenesulfonamide) (<b>26</b>) (100 mg, 0.21 mmol) and potassium carbonate (35 mg, 0.252 mmol) were dissolved in DMF (1.0 mL), and 2,2,2-trifluoroethyl trifluoromethanesulfonate (46 μL, 0.31 mmol) was added. The reaction was stirred overnight. The reaction was diluted with H<sub>2</sub>O and extracted with EtOAc (3 × 10 mL). The combined organics were washed with H<sub>2</sub>O (2 × 20 mL) and brine (20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to afford a crude yellow oil, which was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (0.75 mL) and purified by column chromatography (silica gel; EtOAc/Hexanes, 0:100 to 50:50). The fractions were combined and concentrated <i>in vacuo</i> to yield 37 mg (31% yield) of <b>31</b> as an off-white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>CN) δ 11.62 (br. s, 1H), 8.48 (d, <i>J</i> = 8.3 Hz, 1H), 8.09–7.99 (m, 2H), 7.91–7.77 (m, 3H), 7.74–7.69 (m, 1H), 7.68–7.61 (m, 1H), 7.36–7.23 (m, 4H), 7.09–6.95 (m, 1H), 4.51–4.26 (m, 2H).</div></div><div id="sec4_5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Ethyl <i>N</i>-(4-((<i>N</i>-<i>tert</i>-Butoxycarbonyl)-4-fluorophenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-methoxyphenyl)sulfonyl)glycinate (<b>32</b>)</h3><div class="NLM_p last">In a 4 mL screw-cap vial, <i>tert</i>-butyl ((4-fluorophenyl)sulfonyl)(1-((4-methoxyphenyl)sulfonamide)isoquinolin-4-yl)carbamate (<b>10c</b>) (66 mg, 0.12 mmol) and potassium carbonate (24 mg, 0.18 mmol) were placed, and dimethylformamide (0.5 mL) was added. Ethyl bromoacetate (18.5 μL, 0.17 mmol) was added to the stirred suspension, and the resulting mixture was allowed to stir for 72 h. Upon complete consumption of starting material, as determined by LC-MS, the reaction was diluted with EtOAc (10 mL), washed with H<sub>2</sub>O (20 mL) and brine (20 mL), and dried over Na<sub>2</sub>SO<sub>4.</sub> Solvent was removed under reduced pressure to yield a yellow mixture. The crude product was purified by column chromatography (silica gel; EtOAc/Hexanes 0:100 to 50:50). Pure fractions were combined and concentrated under reduced pressure to yield 46 mg (68% yield) of <b>32</b> as a light yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.96–8.86 (m, 1H), 8.13 (s, 1H), 8.12–8.04 (m, 2H), 7.81–7.73 (m, 2H), 7.62 (dd, <i>J</i> = 6.5, 3.0 Hz, 1H), 7.53–7.43 (m, 2H), 7.33–7.25 (m, 2H), 7.00–6.90 (m, 2H), 4.58 (s, 2H), 4.04 (dd, <i>J</i> = 7.2, 4.0 Hz, 2H), 3.90 (s, 3H), 1.32–1.28 (m, 9H), 1.06 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Ethyl <i>N</i>-(4-((<i>N</i>-(<i>tert</i>-Butoxycarbonyl)-4-methoxyphenyl)sulfonamido)isoquinolin-1-yl)-<i>N</i>-((4-fluorophenyl)sulfonyl)glycinate (<b>33</b>)</h3><div class="NLM_p last">In a 4 mL screw-cap vial, <i>tert</i>-butyl (1-((4-fluorophenyl)sulfonamido)isoquinolin-4-yl)((4-methoxyphenyl)sulfonyl)carbamate (<b>10b</b>) (180 mg, 0.31 mmol) and potassium carbonate (55 mg, 0.40 mmol) were placed, and dimethylformamide (1 mL) was added. Ethyl bromoacetate (68 μL, 0.62 mmol) was added to the stirred suspension, and the resulting mixture was allowed to stir for 72 h. Upon complete consumption of starting material, as determined by LC-MS, the reaction was diluted with EtOAc (15 mL), washed with H<sub>2</sub>O (25 mL) and brine (25 mL), and dried over Na<sub>2</sub>SO<sub>4.</sub> Solvent was removed under reduced pressure to yield a yellow solid. The crude product was purified by column chromatography (silica gel; EtOAc/Hexanes 0:100 to 50:50). Pure fractions were combined and concentrated under reduced pressure to yield 155 mg (83% yield) of <b>33</b> as a light yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.95–8.82 (m, 1H), 8.13 (s, 1H), 8.05–7.94 (m, 2H), 7.85–7.75 (m, 2H), 7.74–7.66 (m, 1H), 7.62–7.53 (m, 2H), 7.19 (t, <i>J</i> = 8.5 Hz, 2H), 7.11–6.95 (m, 2H), 4.58 (s, 2H), 4.06 (dd, <i>J</i> = 7.1, 2.6 Hz, 2H), 3.95 (s, 3H), 1.38–1.29 (m, 9H), 1.08 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Metabolic Stability and Half-Life Studies</h3><div class="NLM_p">The compound working solution was prepared by diluting a 10 mM DMSO stock of the compound to 0.05 mM in DMSO/water (1:1, v/v). A potassium phosphate buffer was prepared at 100 mM (pH 7.4). A NADPH Regenerating system (Cofactor 5X) was prepared by making a solution containing NADP (1.7 mg/mL, 2.22 mM) and G6P (7.8 mg/mL, 27.6 mM) in 100 mM KPi. The resulting solution was aliquoted and stored at −20 °C. Before using, the solution was warmed to 37 °C and G6PDH (2.0 U/mL) was added before use. The Stop solution consisted of MeCN containing 100 ng/mL tolbutamide.</div><div class="NLM_p last">Human liver microsomes were thawed in a water bath (37 °C) and then kept on ice once thawed. Stop solution (200 μL) was added to each well of a 96-deep well sample collection plate. The plate was covered with a sealing mat and kept on ice. Microsome mixtures were prepared with 0.625 mg/mL of the microsomes in potassium phosphate buffer. A base plate was set up with 1.0 mL glass vials, and 7.5 μL of compound working solution was added per vial. Microsomal mixture (592.5 μL/vial) was added and mixed by pipetting. Spiked microsomal mixtures (250 μL) were transferred into two parallel sets of 1 mL glass vials (+NADPH/–NADPH). Potassium phosphate buffer (62.5 μL/vial) was added to the −NADPH vials and mixed by pipetting, and 50 μL of the resulting mixture was transferred into the <i>T</i> = 0 wells of the sample collection plate. Cofactor solution (62.5 μL/vial) was added to the +NADPH vials and mixed by pipetting, and the vials were placed into the incubator (37 °C, 5% CO<sub>2</sub>) with shaking at 200 rpm. For the +NADPH incubations, the solutions were mixed by pipetting, and 50 μL was transferred at 5, 15, 30, and 45 min into the corresponding wells of the sample collection plate. For the −NADPH incubations, the solutions were mixed by pipetting, and 50 μL was transferred at 45 min into the corresponding wells of the sample collection plate. The sample collection plate was vortexed at 1700 rpm for 3 min and centrifuged at 3500 rpm for 15 min. A new 96-deep well plate was used, and 100 μL/well of ultrapure water was added. Supernatant (100 μL/well) was taken from the sample collection plate and transferred into the corresponding wells of the final plate. The final plate was vortexed at 1700 rpm for 1 min, and the samples were analyzed by LC-MS/MS.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Cell Culture and Immunoblot Analysis</h3><div class="NLM_p last">Human keratinocytes (HaCaT cell line) were cultured in Dubecco’s modified Eagle’s medium (DMEM) with 10% FBS and 1% antibiotics. Cells at 70–80% confluence were treated with various compounds as indicated for 16 h in the presence of the complete medium. Cells were lysed in a RIPA extraction buffer (Sigma, cat. no. R0278) containing Halt Protease and Phosphatase Inhibitor cocktail (cat. no. 1861280, Thermo Scientific) and 1 mM PMSF. Protein extract (∼40 μg) was separated on a 10% SDS-PAGE and blotted onto membrane. The membrane was cut at ∼50 kD size, and the top part was probed with anti-NRF2 antibody (16396-1-AP, Proteintech, Rosemont, IL) and the bottom part with anti-NQO1 antibody (11451-1-AP, Proteintech). The bottom blot was stripped and probed with anti-actin antibody (SC-58673, Santa Cruz Biotech, CA). The blots were developed using HyGLO Chemiluminescent Antibody Detection Reagent and ChemiDoc Gel Imaging System (Bio-Rad). NRF2 and NQO1 band intensities were quantified using NIH ImageJ software and were normalized to that of the respective actin band intensity. The normalized values of NRF2 and NQO1 of DMSO-treated samples were taken as one unit. The fold increase in NRF2 and NQO1 expression of two independent sets was presented relative to DMSO controls independently or combined.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Keap1 Kelch E540A/E542A Purification and Crystallization</h3><div class="NLM_p">pET11a vector with human Keap1 Kelch domain (aa 321–609) mutant (E540A/E542A)<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> in frame with N-terminal His<sub>6</sub>-tag and TEV protease cleavage site was obtained from Genscript. The construct was transformed into BL21(DE3) cells and maintained in media containing 50 μg/mL carbenicillin. Protein expression was induced using an autoinduction protocol modified from Studier.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Briefly, 1 mL of 1 day cultures was used to inoculate a 2 L flask with 500 mL of Super LB containing 50 μg/mL carbenicillin. Cells were grown for 24 h at 20 °C and then harvested by centrifugation.</div><div class="NLM_p">All steps of Keap1 Kelch E540A/E542A purification were performed at 4 °C. Protein yield and purity at each step was monitored by Bradford assay and SDS-PAGE, respectively. Frozen cell pellets were lysed by sonication in buffer A (20 mM Tris-HCl, pH 8, 0.5 M NaCl, 8 mM imidazole) containing Roche EDTA-free protease inhibitor tablets, 10 μg/mL DNaseI, and 10 μg/mL lysozyme. The lysate was clarified by centrifugation and loaded onto a 5 mL Talon cobalt column equilibrated with buffer A. Following a 60 mL wash with buffer A, bound His<sub>6</sub>-Keap E540A/E542A protein was eluted with buffer B (20 mM Tris-HCl, pH 8.0, 0.5 M NaCl, 50 mM imidazole). Fractions containing His<sub>6</sub>-Keap E540A/E542A protein were pooled and incubated overnight with 1 mM DTT and 0.01 equiv of TEV protease at 4 °C. The cleaved His<sub>6</sub>-tag and TEV protease were removed from Keap1 Kelch E540A/E542A by diluting the sample 10-fold with 20 mM Tris-HCl, pH 8, 0.5 M NaCl, and passing the sample over a 1 mL Talon cobalt column equilibrated with buffer A. Column flow-through containing unbound Keap1 Kelch E540A/E542A was collected, concentrated, and further purified by size exclusion chromatography. Purified Keap1 E540A/E542A in 20 mM Tris-HCl, pH 7.5, 5 mM DTT, was concentrated to 10 mg/mL and used immediately for cocrystallization experiments.</div><div class="NLM_p last">Crystals of Keap1 Kelch E540A/E542A complexed with compound <b>16b</b> from a previous publication<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> were grown by hanging drop vapor diffusion at 12–16 °C. Prior to crystallization, 5–6 mg/mL Keap1 protein was incubated with 2-fold excess compound <b>16b</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> for 30 min on ice. Crystals of the complex were grown by mixing 2 μL of Keap1 E540A/E542A–compound <b>16b</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> with 0.4 μL of reservoir solution containing 3.5–3.8 M sodium formate, pH 7. Crystals grew overnight and were used to streak seed drops of Keap1 E540A/E542A–compound <b>16b</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> growing at lower saturation (1 μL of Keap1 E540A/E542A–compound <b>16b</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> mixed with 0.3–0.5 μL of reservoir solution containing 3.1–3.6 M sodium formate, pH 7.0). To complex the solvent-accessible subunit (monomer A) of the Keap1 E540A/E542A–compound <b>16b</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> asymmetric unit, crystals were soaked in a solution of mother liquor containing 2 mM <b>13a</b> for 3–4 days, leading to a crystal form containing two monomers of Keap1 Kelch E540A/E542A, with one monomer complexed to compound <b>16b</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and one monomer complexed to <b>13a</b>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Data Collection and Structure Refinement</h3><div class="NLM_p last">The high concentration of sodium formate in the crystallization solution was sufficient to cryoprotect crystals, which were flash-cooled in liquid nitrogen. Data were collected on a MAR300 detector at 0.979 Å at the Life Sciences Collaborative Access Team beamline 21-ID-F at the Advanced Photon Source, Argonne National Laboratory. Data indexing, integration, and scaling were performed using XDS,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and phases were determined by molecular replacement using Molrep<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and a Keap1 Kelch structure (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1U6D">1U6D</a>) as search model. Rigid body refinement followed by iterative rounds of restrained refinement and model building were performed with CCP4i<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> modules Refmac5<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and Coot.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The coordinates and structure factors have been deposited with PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UF0">6UF0</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01074" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66837" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66837" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b01074" class="ext-link">10.1021/acs.jmedchem.9b01074</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Fluorescence anisotropy assay details, LogD<sub>7.4</sub> experimental details, metabolism data tables, Western blot and cellular assay details and quantification, crystal structure parameters, and HPLC chromatogram traces for key target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01074/suppl_file/jm9b01074_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01074/suppl_file/jm9b01074_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01074/suppl_file/jm9b01074_si_001.pdf">jm9b01074_si_001.pdf (888.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01074/suppl_file/jm9b01074_si_002.csv">jm9b01074_si_002.csv (1.73 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01074" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28846" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28846" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Terry W. Moore</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, 
    University of Illinois
Cancer Center, 
    , , , and , University
of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5410-306X" title="Orcid link">http://orcid.org/0000-0002-5410-306X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fd898a9092928f98bd88949ed3989988"><span class="__cf_email__" data-cfemail="384c4f5557574a5d784d515b165d5c4d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Phillip R. Lazzara</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, , , and , University
of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3709-2749" title="Orcid link">http://orcid.org/0000-0003-3709-2749</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian P. David</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, , , and , University
of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5328-5394" title="Orcid link">http://orcid.org/0000-0001-5328-5394</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aparna Ankireddy</span> - <span class="hlFld-Affiliation affiliation">Department of Pediatrics, , , and , University
of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin G. Richardson</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, , , and , University
of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United
States</span>; 
    <span>Present Address:
                        B.G.R.: Department of Chemistry, The Scripps Research Institute, 110 Scripps Way, Jupiter, FL 33458, USA</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6003-3021" title="Orcid link">http://orcid.org/0000-0001-6003-3021</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katherine Dye</span> - <span class="hlFld-Affiliation affiliation">UI Centre for Drug Discovery, , , and , University
of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kiira M. Ratia</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, 
    UI Centre for Drug Discovery, 
    , , , and , University
of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sekhar P. Reddy</span> - <span class="hlFld-Affiliation affiliation">Department of Pediatrics, 
    University of Illinois
Cancer Center, 
    , , , and , University
of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United
States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>P.R.L. and B.P.D. contributed equally. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56378" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56378" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank the following funders for their support of this work: National Institute of Arthritis, Musculoskeletal and Skin Diseases to T.W.M. (1R01 AR069541-01A1) and National Heart, Lung, and Blood Institute to S.P.R. (1R01 HL136946-01). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). The authors acknowledge Alliance Pharma (Malvern, PA) for performing the liver microsomal stability studies. The authors are grateful to Dr. Benjamin Ramirez for his assistance with some of the NMR spectroscopy experiments.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">GST</td><td class="NLM_def"><p class="first last">glutathione-S-transferase</p></td></tr><tr><td class="NLM_term">HO-1</td><td class="NLM_def"><p class="first last">heme oxygenase</p></td></tr><tr><td class="NLM_term">KEAP1</td><td class="NLM_def"><p class="first last">Kelch-like ECH-associated protein 1</p></td></tr><tr><td class="NLM_term">NQO1</td><td class="NLM_def"><p class="first last">NADPH quinone oxidoreductase</p></td></tr><tr><td class="NLM_term"><i>m</i>CPBA</td><td class="NLM_def"><p class="first last"><i>m</i>-chloroperoxybenzoic acid</p></td></tr><tr><td class="NLM_term">NRF2</td><td class="NLM_def"><p class="first last">nuclear factor (erythroid-derived 2)-like 2</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">RNS</td><td class="NLM_def"><p class="first last">reactive nitrogen species</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25811" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25811" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 45 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S. M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Signaling Pathway: Pivotal Roles in Inflammation</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1863</i></span>,  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">597</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2016.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.bbadis.2016.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=27825853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVahtLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2017&pages=585-597&author=S.+M.+U.+Ahmedauthor=L.+Luoauthor=A.+Namaniauthor=X.+J.+Wangauthor=X.+Tang&title=Nrf2+Signaling+Pathway%3A+Pivotal+Roles+in+Inflammation&doi=10.1016%2Fj.bbadis.2016.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 signaling pathway: Pivotal roles in inflammation</span></div><div class="casAuthors">Ahmed, Syed Minhaj Uddin; Luo, Lin; Namani, Akhileshwar; Wang, Xiu Jun; Tang, Xiuwen</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">585-597</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Inflammation is the most common feature of many chronic diseases and complications, while playing crit. roles in carcinogenesis.  Several studies have demonstrated that Nrf2 contributes to the anti-inflammatory process by orchestrating the recruitment of inflammatory cells and regulating gene expression through the antioxidant response element (ARE).  The Keap1 (Kelch-like ECH-assocd. protein)/Nrf2 (NF-E2 p45-related factor 2)/ARE signaling pathway mainly regulates anti-inflammatory gene expression and inhibits the progression of inflammation.  Therefore, the identification of new Nrf2-dependent anti-inflammatory phytochems. has become a key point in drug discovery.  In this review, the authors discuss the members of the Keap1/Nrf2/ARE signal pathway and its downstream genes, the effects of this pathway on animal models of inflammatory diseases, and crosstalk with the NF-κB pathway.  In addn. the authors also discuss about the regulation of NLRP3 inflammasome by Nrf2.  Besides this, the authors summarize the current scenario of the development of anti-inflammatory phytochems. and others that mediate the Nrf2/ARE signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmDI6VHTdR9bVg90H21EOLACvtfcHk0lhVzdU1WZwFTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVahtLrE&md5=ddd05f60f85531bcee5892695c133433</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2016.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2016.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%2BM.%2BU.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DNamani%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DTang%26aufirst%3DX.%26atitle%3DNrf2%2520Signaling%2520Pathway%253A%2520Pivotal%2520Roles%2520in%2520Inflammation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2017%26volume%3D1863%26spage%3D585%26epage%3D597%26doi%3D10.1016%2Fj.bbadis.2016.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">7130</span>– <span class="NLM_lpage">7139</span>, <span class="refDoi"> DOI: 10.1128/MCB.24.16.7130-7139.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1128%2FMCB.24.16.7130-7139.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=15282312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlOjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=7130-7139&author=A.+Kobayashiauthor=M.-I.+Kangauthor=H.+Okawaauthor=M.+Ohtsujiauthor=Y.+Zenkeauthor=T.+Chibaauthor=K.+Igarashiauthor=M.+Yamamoto&title=Oxidative+Stress+Sensor+Keap1+Functions+as+an+Adaptor+for+Cul3-Based+E3+Ligase+To+Regulate+Proteasomal+Degradation+of+Nrf2&doi=10.1128%2FMCB.24.16.7130-7139.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2</span></div><div class="casAuthors">Kobayashi, Akira; Kang, Moon-Il; Okawa, Hiromi; Ohtsuji, Makiko; Zenke, Yukari; Chiba, Tomoki; Igarashi, Kazuhiko; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7130-7139</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Transcription factor Nrf2 is a major regulator of genes encoding phase 2 detoxifying enzymes and antioxidant stress proteins in response to electrophilic agents and oxidative stress.  In the absence of such stimuli, Nrf2 is inactive owing to its cytoplasmic retention by Keap1 and rapid degrdn. through the proteasome system.  We examd. the contribution of Keap1 to the rapid turnover of Nrf2 (half-life of less than 20 min) and found that a direct assocn. between Keap1 and Nrf2 is required for Nrf2 degrdn.  In a series of domain function analyses of Keap1, we found that both the BTB and intervening-region (IVR) domains are crucial for Nrf2 degrdn., implying that these two domains act to recruit ubiquitin-proteasome factors.  Indeed, Cullin 3 (Cul3), a subunit of the E3 ligase complex, was found to interact specifically with Keap1 in vivo.  Keap1 assocs. with the N-terminal region of Cul3 through the IVR domain and promotes the ubiquitination of Nrf2 in cooperation with the Cul3-Roc1 complex.  These results thus provide solid evidence that Keap1 functions as an adaptor of Cul3-based E3 ligase.  To our knowledge, Nrf2 and Keap1 are the first reported mammalian substrate and adaptor, resp., of the Cul3-based E3 ligase system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrut4YvhAuZKrVg90H21EOLACvtfcHk0lgUcMw1VwSAQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlOjt7w%253D&md5=3d6e356865cd6f33c800bf9124d7c8da</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.16.7130-7139.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.16.7130-7139.2004%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DM.-I.%26aulast%3DOkawa%26aufirst%3DH.%26aulast%3DOhtsuji%26aufirst%3DM.%26aulast%3DZenke%26aufirst%3DY.%26aulast%3DChiba%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DOxidative%2520Stress%2520Sensor%2520Keap1%2520Functions%2520as%2520an%2520Adaptor%2520for%2520Cul3-Based%2520E3%2520Ligase%2520To%2520Regulate%2520Proteasomal%2520Degradation%2520of%2520Nrf2%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D7130%26epage%3D7139%26doi%3D10.1128%2FMCB.24.16.7130-7139.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cullinan, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordan, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, J. A.</span></span> <span> </span><span class="NLM_article-title">The Keap1-BTB Protein is an Adaptor That Bridges Nrf2 to a Cul3-Based E3 Ligase: Oxidative Stress Sensing by a Cul3-Keap1 Ligase</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">8477</span>– <span class="NLM_lpage">8486</span>, <span class="refDoi"> DOI: 10.1128/MCB.24.19.8477-8486.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1128%2FMCB.24.19.8477-8486.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=15367669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVakt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=8477-8486&author=S.+B.+Cullinanauthor=J.+D.+Gordanauthor=J.+Jinauthor=J.+W.+Harperauthor=J.+A.+Diehl&title=The+Keap1-BTB+Protein+is+an+Adaptor+That+Bridges+Nrf2+to+a+Cul3-Based+E3+Ligase%3A+Oxidative+Stress+Sensing+by+a+Cul3-Keap1+Ligase&doi=10.1128%2FMCB.24.19.8477-8486.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: Oxidative stress sensing by a Cul3-Keap1 ligase</span></div><div class="casAuthors">Cullinan, Sara B.; Gordan, John D.; Jin, Jianping; Harper, J. Wade; Diehl, J. Alan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8477-8486</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The Nrf2 transcription factor promotes survival following cellular insults that trigger oxidative damage.  Nrf2 activity is opposed by the BTB/POZ domain protein Keap1.  Keap1 is proposed to regulate Nrf2 activity strictly through its capacity to inhibit Nrf2 nuclear import.  Recent work suggests that inhibition of Nrf2 may also depend upon ubiquitin-mediated proteolysis.  To address the contribution of Keap1-dependent sequestration vs. Nrf2 proteolysis, we identified the E3 ligase that regulates Nrf2 ubiquitination.  We demonstrate that Keap1 is not solely a cytosolic anchor; rather, Keap1 is an adaptor that bridges Nrf2 to Cul3.  We demonstrate that Cul3-Keap1 complexes regulate Nrf2 polyubiquitination both in vitro and in vivo.  Inhibition of either Keap1 or Cul3 increases Nrf2 nuclear accumulation, leading to promiscuous activation of Nrf2-dependent gene expression.  Our data demonstrate that Keap1 restrains Nrf2 activity via its capacity to target Nrf2 to a cytoplasmic Cul3-based E3 ligase and suggest a model in which Keap1 coordinately regulates both Nrf2 accumulation and access to target genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokzxnJWH6ecbVg90H21EOLACvtfcHk0lgUcMw1VwSAQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVakt7k%253D&md5=4a51087f90e5eb8f1f1cace9278941ad</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.19.8477-8486.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.19.8477-8486.2004%26sid%3Dliteratum%253Aachs%26aulast%3DCullinan%26aufirst%3DS.%2BB.%26aulast%3DGordan%26aufirst%3DJ.%2BD.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DDiehl%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520Keap1-BTB%2520Protein%2520is%2520an%2520Adaptor%2520That%2520Bridges%2520Nrf2%2520to%2520a%2520Cul3-Based%2520E3%2520Ligase%253A%2520Oxidative%2520Stress%2520Sensing%2520by%2520a%2520Cul3-Keap1%2520Ligase%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D8477%26epage%3D8486%26doi%3D10.1128%2FMCB.24.19.8477-8486.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salinas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallardo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz De
Galarreta, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span> <span> </span><span class="NLM_article-title">Regulation of Heme Oxygenase-1 Expression through the Phosphatidylinositol 3-Kinase/Akt Pathway and the Nrf2 Transcription Factor in Response to the Antioxidant Phytochemical Carnosol</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">8919</span>– <span class="NLM_lpage">8929</span>, <span class="refDoi"> DOI: 10.1074/jbc.M309660200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1074%2Fjbc.M309660200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=14688281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1Onurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=8919-8929&author=D.+Martinauthor=A.+I.+Rojoauthor=M.+Salinasauthor=R.+Diazauthor=G.+Gallardoauthor=J.+Alamauthor=C.+M.+Ruiz+De%0AGalarretaauthor=A.+Cuadrado&title=Regulation+of+Heme+Oxygenase-1+Expression+through+the+Phosphatidylinositol+3-Kinase%2FAkt+Pathway+and+the+Nrf2+Transcription+Factor+in+Response+to+the+Antioxidant+Phytochemical+Carnosol&doi=10.1074%2Fjbc.M309660200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Heme Oxygenase-1 Expression through the Phosphatidylinositol 3-Kinase/Akt Pathway and the Nrf2 Transcription Factor in Response to the Antioxidant Phytochemical Carnosol</span></div><div class="casAuthors">Martin, Daniel; Rojo, Ana I.; Salinas, Marta; Diaz, Raquel; Gallardo, German; Alam, Jawed; Ruiz de Galarreta, Carlos M.; Cuadrado, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">8919-8929</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt pathway elicits a survival signal against multiple apoptotic insults.  In addn., phase II enzymes such as heme oxygenase-1 (HO-1) protect cells against diverse toxins and oxidative stress.  In this work, we describe a link between these defense systems at the level of transcriptional regulation of the antioxidant enzyme HO-1.  The herb-derived phenol carnosol induced HO-1 expression at both mRNA and protein levels.  Luciferase reporter assays indicated that carnosol targeted the mouse ho1 promoter at two enhancer regions comprising the antioxidant response elements (AREs).  Moreover, carnosol increased the nuclear levels of Nrf2, a transcription factor governing AREs.  Electrophoretic mobility shift assays and luciferase reporter assays with a dominant-neg. Nrf2 mutant indicated that carnosol increased the binding of Nrf2 to ARE and induced Nrf2-dependent activation of the ho1 promoter.  While investigating the signaling pathways responsible for HO-1 induction, we obsd. that carnosol activated the ERK, p38, and JNK pathways as well as the survival pathway driven by PI3K.  Inhibition of PI3K reduced the increase in Nrf2 protein levels and activation of the ho1 promoter.  Expression of active PI3K-CAAX (where A is aliph. amino acid) was sufficient to activate AREs.  The use of dominant-neg. mutants of protein kinase Cζ and Akt1, two kinases downstream from PI3K, demonstrated a requirement for active Akt1, but not protein kinase Cζ.  Moreover, the long-term antioxidant effect of carnosol was partially blocked by PI3K or HO-1 inhibitors, further demonstrating that carnosol attenuates oxidative stress through a pathway that involves PI3K and HO-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW9UH0hJnHCbVg90H21EOLACvtfcHk0lgUcMw1VwSAQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1Onurs%253D&md5=e44ad1bec1c702807726d26641c6d8db</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M309660200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M309660200%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DD.%26aulast%3DRojo%26aufirst%3DA.%2BI.%26aulast%3DSalinas%26aufirst%3DM.%26aulast%3DDiaz%26aufirst%3DR.%26aulast%3DGallardo%26aufirst%3DG.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DRuiz%2BDe%2BGalarreta%26aufirst%3DC.%2BM.%26aulast%3DCuadrado%26aufirst%3DA.%26atitle%3DRegulation%2520of%2520Heme%2520Oxygenase-1%2520Expression%2520through%2520the%2520Phosphatidylinositol%25203-Kinase%252FAkt%2520Pathway%2520and%2520the%2520Nrf2%2520Transcription%2520Factor%2520in%2520Response%2520to%2520the%2520Antioxidant%2520Phytochemical%2520Carnosol%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D8919%26epage%3D8929%26doi%3D10.1074%2Fjbc.M309660200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyake, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatayama, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabeshima, Y.-i.</span></span> <span> </span><span class="NLM_article-title">An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>236</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">322</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1997.6943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1006%2Fbbrc.1997.6943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=9240432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADyaK2sXkvVWns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=1997&pages=313-322&author=K.+Itohauthor=T.+Chibaauthor=S.+Takahashiauthor=T.+Oyakeauthor=T.+Ishiiauthor=M.+Yamamotoauthor=Y.+Katohauthor=N.+Hayashiauthor=K.+Satohauthor=K.+Igarashiauthor=I.+Hatayamaauthor=Y.-i.+Nabeshima&title=An+Nrf2%2FSmall+Maf+Heterodimer+Mediates+the+Induction+of+Phase+II+Detoxifying+Enzyme+Genes+through+Antioxidant+Response+Elements&doi=10.1006%2Fbbrc.1997.6943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements</span></div><div class="casAuthors">Itoh, Ken; Chiba, Tomoki; Takahashi, Satoru; Ishii, Tetsuro; Igarashi, Kazuhiko; Katoh, Yasutake; Oyake, Tatsuya; Hayashi, Norio; Satoh, Kimihiko; Hatayama, Ichiro; Yamamoto, Masayuki; Nabeshima, Yo-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">236</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">313-322</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">The induction of phase II detoxifying enzymes in an important defense mechanism against intake of xenobiotics.  While this group of enzymes is believed to be under the transcriptional control of antioxidant response elements (AREs), this contention is exptl. unconfirmed.  Since the ARE resembles the binding sequence of erythroid transcription factor NF-E2, the authors investigated the possibility that the phase II enzyme genes might be regulated by transcription factors that also bind to the NF-E2 sequence.  The expression profiles of a no. of transcription factor suggest that an Nrf2/small Maf heterodimer is the most likely candidate to fulfill this role in vivo.  To directly test these questions, the authors disrupted the murine nrf2 gene in vivo.  While the expression of phase II enzymes (e.g., glutathione S-transferase and NAD(P)H: quinone oxidoreductase) was markedly induced by a phenolic antioxidant in vivo in both wild type and heterozygous mutant mice, the induction was largely eliminated in the liver and intestine of homozygous nrf2-mutant mice.  Nrf2 was found to bind to the ARE with high affinity only as a heterodimer with a small Maf protein, suggesting that Nrf2/small Maf activates gene expression directly through the ARE.  These results demonstrate that Nrf2 is essential for the transcriptional induction of phase II enzymes and the presence of a coordinate transcriptional regulatory mechanism for phase II enzyme genes.  The nrf2-deficient mice may prove to be a very useful model for the in vivo anal. of chem. carcinogenesis and resistance to anti-cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwOKWP1JSQT7Vg90H21EOLACvtfcHk0lgJKJA66uKwAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvVWns78%253D&md5=c3daaa556967bc2aaaa55834e99605c3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1997.6943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1997.6943%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DChiba%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DOyake%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DN.%26aulast%3DSatoh%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DK.%26aulast%3DHatayama%26aufirst%3DI.%26aulast%3DNabeshima%26aufirst%3DY.-i.%26atitle%3DAn%2520Nrf2%252FSmall%2520Maf%2520Heterodimer%2520Mediates%2520the%2520Induction%2520of%2520Phase%2520II%2520Detoxifying%2520Enzyme%2520Genes%2520through%2520Antioxidant%2520Response%2520Elements%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1997%26volume%3D236%26spage%3D313%26epage%3D322%26doi%3D10.1006%2Fbbrc.1997.6943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cousin, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumsey, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attucks, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levonen, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Targeting of the NRF2 and KEAP1 Partnership in Chronic Diseases</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1038/s41573-018-0008-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1038%2Fs41573-018-0008-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=30610225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlslKlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=295-317&author=A.+Cuadradoauthor=A.+I.+Rojoauthor=G.+Wellsauthor=J.+D.+Hayesauthor=S.+P.+Cousinauthor=W.+L.+Rumseyauthor=O.+C.+Attucksauthor=S.+Franklinauthor=A.+L.+Levonenauthor=T.+W.+Kenslerauthor=A.+T.+Dinkova-Kostova&title=Therapeutic+Targeting+of+the+NRF2+and+KEAP1+Partnership+in+Chronic+Diseases&doi=10.1038%2Fs41573-018-0008-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases</span></div><div class="casAuthors">Cuadrado, Antonio; Rojo, Ana I.; Wells, Geoffrey; Hayes, John D.; Cousin, Sharon P.; Rumsey, William L.; Attucks, Otis C.; Franklin, Stephen; Levonen, Anna-Liisa; Kensler, Thomas W.; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  The transcription factor NF-E2 p45-related factor 2 (NRF2; encoded by NFE2L2) and its principal neg. regulator, the E3 ligase adaptor Kelch-like ECH-assocd. protein 1 (KEAP1), are crit. in the maintenance of redox, metabolic and protein homeostasis, as well as the regulation of inflammation.  Thus, NRF2 activation provides cytoprotection against numerous pathologies including chronic diseases of the lung and liver; autoimmune, neurodegenerative and metabolic disorders; and cancer initiation.  One NRF2 activator has received clin. approval and several electrophilic modifiers of the cysteine-based sensor KEAP1 and inhibitors of its interaction with NRF2 are now in clin. development.  However, challenges regarding target specificity, pharmacodynamic properties, efficacy and safety remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW9hICH7_1WbVg90H21EOLACvtfcHk0lgJKJA66uKwAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlslKlsr0%253D&md5=ce3b8d39cd759418444f6e375ee1a38c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fs41573-018-0008-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41573-018-0008-x%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DRojo%26aufirst%3DA.%2BI.%26aulast%3DWells%26aufirst%3DG.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DCousin%26aufirst%3DS.%2BP.%26aulast%3DRumsey%26aufirst%3DW.%2BL.%26aulast%3DAttucks%26aufirst%3DO.%2BC.%26aulast%3DFranklin%26aufirst%3DS.%26aulast%3DLevonen%26aufirst%3DA.%2BL.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DTherapeutic%2520Targeting%2520of%2520the%2520NRF2%2520and%2520KEAP1%2520Partnership%2520in%2520Chronic%2520Diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2019%26volume%3D18%26spage%3D295%26epage%3D317%26doi%3D10.1038%2Fs41573-018-0008-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrándiz, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacher-Juan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaraz, M. J.</span></span> <span> </span><span class="NLM_article-title">Nrf2 as a Therapeutic Target for Rheumatic Diseases</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2018.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.bcp.2018.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=29660314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnslOiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2018&pages=338-346&author=M.+L.+Ferr%C3%A1ndizauthor=J.+Nacher-Juanauthor=M.+J.+Alcaraz&title=Nrf2+as+a+Therapeutic+Target+for+Rheumatic+Diseases&doi=10.1016%2Fj.bcp.2018.04.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 as a therapeutic target for rheumatic diseases</span></div><div class="casAuthors">Ferrandiz, Maria Luisa; Nacher-Juan, Josep; Alcaraz, Maria Jose</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">338-346</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a master regulator of cellular protective processes.  Rheumatic diseases are chronic conditions characterized by inflammation, pain, tissue damage and limitations in function.  Main examples are rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis and osteoporosis.  Their high prevalence constitutes a major health problem with an important social and economic impact.  A wide range of evidence indicates that Nrf2 may control different mechanisms involved in the physiopathol. of rheumatic conditions.  Therefore, the appropriate expression and balance of Nrf2 is necessary for regulation of oxidative stress, inflammation, immune responses, and cartilage and bone metab.  Numerous studies have demonstrated that Nrf2 deficiency aggravates the disease in exptl. models while Nrf2 activation results in immunoregulatory and anti-inflammatory effects.  These reports reinforce the increasing interest in the pharmacol. regulation of Nrf2 and its potential applications.  Nevertheless, a majority of Nrf2 inducers are electrophilic mols. which may present off-target effects.  In recent years, novel strategies have been sought to modulate the Nrf2 pathway which has emerged as a therapeutic target in rheumatic conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Kqw0GQrgYrVg90H21EOLACvtfcHk0lgJKJA66uKwAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnslOiuro%253D&md5=c1810bf46725cf0110662a5e13c705a3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2018.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2018.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DFerr%25C3%25A1ndiz%26aufirst%3DM.%2BL.%26aulast%3DNacher-Juan%26aufirst%3DJ.%26aulast%3DAlcaraz%26aufirst%3DM.%2BJ.%26atitle%3DNrf2%2520as%2520a%2520Therapeutic%2520Target%2520for%2520Rheumatic%2520Diseases%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D152%26spage%3D338%26epage%3D346%26doi%3D10.1016%2Fj.bcp.2018.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nezu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saigusa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Transcription Factor Nrf2 Hyperactivation In Early-Phase Renal Ischemia-Reperfusion Injury Prevents Tubular Damage Progression</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1016/j.kint.2016.08.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.kint.2016.08.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=27789056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCku7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2017&pages=387-401&author=M.+Nezuauthor=T.+Soumaauthor=L.+Yuauthor=T.+Suzukiauthor=D.+Saigusaauthor=S.+Itoauthor=N.+Suzukiauthor=M.+Yamamoto&title=Transcription+Factor+Nrf2+Hyperactivation+In+Early-Phase+Renal+Ischemia-Reperfusion+Injury+Prevents+Tubular+Damage+Progression&doi=10.1016%2Fj.kint.2016.08.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression</span></div><div class="casAuthors">Nezu, Masahiro; Souma, Tomokazu; Yu, Lei; Suzuki, Takafumi; Saigusa, Daisuke; Ito, Sadayoshi; Suzuki, Norio; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">387-401</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Acute kidney injury is a devastating disease with high morbidity in hospitalized patients and contributes to the pathogenesis of chronic kidney disease.  An underlying mechanism of acute kidney injury involves ischemia-reperfusion injury which, in turn, induces oxidative stress and provokes organ damage.  Nrf2 is a master transcription factor that regulates the cellular response to oxidative stress.  Here, we examd. the role of Nrf2 in the progression of ischemia-reperfusion injury-induced kidney damage in mice using genetic and pharmacol. approaches.  Both global and tubular-specific Nrf2 activation enhanced gene expression of antioxidant and NADPH synthesis enzymes, including glucose-6-phosphate dehydrogenase, and ameliorated both the initiation of injury in the outer medulla and the progression of tubular damage in the cortex.  Myeloid-specific Nrf2 activation was ineffective.  Short-term administration of the Nrf2 inducer CDDO during the initial phase of injury ameliorated the late phase of tubular damage.  This inducer effectively protected the human proximal tubular cell line HK-2 from oxidative stress-mediated cell death while glucose-6-phosphate dehydrogenase knockdown increased intracellular reactive oxygen species.  These findings demonstrate that tubular hyperactivation of Nrf2 in the initial phase of injury prevents the progression of reactive oxygen species-mediated tubular damage by inducing antioxidant enzymes and NADPH synthesis.  Thus, Nrf2 may be a promising therapeutic target for preventing acute kidney injury to chronic kidney disease transition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0cKCFdEBWR7Vg90H21EOLACvtfcHk0ljDuBs48r93TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCku7jP&md5=7a1cacbf340881a9b50a4c4aa74c9509</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.kint.2016.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.kint.2016.08.023%26sid%3Dliteratum%253Aachs%26aulast%3DNezu%26aufirst%3DM.%26aulast%3DSouma%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DSaigusa%26aufirst%3DD.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DTranscription%2520Factor%2520Nrf2%2520Hyperactivation%2520In%2520Early-Phase%2520Renal%2520Ischemia-Reperfusion%2520Injury%2520Prevents%2520Tubular%2520Damage%2520Progression%26jtitle%3DKidney%2520Int.%26date%3D2017%26volume%3D91%26spage%3D387%26epage%3D401%26doi%3D10.1016%2Fj.kint.2016.08.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gopal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikulskis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaravadi, L.</span></span> <span> </span><span class="NLM_article-title">Evidence of Activation of the Nrf2 Pathway in Multiple Sclerosis Patients Treated with Delayed-Release Dimethyl Fumarate in the Phase 3 DEFINE and CONFIRM Studies</span>. <i>Multiple Sclerosis Journal</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1875</span>– <span class="NLM_lpage">1883</span>, <span class="refDoi"> DOI: 10.1177/1352458517690617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1177%2F1352458517690617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=28156185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFKmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=1875-1883&author=S.+Gopalauthor=A.+Mikulskisauthor=R.+Goldauthor=R.+J.+Foxauthor=K.+T.+Dawsonauthor=L.+Amaravadi&title=Evidence+of+Activation+of+the+Nrf2+Pathway+in+Multiple+Sclerosis+Patients+Treated+with+Delayed-Release+Dimethyl+Fumarate+in+the+Phase+3+DEFINE+and+CONFIRM+Studies&doi=10.1177%2F1352458517690617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies</span></div><div class="casAuthors">Gopal, Sreeja; Mikulskis, Alvydas; Gold, Ralf; Fox, Robert J.; Dawson, Katherine T.; Amaravadi, Lakshmi</div><div class="citationInfo"><span class="NLM_cas:title">Multiple Sclerosis Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1875-1883</span>CODEN:
                <span class="NLM_cas:coden">MSJUAP</span>;
        ISSN:<span class="NLM_cas:issn">1477-0970</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Delayed-release di-Me fumarate (DMF) is an approved oral treatment for relapsing forms of multiple sclerosis (MS).  Preclin. studies demonstrated that DMF activated the nuclear factor E2-related factor 2 (Nrf2) pathway.  DMF and its primary metabolite monomethyl fumarate (MMF) were also shown to promote cytoprotection of cultured central nervous system (CNS) cells via the Nrf2 pathway.  To investigate the activation of Nrf2 pathway following ex vivo stimulation of human peripheral blood mononuclear cells (PBMCs) with DMF or MMF, and in DMF-treated patients from two Phase 3 relapsing MS studies DEFINE and CONFIRM.  Transcription of Nrf2 target genes NADPH:quinone oxidoreductase-1 (NQO1) and heme-oxygenase-1 (HO1) was measured using Taqman assays.  RNA samples were isolated from ex vivo-stimulated PBMCs and from whole blood samples of 200 patients each from placebo, twice daily (BID) and three times daily (TID) treatments.  DMF and MMF induced NQO1 and HO1 gene expression in ex vivo-stimulated PBMCs, DMF being the more potent inducer.  Induction of NQO1 occurred at lower DMF concns. compared to that of HO1.  In DMF-treated patients, a statistically significant induction of NQO1 was obsd. relative to baseline and compared to placebo.  No statistical significance was reached for HO1 induction.  These data provide the first evidence of Nrf2 pathway activation from two large pivotal Phase 3 studies of DMF-treated MS patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ8WOKcGfF07Vg90H21EOLACvtfcHk0ljDuBs48r93TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFKmurg%253D&md5=9d7f5974a822bc8d3090b351b9ebbef9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1177%2F1352458517690617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1352458517690617%26sid%3Dliteratum%253Aachs%26aulast%3DGopal%26aufirst%3DS.%26aulast%3DMikulskis%26aufirst%3DA.%26aulast%3DGold%26aufirst%3DR.%26aulast%3DFox%26aufirst%3DR.%2BJ.%26aulast%3DDawson%26aufirst%3DK.%2BT.%26aulast%3DAmaravadi%26aufirst%3DL.%26atitle%3DEvidence%2520of%2520Activation%2520of%2520the%2520Nrf2%2520Pathway%2520in%2520Multiple%2520Sclerosis%2520Patients%2520Treated%2520with%2520Delayed-Release%2520Dimethyl%2520Fumarate%2520in%2520the%2520Phase%25203%2520DEFINE%2520and%2520CONFIRM%2520Studies%26jtitle%3DMultiple%2520Sclerosis%2520Journal%26date%3D2017%26volume%3D23%26spage%3D1875%26epage%3D1883%26doi%3D10.1177%2F1352458517690617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabbani, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waqas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sultan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Viso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceradini, D. J.</span></span> <span> </span><span class="NLM_article-title">Targeted Nrf2 Activation Therapy with RTA 408 Enhances Regenerative Capacity of Diabetic Wounds</span>. <i>Diabetes Res. Clin. Pract.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.diabres.2018.02.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.diabres.2018.02.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=29476889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsF2ntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2018&pages=11-23&author=P.+S.+Rabbaniauthor=T.+Ellisonauthor=B.+Waqasauthor=D.+Sultanauthor=S.+Abdouauthor=J.+A.+Davidauthor=J.+M.+Cohenauthor=A.+Gomez-Visoauthor=G.+Lamauthor=C.+Kimauthor=J.+Thomsonauthor=D.+J.+Ceradini&title=Targeted+Nrf2+Activation+Therapy+with+RTA+408+Enhances+Regenerative+Capacity+of+Diabetic+Wounds&doi=10.1016%2Fj.diabres.2018.02.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Nrf2 activation therapy with RTA 408 enhances regenerative capacity of diabetic wounds</span></div><div class="casAuthors">Rabbani, Piul S.; Ellison, Trevor; Waqas, Bukhtawar; Sultan, Darren; Abdou, Salma; David, Joshua A.; Cohen, Joshua M.; Gomez-Viso, Alejandro; Lam, Gretl; Kim, Camille; Thomson, Jennifer; Ceradini, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes Research and Clinical Practice</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-23</span>CODEN:
                <span class="NLM_cas:coden">DRCPE9</span>;
        ISSN:<span class="NLM_cas:issn">0168-8227</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Though unmitigated oxidative stress in diabetic chronic non-healing wounds poses a major therapeutic challenge, currently, there are no effective pharmacol. agents.  We targeted the cytoprotective Nrf2/Keap1 pathway, which is dysfunctional in diabetic skin and the regenerative environment in the diabetic wound.  We assessed the efficacy of a potent Nrf2-activator, RTA 408, a semi-synthetic oleanane triterpenoid, on accelerating diabetic wound healing.Using Leprdb/dbmice, we made 10 mm-diam. excisional humanized wounds in dorsal skin.  We administered RTA 408 formulations daily, and used ANOVA for comparison of time to closure, in vivo real-time ROS, histol., mol. changes.We found that RTA 408, specifically a 0.1% formulation, significantly reduced wound healing time and increased wound closure rate.  While either systemic or topical administration of RTA 408 is effective, wound closure time with the latter was far superior.  RTA 408-treated diabetic wounds upregulated Nrf2 and downstream antioxidant genes, and exhibited well-vascularized granulation tissue that aided in re-epithelialization.  Reintroduction of redox mechanisms via RTA 408-induced Nrf2 resulted in redn. of the oxidative status of wounds, to coordinate successful wound closure.This preclin. study shows that promoting Nrf2-mediated antioxidant activity in the localized regenerative milieu of a diabetic wound markedly improves the mol. and cellular compn. of diabetic wound beds.  RTA 408 treats and corrects the irregularity in redox balance mechanisms involving Nrf2, in an avenue not explored previously for treatment of diabetic wounds and tissue regeneration.  Our study supports development of RTA 408 as a therapeutic modality for chronic diabetic wounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokOe8iphSixLVg90H21EOLACvtfcHk0ljDuBs48r93TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsF2ntbY%253D&md5=51a6357b0334d10f0daaf20d7895908f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.diabres.2018.02.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.diabres.2018.02.021%26sid%3Dliteratum%253Aachs%26aulast%3DRabbani%26aufirst%3DP.%2BS.%26aulast%3DEllison%26aufirst%3DT.%26aulast%3DWaqas%26aufirst%3DB.%26aulast%3DSultan%26aufirst%3DD.%26aulast%3DAbdou%26aufirst%3DS.%26aulast%3DDavid%26aufirst%3DJ.%2BA.%26aulast%3DCohen%26aufirst%3DJ.%2BM.%26aulast%3DGomez-Viso%26aufirst%3DA.%26aulast%3DLam%26aufirst%3DG.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DThomson%26aufirst%3DJ.%26aulast%3DCeradini%26aufirst%3DD.%2BJ.%26atitle%3DTargeted%2520Nrf2%2520Activation%2520Therapy%2520with%2520RTA%2520408%2520Enhances%2520Regenerative%2520Capacity%2520of%2520Diabetic%2520Wounds%26jtitle%3DDiabetes%2520Res.%2520Clin.%2520Pract.%26date%3D2018%26volume%3D139%26spage%3D11%26epage%3D23%26doi%3D10.1016%2Fj.diabres.2018.02.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo de la Vega, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wondrak, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">An Essential Role of NRF2 in Diabetic Wound Healing</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">780</span>– <span class="NLM_lpage">793</span>, <span class="refDoi"> DOI: 10.2337/db15-0564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.2337%2Fdb15-0564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=26718502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKltLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=780-793&issue=3&author=M.+Longauthor=M.+Rojo+de+la+Vegaauthor=Q.+Wenauthor=M.+Bhararaauthor=T.+Jiangauthor=R.+Zhangauthor=S.+Zhouauthor=P.+K.+Wongauthor=G.+T.+Wondrakauthor=H.+Zhengauthor=D.+D.+Zhang&title=An+Essential+Role+of+NRF2+in+Diabetic+Wound+Healing&doi=10.2337%2Fdb15-0564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">An essential role of NRF2 in diabetic wound healing</span></div><div class="casAuthors">Long, Min; Rojo de la Vega, Montserrat; Wen, Qing; Bharara, Manish; Jiang, Tao; Zhang, Rui; Zhou, Shiwen; Wong, Pak K.; Wondrak, Georg T.; Zheng, Hongting; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">780-793</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">The high mortality and disability of diabetic nonhealing skin ulcers create an urgent need for the development of more efficacious strategies targeting diabetic wound healing.  In the current study, using human clin. specimens, we show that perilesional skin tissues from patients with diabetes are under more severe oxidative stress and display higher activation of the nuclear factor-E2-related factor 2 (NRF2)-mediated antioxidant response than perilesional skin tissues from normoglycemic patients.  In a streptozotocin-induced diabetes mouse model, Nrf2-/- mice have delayed wound closure rates compared with Nrf2+/+mice, which is, at least partially, due to greater oxidative DNA damage, low transforming growth factor-β1 (TGF-β1) and high matrix metalloproteinase 9 (MMP9) expression, and increased apoptosis.  More importantly, pharmacol. activation of the NRF2 pathway significantly improves diabetic wound healing.  In vitro expts. in human immortalized keratinocyte cells confirm that NRF2 contributes to wound healing by alleviating oxidative stress, increasing proliferation and migration, decreasing apoptosis, and increasing the expression of TGF-β1 and lowering MMP9 under high-glucose conditions.  This study indicates an essential role for NRF2 in diabetic wound healing and the therapeutic benefits of activating NRF2 in this disease, laying the foundation for future clin. trials using NRF2 activators in treating diabetic skin ulcers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqldj1KoAeHQbVg90H21EOLACvtfcHk0ljDuBs48r93TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKltLbM&md5=af5090db91645197a35e867fb350f711</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2337%2Fdb15-0564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb15-0564%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DM.%26aulast%3DRojo%2Bde%2Bla%2BVega%26aufirst%3DM.%26aulast%3DWen%26aufirst%3DQ.%26aulast%3DBharara%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DP.%2BK.%26aulast%3DWondrak%26aufirst%3DG.%2BT.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DAn%2520Essential%2520Role%2520of%2520NRF2%2520in%2520Diabetic%2520Wound%2520Healing%26jtitle%3DDiabetes%26date%3D2016%26volume%3D65%26issue%3D3%26spage%3D780%26epage%3D793%26doi%3D10.2337%2Fdb15-0564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Molecular Basis of the Keap1-Nrf2 System</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.freeradbiomed.2015.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=26117331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Cku7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=93-100&author=T.+Suzukiauthor=M.+Yamamoto&title=Molecular+Basis+of+the+Keap1-Nrf2+System&doi=10.1016%2Fj.freeradbiomed.2015.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of the Keap1-Nrf2 system</span></div><div class="casAuthors">Suzuki, Takafumi; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">93-100</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nrf2 (NF-E2-related factor 2) is a master regulator of cellular responses against environmental stresses.  Nrf2 induces the expression of detoxification and antioxidant enzymes, and Keap1 (Kelch-like ECH-assocd. protein 1), an adaptor subunit of Cullin 3-based E3 ubiquitin ligase, regulates Nrf2 activity.  Keap1 also acts as a sensor for oxidative and electrophilic stresses.  Keap1 retains multiple sensor cysteine residues that detect various stress stimuli.  Increasing attention has been paid to the roles that Nrf2 plays in the protection of our bodies against drug toxicity and stress-induced diseases.  On the other hand, Nrf2 is found to promote both oncogenesis and cancer cell resistance against chemotherapeutic drugs.  Thus, although Nrf2 acts to protect our body from deleterious stresses, cancer cells hijack the Nrf2 activity to support their malignant growth.  Nrf2 has emerged as a new therapeutic target, and both inducers and inhibitors of Nrf2 are awaited.  Studies challenging the mol. basis of the Keap1-Nrf2 system functions are now critically important to improve translational studies of the system.  Indeed, recent studies identified cross talk between Nrf2 and other signaling pathways, which provides new insights into the mechanisms by which the Keap1-Nrf2 system serves as a potent regulator of our health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3SXIMvWYgU7Vg90H21EOLACvtfcHk0lhKT2qVio0V5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Cku7bL&md5=893e5dbf9b3cfe85fd30590a4a93b49c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DMolecular%2520Basis%2520of%2520the%2520Keap1-Nrf2%2520System%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D88%26spage%3D93%26epage%3D100%26doi%3D10.1016%2Fj.freeradbiomed.2015.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boobis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldring, C. E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenna, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laverty, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naisbitt, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoll-Griffith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routledge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweedie, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermeulen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span> <span> </span><span class="NLM_article-title">Managing the Challenge of Chemically Reactive Metabolites in Drug Development</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">292</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1038/nrd3408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1038%2Fnrd3408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=21455238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=292-306&author=B.+K.+Parkauthor=A.+Boobisauthor=S.+Clarkeauthor=C.+E.+P.+Goldringauthor=D.+Jonesauthor=J.+G.+Kennaauthor=C.+Lambertauthor=H.+G.+Lavertyauthor=D.+J.+Naisbittauthor=S.+Nelsonauthor=D.+A.+Nicoll-Griffithauthor=R.+S.+Obachauthor=P.+Routledgeauthor=D.+A.+Smithauthor=D.+J.+Tweedieauthor=N.+Vermeulenauthor=D.+P.+Williamsauthor=I.+D.+Wilsonauthor=T.+A.+Baillie&title=Managing+the+Challenge+of+Chemically+Reactive+Metabolites+in+Drug+Development&doi=10.1038%2Fnrd3408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Managing the challenge of chemically reactive metabolites in drug development</span></div><div class="casAuthors">Park, B. Kevin; Boobis, Alan; Clarke, Stephen; Goldring, Chris E. P.; Jones, David; Kenna, J. Gerry; Lambert, Craig; Laverty, Hugh G.; Naisbitt, Dean J.; Nelson, Sidney; Nicoll-Griffith, Deborah A.; Obach, R. Scott; Routledge, Philip; Smith, Dennis A.; Tweedie, Donald J.; Vermeulen, Nico; Williams, Dominic P.; Wilson, Ian D.; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">292-306</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The normal metab. of drugs can generate metabolites that have intrinsic chem. reactivity towards cellular mols., and therefore have the potential to alter biol. function and initiate serious adverse drug reactions.  Here, we present an assessment of the current approaches used for the evaluation of chem. reactive metabolites.  We also describe how these approaches are being used within the pharmaceutical industry to assess and minimize the potential of drug candidates to cause toxicity.  At early stages of drug discovery, iteration between medicinal chem. and drug metab. can eliminate perceived reactive metabolite-mediated chem. liabilities without compromising pharmacol. activity or the need for extensive safety evaluation beyond std. practices.  In the future, reactive metabolite evaluation may also be useful during clin. development for improving clin. risk assessment and risk management.  Currently, there remains a huge gap in our understanding of the basic mechanisms that underlie chem. stress-mediated adverse reactions in humans.  This Review summarizes our views on this complex topic, and includes insights into practices considered by the pharmaceutical industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBv41vr7ZlNLVg90H21EOLACvtfcHk0lhKT2qVio0V5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGnu78%253D&md5=8f6865f17bbe50b51aa4282379e82a08</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd3408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3408%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DB.%2BK.%26aulast%3DBoobis%26aufirst%3DA.%26aulast%3DClarke%26aufirst%3DS.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%2BP.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26aulast%3DLambert%26aufirst%3DC.%26aulast%3DLaverty%26aufirst%3DH.%2BG.%26aulast%3DNaisbitt%26aufirst%3DD.%2BJ.%26aulast%3DNelson%26aufirst%3DS.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DRoutledge%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DTweedie%26aufirst%3DD.%2BJ.%26aulast%3DVermeulen%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26aulast%3DWilson%26aufirst%3DI.%2BD.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DManaging%2520the%2520Challenge%2520of%2520Chemically%2520Reactive%2520Metabolites%2520in%2520Drug%2520Development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D292%26epage%3D306%26doi%3D10.1038%2Fnrd3408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">To, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shilton, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Guglielmo, G. M.</span></span> <span> </span><span class="NLM_article-title">Synthetic Triterpenoids Target the Arp2/3 Complex and Inhibit Branched Actin Polymerization</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">27944</span>– <span class="NLM_lpage">27957</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.103036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1074%2Fjbc.M110.103036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=20566646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVOnsLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=27944-27957&author=C.+Toauthor=B.+H.+Shiltonauthor=G.+M.+Di+Guglielmo&title=Synthetic+Triterpenoids+Target+the+Arp2%2F3+Complex+and+Inhibit+Branched+Actin+Polymerization&doi=10.1074%2Fjbc.M110.103036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Triterpenoids Target the Arp2/3 Complex and Inhibit Branched Actin Polymerization</span></div><div class="casAuthors">To, Ciric; Shilton, Brian H.; Di Guglielmo, Gianni M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">27944-27957</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Synthetic triterpenoids are anti-tumor agents that affect numerous cellular functions including apoptosis and growth inhibition.  Here, we used mass spectrometric and protein array approaches and uncovered that triterpenoids assoc. with proteins of the actin cytoskeleton, including actin-related protein 3 (Arp3).  Arp3, a subunit of the Arp2/3 complex, is involved in branched actin polymn. and the formation of lamellipodia.  2-Cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO)-Im and CDDO-Me were obsd. to (1) inhibit the localization of Arp3 and actin at the leading edge of cells, (2) abrogate cell polarity, and (3) inhibit Arp2/3-dependent branched actin polymn.  We confirmed our drug effects with siRNA targeting of Arp3 and obsd. a decrease in Rat2 cell migration.  Taken together, our data suggest that synthetic triterpenoids target Arp3 and branched actin polymn. to inhibit cell migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0cef7euFKLrVg90H21EOLACvtfcHk0lhKT2qVio0V5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVOnsLrP&md5=b3205f082ce74377971c4f54b6bcda71</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.103036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.103036%26sid%3Dliteratum%253Aachs%26aulast%3DTo%26aufirst%3DC.%26aulast%3DShilton%26aufirst%3DB.%2BH.%26aulast%3DDi%2BGuglielmo%26aufirst%3DG.%2BM.%26atitle%3DSynthetic%2520Triterpenoids%2520Target%2520the%2520Arp2%252F3%2520Complex%2520and%2520Inhibit%2520Branched%2520Actin%2520Polymerization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D27944%26epage%3D27957%26doi%3D10.1074%2Fjbc.M110.103036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prigge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Z.</span></span> <span> </span><span class="NLM_article-title">Chemoprevention of Oxidative Stress-Associated Oral Carcinogenesis by Sulforaphane Depends on NRF2 and the Isothiocyanate Moiety</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">53502</span>– <span class="NLM_lpage">53514</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.10609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.18632%2Foncotarget.10609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=27447968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A280%3ADC%252BC2s3jt1Sguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=53502-53514&author=A.+Lanauthor=W.+Liauthor=Y.+Liuauthor=X.+Zhangauthor=S.+Zhouauthor=O.+Palkoauthor=H.+Chenauthor=M.+Kapitaauthor=J.+Priggeauthor=E.+Schmidtauthor=X.+Chenauthor=Z.+Sunauthor=X.+L.+Chenauthor=Z.+Xiong&title=Chemoprevention+of+Oxidative+Stress-Associated+Oral+Carcinogenesis+by+Sulforaphane+Depends+on+NRF2+and+the+Isothiocyanate+Moiety&doi=10.18632%2Foncotarget.10609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoprevention of oxidative stress-associated oral carcinogenesis by sulforaphane depends on NRF2 and the isothiocyanate moiety</span></div><div class="casAuthors">Lan Aixian; Li Wenjun; Liu Yao; Zhang Xinyan; Sun Zheng; Xiong Zhaohui; Palko Olesya; Chen Hao; Kapita Mayanga; Chen Xiaoxin Luke; Zhou Shanshan; Chen Xin; Prigge Justin R; Schmidt Edward E</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">53502-53514</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxidative stress is known to play an important role in oral cancer development.  In this study we aimed to examine whether a chemical activator of NRF2, sulforaphane (SFN), may have chemopreventive effects on oxidative stress-associated oral carcinogenesis.  We first showed that Nrf2 activation and oxidative damage were commonly seen in human samples of oral leukoplakia.  With gene microarray and immunostaining, we found 4-nitroquinoline 1-oxide (4NQO) in drink activated the Nrf2 pathway and produced oxidative damage in mouse tongue.  Meanwhile whole exome sequencing of mouse tongue identified mutations consistent with 4NQO's mutagenic profile.  Using cultured human oral keratinocytes and 4NQO-treated mouse tongue, we found that SFN pre-treatment activated the NRF2 pathway and inhibited oxidative damage both in vitro and in vivo.  On the contrary, a structural analogue of SFN without the isothiocyanate moiety did not have such effects.  In a long-term chemoprevention study using wild-type and Nrf2-/- mice, we showed that topical application of SFN activated the NRF2 pathway, inhibited oxidative damage, and prevented 4NQO-induced oral carcinogenesis in an Nrf2-dependent manner.  Our data clearly demonstrate that SFN has chemopreventive effects on oxidative stress-associated oral carcinogenesis, and such effects depend on Nrf2 and the isothiocyanate moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSPWXwNzPqwq7qxQ2mb9Pu8fW6udTcc2eYbsdL88w_5qrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3jt1Sguw%253D%253D&md5=4457a77e4fd52f2e2457ac993c075412</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.10609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.10609%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DPalko%26aufirst%3DO.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DKapita%26aufirst%3DM.%26aulast%3DPrigge%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%2BL.%26aulast%3DXiong%26aufirst%3DZ.%26atitle%3DChemoprevention%2520of%2520Oxidative%2520Stress-Associated%2520Oral%2520Carcinogenesis%2520by%2520Sulforaphane%2520Depends%2520on%2520NRF2%2520and%2520the%2520Isothiocyanate%2520Moiety%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D53502%26epage%3D53514%26doi%3D10.18632%2Foncotarget.10609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCullough, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, S.</span></span> <span> </span><span class="NLM_article-title">Cardiac and Renal Function in Patients with Type 2 Diabetes Who have Chronic Kidney Disease: Potential Effects of Bardoxolone Methyl</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S26714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.2147%2FDDDT.S26714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=22787387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVWmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&pages=141-149&author=P.+A.+McCulloughauthor=S.+Ali&title=Cardiac+and+Renal+Function+in+Patients+with+Type+2+Diabetes+Who+have+Chronic+Kidney+Disease%3A+Potential+Effects+of+Bardoxolone+Methyl&doi=10.2147%2FDDDT.S26714"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac and renal function in patients with type 2 diabetes who have chronic kidney disease: potential effects of bardoxolone methyl</span></div><div class="casAuthors">McCullough, Peter A.; Ali, Sajid</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141-149</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The intracellular and tissue balance of oxidant and antioxidant forces is a potential therapeutic target for a variety of agents in the treatment of complications due to chronic disease including diabetes mellitus and hypertension.  There are a myriad of processes controlled at the level of genes, transcription factors, and protein messages that work to control the normal use of oxidative reactions within cells.  Loss of control of these processes may lead to reversible dysfunction in many cell lines including the podocyte, renal tubular cells, and cardiac myocytes.  Bardoxolone Me is a novel nuclear regulator factor (Nrf-2) activator which works to tip the balance of effects towards antioxidn. and as an observation made serendipitously, improves renal filtration function in humans after approx. 12 wk of therapy.  The improvement in estd. glomerular filtration can be up to 30% in those with stage 3 and 4 chronic kidney disease.  However, exptl. evidence suggests there may be a consequence of relative hyperfiltration in diseased kidneys as well as potential adverse effects on skeletal and cardiac myocytes.  Only large, prospective randomized trials with carefully collected and adjudicated clin. outcomes will inform the research community on the therapeutic risks and benefits of this important new agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLVpv2PudfnrVg90H21EOLACvtfcHk0lijncal8YmDRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVWmtL8%253D&md5=25a039b43a061dc0911065e23f9b4662</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S26714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S26714%26sid%3Dliteratum%253Aachs%26aulast%3DMcCullough%26aufirst%3DP.%2BA.%26aulast%3DAli%26aufirst%3DS.%26atitle%3DCardiac%2520and%2520Renal%2520Function%2520in%2520Patients%2520with%2520Type%25202%2520Diabetes%2520Who%2520have%2520Chronic%2520Kidney%2520Disease%253A%2520Potential%2520Effects%2520of%2520Bardoxolone%2520Methyl%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2012%26volume%3D6%26spage%3D141%26epage%3D149%26doi%3D10.2147%2FDDDT.S26714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Zeeuw, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audhya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakris, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ-Schmidt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsberry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambers Heerspink, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurray, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parving, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remuzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toto, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaziri, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrolstad, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chertow, G. M.</span></span> <span> </span><span class="NLM_article-title">Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>369</i></span>,  <span class="NLM_fpage">2492</span>– <span class="NLM_lpage">2503</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1306033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1056%2FNEJMoa1306033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=24206459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=2492-2503&author=D.+de%0AZeeuwauthor=T.+Akizawaauthor=P.+Audhyaauthor=G.+L.+Bakrisauthor=M.+Chinauthor=H.+Christ-Schmidtauthor=A.+Goldsberryauthor=M.+Houserauthor=M.+Krauthauthor=H.+J.+Lambers+Heerspinkauthor=J.+J.+McMurrayauthor=C.+J.+Meyerauthor=H.-H.+Parvingauthor=G.+Remuzziauthor=R.+D.+Totoauthor=N.+D.+Vaziriauthor=C.+Wannerauthor=J.+Wittesauthor=D.+Wrolstadauthor=G.+M.+Chertow&title=Bardoxolone+Methyl+in+Type+2+Diabetes+and+Stage+4+Chronic+Kidney+Disease&doi=10.1056%2FNEJMoa1306033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease</span></div><div class="casAuthors">de Zeeuw, Dick; Akizawa, Tadao; Audhya, Paul; Bakris, George L.; Chin, Melanie; Christ-Schmidt, Heidi; Goldsberry, Angie; Houser, Mark; Krauth, Melissa; Lambers Heerspink, Hiddo J.; McMurray, John J.; Meyer, Colin J.; Parving, Hans-Henrik; Remuzzi, Giuseppe; Toto, Robert D.; Vaziri, Nosratola D.; Wanner, Christoph; Wittes, Janet; Wrolstad, Danielle; Chertow, Glenn M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2492-2503</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Although inhibitors of the renin-angiotensin-aldosterone system can slow the progression of diabetic kidney disease, the residual risk is high.  Whether nuclear I factor (erythroid-derived 2)-related factor 2 activators further reduce this risk is unknown.  METHODS: We randomly assigned 2185 patients with type 2 diabetes mellitus and stage 4 chronic kidney disease (estd. glomerular filtration rate [GFR], 15 to <30 mL per min per 1.73 m2 of body-surface area) to bardoxolone Me, at a daily dose of 20 mg, or placebo.  The primary composite outcome was end-stage renal disease (ESRD) or death from cardiovascular causes.  RESULTS: The sponsor and the steering committee terminated the trial on the recommendation of the independent data and safety monitoring committee; the median follow-up was 9 mo.  A total of 69 of 1088 patients (6%) randomly assigned to bardoxolone Me and 69 of 1097 (6%) randomly assigned to placebo had a primary composite outcome (hazard ratio in the bardoxolone Me group vs. the placebo group, 0.98; 95% confidence interval [CI], 0.70 to 1.37; P = 0.92).  In the bardoxolone Me group, ESRD developed in 43 patients, and 27 patients died from cardiovascular causes; in the placebo group, ESRD developed In 51 patients, and 19 patients died from cardiovascular causes.  A total of 96 patients in the bardoxolone Me group were hospitalized for heart failure or died from heart failure, as compared with 55 in the placebo group (hazard ratio, 1.83; 95% CI, 1.32 to 2.55; P < 0.001).  Estd. GFR, blood pressure, and the urinary albumin-to-creatinine ratio increased significantly and body wt. decreased significantly in the bardoxolone Me group, as compared with the placebo group.  CONCLUSIONS: Among patients with type 2 diabetes mellitus and stage 4 chronic kidney disease, bardoxolone Me did not reduce the risk of ESRD or death from cardiovascular causes.  A higher rate of cardiovascular events with bardoxolone Me than with placebo prompted termination of the trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomI6Z9q4C0LLVg90H21EOLACvtfcHk0lijncal8YmDRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKqs74%253D&md5=1bcc997b57ba700423e0549a617231b5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1306033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1306033%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BZeeuw%26aufirst%3DD.%26aulast%3DAkizawa%26aufirst%3DT.%26aulast%3DAudhya%26aufirst%3DP.%26aulast%3DBakris%26aufirst%3DG.%2BL.%26aulast%3DChin%26aufirst%3DM.%26aulast%3DChrist-Schmidt%26aufirst%3DH.%26aulast%3DGoldsberry%26aufirst%3DA.%26aulast%3DHouser%26aufirst%3DM.%26aulast%3DKrauth%26aufirst%3DM.%26aulast%3DLambers%2BHeerspink%26aufirst%3DH.%2BJ.%26aulast%3DMcMurray%26aufirst%3DJ.%2BJ.%26aulast%3DMeyer%26aufirst%3DC.%2BJ.%26aulast%3DParving%26aufirst%3DH.-H.%26aulast%3DRemuzzi%26aufirst%3DG.%26aulast%3DToto%26aufirst%3DR.%2BD.%26aulast%3DVaziri%26aufirst%3DN.%2BD.%26aulast%3DWanner%26aufirst%3DC.%26aulast%3DWittes%26aufirst%3DJ.%26aulast%3DWrolstad%26aufirst%3DD.%26aulast%3DChertow%26aufirst%3DG.%2BM.%26atitle%3DBardoxolone%2520Methyl%2520in%2520Type%25202%2520Diabetes%2520and%2520Stage%25204%2520Chronic%2520Kidney%2520Disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D2492%26epage%3D2503%26doi%3D10.1056%2FNEJMoa1306033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallesen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solbak, S. M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguayo-Orozco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmona, R. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span> <span> </span><span class="NLM_article-title">A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">8028</span>– <span class="NLM_lpage">8052</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00723</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00723" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFOqt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8028-8052&issue=17&author=K.+T.+Tranauthor=J.+S.+Pallesenauthor=S.+M.+O.+Solbakauthor=D.+Narayananauthor=A.+Baigauthor=J.+Zangauthor=A.+Aguayo-Orozcoauthor=R.+M.+C.+Carmonaauthor=A.+D.+Garciaauthor=A.+Bach&title=A+Comparative+Assessment+Study+of+Known+Small-Molecule+Keap1-Nrf2+Protein-Protein+Interaction+Inhibitors%3A+Chemical+Synthesis%2C+Binding+Properties%2C+and+Cellular+Activity&doi=10.1021%2Facs.jmedchem.9b00723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity</span></div><div class="casAuthors">Tran, Kim T.; Pallesen, Jakob S.; Solbak, Sara M. Oe.; Narayanan, Dilip; Baig, Amina; Zang, Jie; Aguayo-Orozco, Alejandro; Carmona, Rosa M. C.; Garcia, Anthony D.; Bach, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8028-8052</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibiting the protein-protein interaction (PPI) between the transcription factor Nrf2 and its repressor protein Keap1 has emerged as a promising strategy to target oxidative stress in diseases, including central nervous system (CNS) disorders.  Numerous non-covalent small-mol. Keap1-Nrf2 PPI inhibitors have been reported to date, but many feature suboptimal physicochem. properties for permeating the blood-brain barrier, while others contain problematic structural moieties.  Here, we present the first side-by-side assessment of all reported Keap1-Nrf2 PPI inhibitor classes using fluorescence polarization, thermal shift assay, and surface plasmon resonance-and further evaluate the compds. in an NQO1 induction cell assay and in counter tests for nonspecific activities.  Surprisingly, half of the compds. were inactive or deviated substantially from reported activities, while we confirm the cross-assay activities for others.  Through this study, we have identified the most promising Keap1-Nrf2 inhibitors that can serve as pharmacol. probes or starting points for developing CNS-active Keap1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX8UEx5LbA87Vg90H21EOLACvtfcHk0lh7j9sjSTOuLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFOqt73P&md5=a80925ac602d3b3e4cae05bf5454ff34</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00723%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DPallesen%26aufirst%3DJ.%2BS.%26aulast%3DSolbak%26aufirst%3DS.%2BM.%2BO.%26aulast%3DNarayanan%26aufirst%3DD.%26aulast%3DBaig%26aufirst%3DA.%26aulast%3DZang%26aufirst%3DJ.%26aulast%3DAguayo-Orozco%26aufirst%3DA.%26aulast%3DCarmona%26aufirst%3DR.%2BM.%2BC.%26aulast%3DGarcia%26aufirst%3DA.%2BD.%26aulast%3DBach%26aufirst%3DA.%26atitle%3DA%2520Comparative%2520Assessment%2520Study%2520of%2520Known%2520Small-Molecule%2520Keap1-Nrf2%2520Protein-Protein%2520Interaction%2520Inhibitors%253A%2520Chemical%2520Synthesis%252C%2520Binding%2520Properties%252C%2520and%2520Cellular%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D17%26spage%3D8028%26epage%3D8052%26doi%3D10.1021%2Facs.jmedchem.9b00723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2736</span>– <span class="NLM_lpage">2745</span>, <span class="refDoi"> DOI: 10.1021/jm5000529</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5000529" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2736-2745&author=Z.+Y.+Jiangauthor=M.+C.+Luauthor=L.+L.+Xuauthor=T.+T.+Yangauthor=M.+Y.+Xiauthor=X.+L.+Xuauthor=X.+K.+Guoauthor=X.+J.+Zhangauthor=Q.+D.+Youauthor=H.+P.+Sun&title=Discovery+of+Potent+Keap1-Nrf2+Protein-Protein+Interaction+Inhibitor+Based+on+Molecular+Binding+Determinants+Analysis&doi=10.1021%2Fjm5000529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis</span></div><div class="casAuthors">Jiang, Zheng-Yu; Lu, Meng-Chen; Xu, Li-Li; Yang, Ting-Ting; Xi, Mei-Yang; Xu, Xiao-Li; Guo, Xiao-Ke; Zhang, Xiao-Jin; You, Qi-Dong; Sun, Hao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2736-2745</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Keap1 is known to mediate the ubiquitination of Nrf2, a master regulator of the antioxidant response.  Directly interrupting the Keap1-Nrf2 interaction has been emerged as a promising strategy to develop novel class of antioxidant, antiinflammatory, and anticancer agents.  On the basis of the mol. binding determinants anal. of Keap1, we successfully designed and characterized the most potent protein-protein interaction (PPI) inhibitor of Keap1-Nrf2, compd. 2, with KD value of 3.59 nM binding to Keap1 for the first time to single-digit nanomolar.  Compd. 2 can effectively disrupt the Nrf2-Keap1 interaction with an EC50 of 28.6 nM in the fluorescence polarization assay.  It can also activate the Nrf2 transcription activity in the cell-based ARE-luciferase reporter assay in a dose-dependent manner.  The qRT-PCR results of Nrf2 transcription targets gave the consistent results.  These results confirm direct and highly efficient interruption of the Keap1-Nrf2 PPI can be fully achieved by small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRS8nWHc40ZrVg90H21EOLACvtfcHk0lh7j9sjSTOuLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKmtro%253D&md5=b5d43ac3973478ecc54e26c74435f2c4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm5000529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5000529%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DXu%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DT.%2BT.%26aulast%3DXi%26aufirst%3DM.%2BY.%26aulast%3DXu%26aufirst%3DX.%2BL.%26aulast%3DGuo%26aufirst%3DX.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DSun%26aufirst%3DH.%2BP.%26atitle%3DDiscovery%2520of%2520Potent%2520Keap1-Nrf2%2520Protein-Protein%2520Interaction%2520Inhibitor%2520Based%2520on%2520Molecular%2520Binding%2520Determinants%2520Analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2736%26epage%3D2745%26doi%3D10.1021%2Fjm5000529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potteti, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kingsley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciano, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryuzoji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krunic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesecar, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span> <span> </span><span class="NLM_article-title">Probing the Structural Requirements of Non-Electrophilic Naphthalene-Based Nrf2 Activators</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.08.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.ejmech.2015.08.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=26363505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2nsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2015&pages=252-268&author=A.+D.+Jainauthor=H.+Pottetiauthor=B.+G.+Richardsonauthor=L.+Kingsleyauthor=J.+P.+Lucianoauthor=A.+F.+Ryuzojiauthor=H.+Leeauthor=A.+Krunicauthor=A.+D.+Mesecarauthor=S.+P.+Reddyauthor=T.+W.+Moore&title=Probing+the+Structural+Requirements+of+Non-Electrophilic+Naphthalene-Based+Nrf2+Activators&doi=10.1016%2Fj.ejmech.2015.08.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators</span></div><div class="casAuthors">Jain, Atul D.; Potteti, Haranatha; Richardson, Benjamin G.; Kingsley, Laura; Luciano, Julia P.; Ryuzoji, Aya F.; Lee, Hyun; Krunic, Aleksej; Mesecar, Andrew D.; Reddy, Sekhar P.; Moore, Terry W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">252-268</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Activation of the transcription factor Nrf2 has been posited to be a promising therapeutic strategy in a no. of inflammatory and oxidative stress diseases due to its regulation of detoxifying enzymes.  In this work, the authors have developed a comprehensive structure-activity relationship around a known, naphthalene-based nonelectrophilic activator of Nrf2, and the authors report highly potent nonelectrophilic activators of Nrf2.  Computational docking anal. of a subset of the compd. series demonstrates the importance of water mol. displacement for affinity, and the x-ray structure of di-amide I supports the computational anal.  One of the best compds., acid II, has an IC50 of 61 nM in a fluorescence anisotropy assay and a Kd of 120 nM in a surface plasmon resonance assay.  Addnl., the authors demonstrate that the Et ester of II is an efficacious inducer of Nrf2 target genes, exhibiting ex vivo efficacy similar to the well-known electrophilic activator, sulforaphane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzcvlMBGU0C7Vg90H21EOLACvtfcHk0lgBQJ9H3RJLgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2nsrzJ&md5=750fd3ca47f1a122618942312390891b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.08.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.08.049%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DA.%2BD.%26aulast%3DPotteti%26aufirst%3DH.%26aulast%3DRichardson%26aufirst%3DB.%2BG.%26aulast%3DKingsley%26aufirst%3DL.%26aulast%3DLuciano%26aufirst%3DJ.%2BP.%26aulast%3DRyuzoji%26aufirst%3DA.%2BF.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKrunic%26aufirst%3DA.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26aulast%3DReddy%26aufirst%3DS.%2BP.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26atitle%3DProbing%2520the%2520Structural%2520Requirements%2520of%2520Non-Electrophilic%2520Naphthalene-Based%2520Nrf2%2520Activators%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D103%26spage%3D252%26epage%3D268%26doi%3D10.1016%2Fj.ejmech.2015.08.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winkel, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margerie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szillat, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glombik, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Güssregen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herling, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Knethen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmoll, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">28446</span>– <span class="NLM_lpage">28455</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.678136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1074%2Fjbc.M115.678136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=26459563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOlsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=28446-28455&author=A.+F.+Winkelauthor=C.+K.+Engelauthor=D.+Margerieauthor=A.+Kanntauthor=H.+Szillatauthor=H.+Glombikauthor=C.+Kallusauthor=S.+Rufauthor=S.+G%C3%BCssregenauthor=J.+Riedelauthor=A.+W.+Herlingauthor=A.+Von+Knethenauthor=A.+Weigertauthor=B.+Br%C3%BCneauthor=D.+Schmoll&title=Characterization+of+RA839%2C+a+Noncovalent+Small+Molecule+Binder+to+Keap1+and+Selective+Activator+of+Nrf2+Signaling&doi=10.1074%2Fjbc.M115.678136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling</span></div><div class="casAuthors">Winkel, Angelika F.; Engel, Christian K.; Margerie, Daniel; Kannt, Aimo; Szillat, Hauke; Glombik, Heiner; Kallus, Christopher; Ruf, Sven; Guessregen, Stefan; Riedel, Jens; Herling, Andreas W.; von Knethen, Andreas; Weigert, Andreas; Bruene, Bernhard; Schmoll, Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">28446-28455</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The activation of the transcription factor NF-E2-related factor 2 (Nrf2) maintains cellular homeostasis in response to oxidative stress by the regulation of multiple cytoprotective genes.  Without stressors, the activity of Nrf2 is inhibited by its interaction with the Keap1 (kelch-like ECH-assocd. protein 1).  Here, we describe (3S)-1-[4-[(2,3,5,6-tetramethylphenyl) sulfonylamino]-1-naphthyl]pyrrolidine-3-carboxylic acid (RA839), a small mol. that binds noncovalently to the Nrf2-interacting kelch domain of Keap1 with a Kd of ∼6 μm, as demonstrated by x-ray co-crystn. and isothermal titrn. calorimetry.  Whole genome DNA arrays showed that at 10 μm RA839 significantly regulated 105 probe sets in bone marrow-derived macrophages.  Canonical pathway mapping of these probe sets revealed an activation of pathways linked with Nrf2 signaling.  These pathways were also activated after the activation of Nrf2 by the silencing of Keap1 expression.  RA839 regulated only two genes in Nrf2 knock-out macrophages.  Similar to the activation of Nrf2 by either silencing of Keap1 expression or by the reactive compd. 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid Me ester (CDDO-Me), RA839 prevented the induction of both inducible nitric-oxide synthase expression and nitric oxide release in response to lipopolysaccharides in macrophages.  In mice, RA839 acutely induced Nrf2 target gene expression in liver.  RA839 is a selective inhibitor of the Keap1/Nrf2 interaction and a useful tool compd. to study the biol. of Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqu4FlVebzcbVg90H21EOLACvtfcHk0lgBQJ9H3RJLgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOlsrjF&md5=082998a0e4685dc8622662270fbba223</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.678136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.678136%26sid%3Dliteratum%253Aachs%26aulast%3DWinkel%26aufirst%3DA.%2BF.%26aulast%3DEngel%26aufirst%3DC.%2BK.%26aulast%3DMargerie%26aufirst%3DD.%26aulast%3DKannt%26aufirst%3DA.%26aulast%3DSzillat%26aufirst%3DH.%26aulast%3DGlombik%26aufirst%3DH.%26aulast%3DKallus%26aufirst%3DC.%26aulast%3DRuf%26aufirst%3DS.%26aulast%3DG%25C3%25BCssregen%26aufirst%3DS.%26aulast%3DRiedel%26aufirst%3DJ.%26aulast%3DHerling%26aufirst%3DA.%2BW.%26aulast%3DVon%2BKnethen%26aufirst%3DA.%26aulast%3DWeigert%26aufirst%3DA.%26aulast%3DBr%25C3%25BCne%26aufirst%3DB.%26aulast%3DSchmoll%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520RA839%252C%2520a%2520Noncovalent%2520Small%2520Molecule%2520Binder%2520to%2520Keap1%2520and%2520Selective%2520Activator%2520of%2520Nrf2%2520Signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D28446%26epage%3D28455%26doi%3D10.1074%2Fjbc.M115.678136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wixted, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths-Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMenamin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, H. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottom, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kou, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonchuk, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldser, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognese, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podolin, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, J. K.</span></span> <span> </span><span class="NLM_article-title">Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3991</span>– <span class="NLM_lpage">4006</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00228</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00228" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1Gjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3991-4006&author=T.+G.+Daviesauthor=W.+E.+Wixtedauthor=J.+E.+Coyleauthor=C.+Griffiths-Jonesauthor=K.+Hearnauthor=R.+McMenaminauthor=D.+Nortonauthor=S.+J.+Richauthor=C.+Richardsonauthor=G.+Saxtyauthor=H.+M.+G.+Willemsauthor=A.+J.+A.+Woolfordauthor=J.+E.+Cottomauthor=J.+P.+Kouauthor=J.+G.+Yonchukauthor=H.+G.+Feldserauthor=Y.+Sanchezauthor=J.+P.+Foleyauthor=B.+J.+Bologneseauthor=G.+Loganauthor=P.+L.+Podolinauthor=H.+Yanauthor=J.+F.+Callahanauthor=T.+D.+Heightmanauthor=J.+K.+Kerns&title=Monoacidic+Inhibitors+of+the+Kelch-like+ECH-Associated+Protein+1%3A+Nuclear+Factor+Erythroid+2-Related+Factor+2+%28KEAP1%3ANRF2%29+Protein-Protein+Interaction+with+High+Cell+Potency+Identified+by+Fragment-Based+Discovery&doi=10.1021%2Facs.jmedchem.6b00228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery</span></div><div class="casAuthors">Davies, Thomas G.; Wixted, William E.; Coyle, Joseph E.; Griffiths-Jones, Charlotte; Hearn, Keisha; McMenamin, Rachel; Norton, David; Rich, Sharna J.; Richardson, Caroline; Saxty, Gordon; Willems, Henriette M. G.; Woolford, Alison J.-A.; Cottom, Joshua E.; Kou, Jen-Pyng; Yonchuk, John G.; Feldser, Heidi G.; Sanchez, Yolanda; Foley, Joseph P.; Bolognese, Brian J.; Logan, Gregory; Podolin, Patricia L.; Yan, Hongxing; Callahan, James F.; Heightman, Tom D.; Kerns, Jeffrey K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3991-4006</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">KEAP1 is the key regulator of the NRF2-mediated cytoprotective response, and increasingly recognized as a target for diseases involving oxidative stress.  Pharmacol. intervention has focused on mols. that decrease NRF2-ubiquitination through covalent modification of KEAP1 cysteine residues, but such electrophilic compds. lack selectivity and may be assocd. with off-target toxicity.  We report here the first use of a fragment-based approach to directly target the KEAP1 Kelch-NRF2 interaction.  X-ray crystallog. screening identified three distinct "hot-spots" for fragment binding within the NRF2 binding pocket of KEAP1, allowing progression of a weak fragment hit to mols. with nanomolar affinity for KEAP1 while maintaining drug-like properties.  This work resulted in a promising lead compd. (I) which exhibits tight and selective binding to KEAP1, and activates the NRF2 antioxidant response in cellular and in vivo models, thereby providing a high quality chem. probe to explore the therapeutic potential of disrupting the KEAP1-NRF2 interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq-gfBTuYreLVg90H21EOLACvtfcHk0lgBQJ9H3RJLgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Gjtr0%253D&md5=ae42cc9f06d14b340cb3a8f5d6c157a7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00228%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DWixted%26aufirst%3DW.%2BE.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DGriffiths-Jones%26aufirst%3DC.%26aulast%3DHearn%26aufirst%3DK.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DNorton%26aufirst%3DD.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DWillems%26aufirst%3DH.%2BM.%2BG.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%2BA.%26aulast%3DCottom%26aufirst%3DJ.%2BE.%26aulast%3DKou%26aufirst%3DJ.%2BP.%26aulast%3DYonchuk%26aufirst%3DJ.%2BG.%26aulast%3DFeldser%26aufirst%3DH.%2BG.%26aulast%3DSanchez%26aufirst%3DY.%26aulast%3DFoley%26aufirst%3DJ.%2BP.%26aulast%3DBolognese%26aufirst%3DB.%2BJ.%26aulast%3DLogan%26aufirst%3DG.%26aulast%3DPodolin%26aufirst%3DP.%2BL.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DKerns%26aufirst%3DJ.%2BK.%26atitle%3DMonoacidic%2520Inhibitors%2520of%2520the%2520Kelch-like%2520ECH-Associated%2520Protein%25201%253A%2520Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528KEAP1%253ANRF2%2529%2520Protein-Protein%2520Interaction%2520with%2520High%2520Cell%2520Potency%2520Identified%2520by%2520Fragment-Based%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3991%26epage%3D4006%26doi%3D10.1021%2Facs.jmedchem.6b00228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarparin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths-Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakdawala, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMenamin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortenson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumsey, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, H. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, T. G.</span></span> <span> </span><span class="NLM_article-title">Structure–Activity and Structure–Conformation Relationships of Aryl Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1/Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1/NRF2) Protein–Protein Interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4683</span>– <span class="NLM_lpage">4702</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00279</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00279" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntlegs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4683-4702&author=T.+D.+Heightmanauthor=J.+F.+Callahanauthor=E.+Chiarparinauthor=J.+E.+Coyleauthor=C.+Griffiths-Jonesauthor=A.+S.+Lakdawalaauthor=R.+McMenaminauthor=P.+N.+Mortensonauthor=D.+Nortonauthor=T.+M.+Peakmanauthor=S.+J.+Richauthor=C.+Richardsonauthor=W.+L.+Rumseyauthor=Y.+Sanchezauthor=G.+Saxtyauthor=H.+M.+G.+Willemsauthor=L.+Wolfeauthor=A.+J.-A.+Woolfordauthor=Z.+Wuauthor=H.+Yanauthor=J.+K.+Kernsauthor=T.+G.+Davies&title=Structure%E2%80%93Activity+and+Structure%E2%80%93Conformation+Relationships+of+Aryl+Propionic+Acid+Inhibitors+of+the+Kelch-like+ECH-Associated+Protein+1%2FNuclear+Factor+Erythroid+2-Related+Factor+2+%28KEAP1%2FNRF2%29+Protein%E2%80%93Protein+Interaction&doi=10.1021%2Facs.jmedchem.9b00279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity and Structure-Conformation Relationships of Aryl Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1/Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1/NRF2) Protein-Protein Interaction</span></div><div class="casAuthors">Heightman, Tom D.; Callahan, James F.; Chiarparin, Elisabetta; Coyle, Joseph E.; Griffiths-Jones, Charlotte; Lakdawala, Ami S.; McMenamin, Rachel; Mortenson, Paul N.; Norton, David; Peakman, Torren M.; Rich, Sharna J.; Richardson, Caroline; Rumsey, William L.; Sanchez, Yolanda; Saxty, Gordon; Willems, Henriette M. G.; Wolfe, Lawrence; Woolford, Alison J.-A.; Wu, Zining; Yan, Hongxing; Kerns, Jeffrey K.; Davies, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4683-4702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The KEAP1-NRF2-mediated cytoprotective response plays a key role in cellular homoeostasis.  Insufficient NRF2 signaling during chronic oxidative stress may be assocd. with the pathophysiol. of several diseases with an inflammatory component, and pathway activation through direct modulation of the KEAP1-NRF2 protein-protein interaction is being increasingly explored as a potential therapeutic strategy.  Nevertheless, the physicochem. nature of the KEAP1-NRF2 interface suggests that achieving high affinity for a cell-penetrant druglike inhibitor might be challenging.  We recently reported the discovery of a highly potent tool compd. which was used to probe the biol. assocd. with directly disrupting the interaction of NRF2 with the KEAP1 Kelch domain.  We now present a detailed account of the medicinal chem. campaign leading to this mol., which included exploration and optimization of protein-ligand interactions in three energetic "hot spots" identified by fragment screening.  In particular, we also discuss how consideration of ligand conformational stabilization was important to its development and present evidence for preorganization of the lead compd. which may contribute to its high affinity and cellular activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraCUAFq5SVmLVg90H21EOLACvtfcHk0lgw4A-8oX42ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntlegs7c%253D&md5=b946f7b770bc2c4e020e7e796483a753</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00279%26sid%3Dliteratum%253Aachs%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DChiarparin%26aufirst%3DE.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DGriffiths-Jones%26aufirst%3DC.%26aulast%3DLakdawala%26aufirst%3DA.%2BS.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DNorton%26aufirst%3DD.%26aulast%3DPeakman%26aufirst%3DT.%2BM.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DRumsey%26aufirst%3DW.%2BL.%26aulast%3DSanchez%26aufirst%3DY.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DWillems%26aufirst%3DH.%2BM.%2BG.%26aulast%3DWolfe%26aufirst%3DL.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.-A.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DKerns%26aufirst%3DJ.%2BK.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26atitle%3DStructure%25E2%2580%2593Activity%2520and%2520Structure%25E2%2580%2593Conformation%2520Relationships%2520of%2520Aryl%2520Propionic%2520Acid%2520Inhibitors%2520of%2520the%2520Kelch-like%2520ECH-Associated%2520Protein%25201%252FNuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528KEAP1%252FNRF2%2529%2520Protein%25E2%2580%2593Protein%2520Interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4683%26epage%3D4702%26doi%3D10.1021%2Facs.jmedchem.9b00279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pallesen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span> <span> </span><span class="NLM_article-title">Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8088</span>– <span class="NLM_lpage">8103</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00358</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00358" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt12hsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8088-8103&author=J.+S.+Pallesenauthor=K.+T.+Tranauthor=A.+Bach&title=Non-covalent+Small-Molecule+Kelch-like+ECH-Associated+Protein+1-Nuclear+Factor+Erythroid+2-Related+Factor+2+%28Keap1-Nrf2%29+Inhibitors+and+Their+Potential+for+Targeting+Central+Nervous+System+Diseases&doi=10.1021%2Facs.jmedchem.8b00358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases</span></div><div class="casAuthors">Pallesen, Jakob S.; Tran, Kim T.; Bach, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8088-8103</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) has a protective effect against oxidative stress and plays a major role in inflammation and central nervous system (CNS) diseases.  Inhibition of the protein-protein interaction (PPI) between Nrf2 and its repressor protein, Kelch-like ECH-assocd. protein 1 (Keap1), leads to translocation of Nrf2 from the cytosol to the nucleus and expression of detoxifying antioxidant enzymes.  To date, several non-covalent small-mol. Keap1-Nrf2 inhibitors have been identified; however, many of them contain carboxylic acids and are rather large in size, which likely prevents or decreases CNS permeability.  This Perspective describes current small-mol. Keap1-Nrf2 inhibitors with exptl. evidence for the ability to inhibit the Keap1-Nrf2 interaction by binding to Keap1 in a non-covalent manner.  Binding data, biostructural studies, and biol. activity are summarized for the inhibitors, and their potential as CNS tool compds. is discussed by analyzing physicochem. properties, including CNS multiparameter optimization (MPO) scoring algorithms.  Finally, several strategies for identifying CNS-targeting Keap1 inhibitors are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAnObBnG8ca7Vg90H21EOLACvtfcHk0lgw4A-8oX42ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt12hsb8%253D&md5=0492259af2532169001a1d4ef532fdbb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00358%26sid%3Dliteratum%253Aachs%26aulast%3DPallesen%26aufirst%3DJ.%2BS.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DBach%26aufirst%3DA.%26atitle%3DNon-covalent%2520Small-Molecule%2520Kelch-like%2520ECH-Associated%2520Protein%25201-Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528Keap1-Nrf2%2529%2520Inhibitors%2520and%2520Their%2520Potential%2520for%2520Targeting%2520Central%2520Nervous%2520System%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8088%26epage%3D8103%26doi%3D10.1021%2Facs.jmedchem.8b00358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speltz, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span> <span> </span><span class="NLM_article-title">Non-electrophilic Modulators of the Canonical Keap1/Nrf2 Pathway</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2261</span>– <span class="NLM_lpage">2268</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.bmcl.2015.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=25937010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslehs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2261-2268&issue=11&author=B.+G.+Richardsonauthor=A.+D.+Jainauthor=T.+E.+Speltzauthor=T.+W.+Moore&title=Non-electrophilic+Modulators+of+the+Canonical+Keap1%2FNrf2+Pathway&doi=10.1016%2Fj.bmcl.2015.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway</span></div><div class="casAuthors">Richardson, B. G.; Jain, A. D.; Speltz, T. E.; Moore, T. W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2261-2268</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nrf2 is the major transcription factor that regulates many of the cytoprotective enzymes involved in the adaptive stress response.  Modulation of Nrf2 could be therapeutically useful in a no. of disease states.  Activation can occur through either an electrophilic or non-electrophilic mechanism.  To date, most of the research has focused on electrophilic Nrf2 activators, but there is increasing interest in non-electrophilic modulators of Nrf2.  This Digest examines the current selection of small mols. that modulate Nrf2 through non-electrophilic mechanisms, and it highlights new opportunities for this important therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojMkBabiNYC7Vg90H21EOLACvtfcHk0liAQhnYdqthHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslehs7c%253D&md5=2e5ec64ce19ef7805892ea70a240c7df</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DB.%2BG.%26aulast%3DJain%26aufirst%3DA.%2BD.%26aulast%3DSpeltz%26aufirst%3DT.%2BE.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26atitle%3DNon-electrophilic%2520Modulators%2520of%2520the%2520Canonical%2520Keap1%252FNrf2%2520Pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D11%26spage%3D2261%26epage%3D2268%26doi%3D10.1016%2Fj.bmcl.2015.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span> <span> </span><span class="NLM_article-title">The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">924</span>– <span class="NLM_lpage">963</span>, <span class="refDoi"> DOI: 10.1002/med.21396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1002%2Fmed.21396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=27192495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSms7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=924-963&issue=5&author=M.+C.+Luauthor=J.+A.+Jiauthor=Z.+Y.+Jiangauthor=Q.+D.+You&title=The+Keap1-Nrf2-ARE+Pathway+As+a+Potential+Preventive+and+Therapeutic+Target%3A+An+Update&doi=10.1002%2Fmed.21396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update</span></div><div class="casAuthors">Lu, Meng-Chen; Ji, Jian-Ai; Jiang, Zheng-Yu; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">924-963</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Keap1-Nrf2-ARE ((Kelch-like ECH-Assocg. protein 1) nuclear factor erythroid 2 related factor 2-antioxidant response element) pathway is one of the most important defense mechanisms against oxidative and/or electrophilic stresses, and it is closely assocd. with inflammatory diseases, including cancer, neurodegenerative diseases, cardiovascular diseases, and aging.  In recent years, progress has been made in strategies aimed at modulating the Keap1-Nrf2-ARE pathway.  The Nrf2 activator DMF (Dimethylfumarates) has been approved by the FDA as a new first-line oral drug to treat patients with relapsing forms of multiple sclerosis, while a phase 3 study of another promising candidate, CDDO-Me, was terminated for safety reasons.  Directly inhibiting Keap1-Nrf2 protein-protein interactions as a novel Nrf2-modulating strategy has many advantages over using electrophilic Nrf2 activators.  The development of Keap1-Nrf2 protein-protein interaction inhibitors has become a topic of intense research, and potent inhibitors of this target have been identified.  In addn., inhibiting Nrf2 activity has attracted an increasing amt. of attention because it may provide an alternative cancer therapy.  This review summarizes the mol. mechanisms and biol. functions of the Keap1-Nrf2-ARE system.  The main focus of this review is on recent progress in studies of agents that target the Keap1-Nrf2-ARE pathway and the therapeutic applications of such agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFT_JWBNP5w7Vg90H21EOLACvtfcHk0liAQhnYdqthHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSms7bL&md5=b5514acfaaa6ecb31efe0d75387dd56e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fmed.21396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21396%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DJi%26aufirst%3DJ.%2BA.%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26atitle%3DThe%2520Keap1-Nrf2-ARE%2520Pathway%2520As%2520a%2520Potential%2520Preventive%2520and%2520Therapeutic%2520Target%253A%2520An%2520Update%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2016%26volume%3D36%26issue%3D5%26spage%3D924%26epage%3D963%26doi%3D10.1002%2Fmed.21396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span> <span> </span><span class="NLM_article-title">Peptide and Small Molecule Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">674</span>– <span class="NLM_lpage">679</span>, <span class="refDoi"> DOI: 10.1042/BST20150051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1042%2FBST20150051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=26551711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=674-679&issue=4&author=G.+Wells&title=Peptide+and+Small+Molecule+Inhibitors+of+the+Keap1-Nrf2+Protein-Protein+Interaction&doi=10.1042%2FBST20150051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction</span></div><div class="casAuthors">Wells, Geoff</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">674-679</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The transcription factor nuclear factor erythroid-2-related factor 2 (Nrf2) up-regulates the expression of a range of cytoprotective enzymes with antioxidant response elements in their promoter regions and thus can protect cells against oxidative damage.  Increasing Nrf2 activity has been proposed as a therapeutic intervention in a range of chronic neurodegenerative conditions and cancer chemoprevention.  One of the main mechanisms by which Nrf2 is neg. regulated involves an interaction with the ubiquitination facilitator protein, Kelch-like ECH-assocd. protein 1 (Keap1) that facilitates degrdn. of Nrf2.  Inhibition of this process underlies the mode of action of a broad group of compds. that increase Nrf2 activity.  A no. of natural products, including the isothiocyanate sulforaphane, up-regulate Nrf2 by interacting with Keap1 in a covalent manner to stall its activity.  Recently, a no. of peptide and small mol. inhibitors of the protein-protein interaction (PPI) between Keap1 and Nrf2 have been described.  These classes of compd. have contrasting modes of action at the mol. level and there is emerging evidence that their biol. activities have similarities and differences.  This review describes the various classes of PPI inhibitor that have been described in the literature and the biol. evaluations that have been performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjQzcvZNfjrLVg90H21EOLACvtfcHk0ljT2tQWPTHnoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsb3E&md5=2cb4acbd2a04ecdf29424638894c81e3</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1042%2FBST20150051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20150051%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DG.%26atitle%3DPeptide%2520and%2520Small%2520Molecule%2520Inhibitors%2520of%2520the%2520Keap1-Nrf2%2520Protein-Protein%2520Interaction%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2015%26volume%3D43%26issue%3D4%26spage%3D674%26epage%3D679%26doi%3D10.1042%2FBST20150051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potteti, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzara, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamatam, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choma, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skowron, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dye, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krunic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span> <span> </span><span class="NLM_article-title">Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8029</span>– <span class="NLM_lpage">8047</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01133</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01133" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFertbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8029-8047&author=B.+G.+Richardsonauthor=A.+D.+Jainauthor=H.+R.+Pottetiauthor=P.+R.+Lazzaraauthor=B.+P.+Davidauthor=C.+R.+Tamatamauthor=E.+Chomaauthor=K.+Skowronauthor=K.+Dyeauthor=Z.+Siddiquiauthor=Y.+T.+Wangauthor=A.+Krunicauthor=S.+P.+Reddyauthor=T.+W.+Moore&title=Replacement+of+a+Naphthalene+Scaffold+in+Kelch-like+ECH-Associated+Protein+1+%28KEAP1%29%2FNuclear+Factor+%28Erythroid-derived+2%29-like+2+%28NRF2%29+Inhibitors&doi=10.1021%2Facs.jmedchem.8b01133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) Inhibitors</span></div><div class="casAuthors">Richardson, Benjamin G.; Jain, Atul D.; Potteti, Haranatha R.; Lazzara, Phillip R.; David, Brian P.; Tamatam, Chandra R.; Choma, Ewelina; Skowron, Kornelia; Dye, Katherine; Siddiqui, Zamia; Wang, Yue-Ting; Krunic, Aleksej; Reddy, Sekhar P.; Moore, Terry W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8029-8047</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activators of nuclear factor-erythroid 2-related factor 2 (NRF2) could lead to promising therapeutics for prevention and treatment of oxidative stress and inflammatory disorders.  Ubiquitination and subsequent degrdn. of the transcription factor NRF2 is mediated by Kelch-like ECH-assocd. protein-1 (KEAP1).  Inhibition of the KEAP1/NRF2 interaction with small mols. leads to NRF2 activation.  Previously, we and others described naphthalene-based NRF2 activators, but the 1,4-diaminonaphthalene scaffold may not represent a drug-like scaffold.  Paying particular attention to aq. soly., metabolic stability, potency, and mutagenicity, we modified a previously known, naphthalene-based nonelectrophilic NRF2 activator to give a series of non-naphthalene and heterocyclic scaffolds.  We found that, compared to previously reported naphthalene-based compds., a 1,4-isoquinoline scaffold provides a better mutagenic profile without sacrificing potency, stability, or soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP0I8lhXc6Q7Vg90H21EOLACvtfcHk0ljT2tQWPTHnoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFertbfE&md5=69c77e7ee6f55d87ca61ef78a734c964</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01133%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DB.%2BG.%26aulast%3DJain%26aufirst%3DA.%2BD.%26aulast%3DPotteti%26aufirst%3DH.%2BR.%26aulast%3DLazzara%26aufirst%3DP.%2BR.%26aulast%3DDavid%26aufirst%3DB.%2BP.%26aulast%3DTamatam%26aufirst%3DC.%2BR.%26aulast%3DChoma%26aufirst%3DE.%26aulast%3DSkowron%26aufirst%3DK.%26aulast%3DDye%26aufirst%3DK.%26aulast%3DSiddiqui%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%2BT.%26aulast%3DKrunic%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DS.%2BP.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26atitle%3DReplacement%2520of%2520a%2520Naphthalene%2520Scaffold%2520in%2520Kelch-like%2520ECH-Associated%2520Protein%25201%2520%2528KEAP1%2529%252FNuclear%2520Factor%2520%2528Erythroid-derived%25202%2529-like%25202%2520%2528NRF2%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8029%26epage%3D8047%26doi%3D10.1021%2Facs.jmedchem.8b01133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, M.</span></span> <span> </span><span class="NLM_article-title">Intermolecular Amidation of Quinoline N-Oxides with Arylsulfonamides under Metal-Free Conditions</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6088</span>– <span class="NLM_lpage">6091</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.7b02922</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.7b02922" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslClsr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=6088-6091&author=X.+Yuauthor=S.+Yangauthor=Y.+Zhangauthor=M.+Guoauthor=Y.+Yamamotoauthor=M.+Bao&title=Intermolecular+Amidation+of+Quinoline+N-Oxides+with+Arylsulfonamides+under+Metal-Free+Conditions&doi=10.1021%2Facs.orglett.7b02922"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Intermolecular Amidation of Quinoline N-Oxides with Arylsulfonamides under Metal-Free Conditions</span></div><div class="casAuthors">Yu, Xiaoqiang; Yang, Sana; Zhang, Yue; Guo, Mingju; Yamamoto, Yoshinori; Bao, Ming</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6088-6091</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient method for the synthesis of N-(quinolin-2-yl)sulfonamides I (Ar = Ph, 4-MeC6H4, 4-BrC6H4, etc.; R = H, 4-Me, 3-Me, 6-MeO, etc.) is described.  The intermol. amidation of quinoline N-oxides with sulfonamides proceeded smoothly in the presence of PhI(OAc)2 and PPh3 to afford N-(quinolin-2-yl)sulfonamides in satisfactory to excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwrxoDCPrrcrVg90H21EOLACvtfcHk0ljT2tQWPTHnoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslClsr%252FP&md5=09888cb54c4c0707f13b7cf39dc0e32e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.7b02922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.7b02922%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DBao%26aufirst%3DM.%26atitle%3DIntermolecular%2520Amidation%2520of%2520Quinoline%2520N-Oxides%2520with%2520Arylsulfonamides%2520under%2520Metal-Free%2520Conditions%26jtitle%3DOrg.%2520Lett.%26date%3D2017%26volume%3D19%26spage%3D6088%26epage%3D6091%26doi%3D10.1021%2Facs.orglett.7b02922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inoyama, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beamer, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">Optimization of Fluorescently Labeled Nrf2 Peptide Probes and the Development of a Fluorescence Polarization Assay for the Discovery of Inhibitors of Keap1-Nrf2 Interaction</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1177/1087057111430124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1177%2F1087057111430124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=22156223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlGktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=435-447&issue=4&author=D.+Inoyamaauthor=Y.+Chenauthor=X.+Huangauthor=L.+J.+Beamerauthor=A.+N.+Kongauthor=L.+Hu&title=Optimization+of+Fluorescently+Labeled+Nrf2+Peptide+Probes+and+the+Development+of+a+Fluorescence+Polarization+Assay+for+the+Discovery+of+Inhibitors+of+Keap1-Nrf2+Interaction&doi=10.1177%2F1087057111430124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of fluorescently labeled Nrf2 peptide probes and the development of a fluorescence polarization assay for the discovery of inhibitors of Keap I-Nrf2 interaction</span></div><div class="casAuthors">Inoyama, Daigo; Chen, Yu; Huang, Xinyi; Beamer, Lesa J.; Kong, Ah-Ng Tony; Hu, Longqin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">435-447</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Activation of the antioxidant response element (ARE) upregulates enzymes involved in detoxification of electrophiles and reactive oxygen species.  The induction of ARE genes is regulated by the interaction between redox sensor protein Keap1 and the transcription factor Nrf2.  Fluorescently labeled Nrf2 peptides contg. the ETGE motif were synthesized and optimized as tracers in the development of a fluorescence polarization (FP) assay to identify small-mol. inhibitors of the Keap1-Nrf2 interaction.  The tracers were optimized to increase the dynamic range of the assay and their binding affinities to the Keap1 Kelch domain.  The binding affinities of Nrf2 peptide inhibitors obtained in our FP assay using FITC-9mer Nrf2 peptide amide as the probe were in good agreement with those obtained previously by a surface plasmon resonance assay.  The FP assay exhibits considerable tolerance toward DMSO and produced a Z' factor greater than 0.6 in a 384-well format.  Further optimization of the probe led to cyanine-labeled 9mer Nrf2 peptide amide, which can be used along with the FITC-9mer Nrf2 peptide amide in a high-throughput screening assay to discover small-mol. inhibitors of Keap1-Nrf2 interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhQhh_psWArVg90H21EOLACvtfcHk0liM53t7Yd5_LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlGktL4%253D&md5=91348dd302ddbe9cb9d3d9c21a2097f6</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1177%2F1087057111430124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057111430124%26sid%3Dliteratum%253Aachs%26aulast%3DInoyama%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBeamer%26aufirst%3DL.%2BJ.%26aulast%3DKong%26aufirst%3DA.%2BN.%26aulast%3DHu%26aufirst%3DL.%26atitle%3DOptimization%2520of%2520Fluorescently%2520Labeled%2520Nrf2%2520Peptide%2520Probes%2520and%2520the%2520Development%2520of%2520a%2520Fluorescence%2520Polarization%2520Assay%2520for%2520the%2520Discovery%2520of%2520Inhibitors%2520of%2520Keap1-Nrf2%2520Interaction%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2012%26volume%3D17%26issue%3D4%26spage%3D435%26epage%3D447%26doi%3D10.1177%2F1087057111430124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinner, M. J.</span></span> <span> </span><span class="NLM_article-title">Getting Across the Cell Membrane: An Overview for Small Molecules, Peptides, and Proteins</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1266</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-2272-7_3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1007%2F978-1-4939-2272-7_3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=25560066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Siur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1266&publication_year=2015&pages=29-53&author=N.+J.+Yangauthor=M.+J.+Hinner&title=Getting+Across+the+Cell+Membrane%3A+An+Overview+for+Small+Molecules%2C+Peptides%2C+and+Proteins&doi=10.1007%2F978-1-4939-2272-7_3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Getting Across the Cell Membrane: An Overview for Small Molecules, Peptides, and Proteins</span></div><div class="casAuthors">Yang, Nicole J.; Hinner, Marlon J.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1266</span>
        (<span class="NLM_cas:issue">Site-Specific Protein Labeling</span>),
    <span class="NLM_cas:pages">29-53</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The ability to efficiently access cytosolic proteins is desired in both biol. research and medicine.  However, targeting intracellular proteins is often challenging, because to reach the cytosol, exogenous mols. must first traverse the cell membrane.  This review provides a broad overview of how certain mols. are thought to cross this barrier, and what kinds of approaches are being made to enhance the intracellular delivery of those that are impermeable.  We first discuss rules that govern the passive permeability of small mols. across the lipid membrane, and mechanisms of membrane transport that have evolved in nature for certain metabolites, peptides, and proteins.  Then, we introduce design strategies that have emerged in the development of small mols. and peptides with improved permeability.  Finally, intracellular delivery systems that have been engineered for protein payloads are surveyed.  Viewpoints from varying disciplines have been brought together to provide a cohesive overview of how the membrane barrier is being overcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptS-9wM3Z8jbVg90H21EOLACvtfcHk0liM53t7Yd5_LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Siur4%253D&md5=4002e2e8ab2fcc86d9ea400e1aa2a29b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-2272-7_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-2272-7_3%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DN.%2BJ.%26aulast%3DHinner%26aufirst%3DM.%2BJ.%26atitle%3DGetting%2520Across%2520the%2520Cell%2520Membrane%253A%2520An%2520Overview%2520for%2520Small%2520Molecules%252C%2520Peptides%252C%2520and%2520Proteins%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2015%26volume%3D1266%26spage%3D29%26epage%3D53%26doi%3D10.1007%2F978-1-4939-2272-7_3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wenlock, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1250</span>– <span class="NLM_lpage">1256</span>, <span class="refDoi"> DOI: 10.1021/jm021053p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm021053p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1250-1256&issue=7&author=M.+C.+Wenlockauthor=R.+P.+Austinauthor=P.+Bartonauthor=A.+M.+Davisauthor=P.+D.+Leeson&title=A+Comparison+of+Physiochemical+Property+Profiles+of+Development+and+Marketed+Oral+Drugs&doi=10.1021%2Fjm021053p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs</span></div><div class="casAuthors">Wenlock, Mark C.; Austin, Rupert P.; Barton, Patrick; Davis, Andrew M.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1250-1256</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The process of drug discovery applies rigorous selection pressures.  Marketed oral drugs will generally possess favorable physiochem. properties with respect to absorption, metab., distribution, and clearance.  This paper describes a study in which the distributions of physiochem. properties of oral drugs in different phases of clin. development are compared to those already marketed.  The aim is to identify the trends in physiochem. properties that favor a drug's successful passage through clin. development and on to the market.  Two libraries were created, one of current development oral drugs and one of marketed oral drugs.  Statistical anal. of the two showed that the mean mol. wt. of orally administered drugs in development decreases on passing through each of the different clin. phases and gradually converges toward the mean mol. wt. of marketed oral drugs.  It is also clear that the most lipophilic compds. are being discontinued from development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF0PksUFJq0bVg90H21EOLACvtfcHk0liM53t7Yd5_LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbY%253D&md5=b9809c803a61ec99a1b4171e97952452</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm021053p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm021053p%26sid%3Dliteratum%253Aachs%26aulast%3DWenlock%26aufirst%3DM.%2BC.%26aulast%3DAustin%26aufirst%3DR.%2BP.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DA%2520Comparison%2520of%2520Physiochemical%2520Property%2520Profiles%2520of%2520Development%2520and%2520Marketed%2520Oral%2520Drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D7%26spage%3D1250%26epage%3D1256%26doi%3D10.1021%2Fjm021053p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahr, A.</span></span> <span> </span><span class="NLM_article-title">Lipophilicity and its Relationship with Passive Drug Permeation</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">977</span>, <span class="refDoi"> DOI: 10.1007/s11095-010-0303-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1007%2Fs11095-010-0303-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=21052797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlOqtrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=962-977&issue=5&author=X.+Liuauthor=B.+Testaauthor=A.+Fahr&title=Lipophilicity+and+its+Relationship+with+Passive+Drug+Permeation&doi=10.1007%2Fs11095-010-0303-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity and Its Relationship with Passive Drug Permeation</span></div><div class="casAuthors">Liu, Xiangli; Testa, Bernard; Fahr, Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">962-977</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In this review, we first summarize the structure and properties of biol. membranes and the routes of passive drug transfer through physiol. barriers.  Lipophilicity is then introduced in terms of the intermol. interactions it encodes.  Finally, lipophilicity indexes from isotropic solvent systems and from anisotropic membrane-like systems are discussed for their capacity to predict passive drug permeation across biol. membranes such as the intestinal epithelium, the blood-brain barrier (BBB) or the skin.  The broad evidence presented here shows that beyond the predictive power of lipophilicity parameters, the various intermol. forces they encode allow a mechanistic interpretation of passive drug permeation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxn2Ic1yX8SbVg90H21EOLACvtfcHk0liM53t7Yd5_LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlOqtrzK&md5=6bd2bb54a14574f31b046204f260595a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2Fs11095-010-0303-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-010-0303-7%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DFahr%26aufirst%3DA.%26atitle%3DLipophilicity%2520and%2520its%2520Relationship%2520with%2520Passive%2520Drug%2520Permeation%26jtitle%3DPharm.%2520Res.%26date%3D2011%26volume%3D28%26issue%3D5%26spage%3D962%26epage%3D977%26doi%3D10.1007%2Fs11095-010-0303-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span> <span> </span><span class="NLM_article-title">Beyond the Rule of 5: Lessons Learned from AbbVie’s Drugs and Compound Collection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2636</span>– <span class="NLM_lpage">2651</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00717</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00717" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFeitbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2636-2651&issue=7&author=D.+A.+DeGoeyauthor=H.+J.+Chenauthor=P.+B.+Coxauthor=M.+D.+Wendt&title=Beyond+the+Rule+of+5%3A+Lessons+Learned+from+AbbVie%E2%80%99s+Drugs+and+Compound+Collection&doi=10.1021%2Facs.jmedchem.7b00717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond the Rule of 5: Lessons Learned from AbbVie's Drugs and Compound Collection</span></div><div class="casAuthors">DeGoey, David A.; Chen, Hui-Ju; Cox, Philip B.; Wendt, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2636-2651</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, there has been an increasing focus on the pursuit of targets considered to be less druggable that offer potential for development of promising new therapeutic agents for the treatment of diseases with large unmet medical need, particularly in the areas of oncol. and virol.  However, conducting drug discovery campaigns in "beyond rule of 5" (bRo5) chem. space presents a significant drug design and development challenge to medicinal chemists to achieve acceptable oral pharmacokinetics.  Retrospective anal. of past successes and failures in drug discovery bRo5 may shed light on the key principles that contribute to the oral bioavailability of successful bRo5 compds. and improve the efficiency of drug design for future projects.  We present here highlights and case studies of lessons learned from discovery of bRo5 compds.  A simple multiparametric scoring function (AB-MPS) was devised that correlated preclin. PK results with cLogD, no. of rotatable bonds, and no. of arom. rings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTHuaXbtjlALVg90H21EOLACvtfcHk0li5lnrltV_5yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFeitbjJ&md5=48984dc65410d83d4ac8ddaca030b024</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00717%26sid%3Dliteratum%253Aachs%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DChen%26aufirst%3DH.%2BJ.%26aulast%3DCox%26aufirst%3DP.%2BB.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26atitle%3DBeyond%2520the%2520Rule%2520of%25205%253A%2520Lessons%2520Learned%2520from%2520AbbVie%25E2%2580%2599s%2520Drugs%2520and%2520Compound%2520Collection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D7%26spage%3D2636%26epage%3D2651%26doi%3D10.1021%2Facs.jmedchem.7b00717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peirson, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, G. M.</span></span> <span> </span><span class="NLM_article-title">The Rule of Five Revisited: Applying log D in Place of log P in Drug-Likeness Filters</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">556</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1021/mp0700209</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp0700209" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1Oru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=556-560&issue=4&author=S.+K.+Bhalauthor=K.+Kassamauthor=I.+G.+Peirsonauthor=G.+M.+Pearl&title=The+Rule+of+Five+Revisited%3A+Applying+log+D+in+Place+of+log+P+in+Drug-Likeness+Filters&doi=10.1021%2Fmp0700209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The Rule of Five Revisited: Applying Log D in Place of Log P in Drug-Likeness Filters</span></div><div class="casAuthors">Bhal, Sanjivanjit K.; Kassam, Karim; Peirson, Ian G.; Pearl, Greg M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">556-560</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The much publicized "Rule of 5" has been widely adopted among the pharmaceutical industry.  It is used as a first step filter to perform virtual screening of compd. libraries, in an effort to quickly eliminate lead candidates that have poor physicochem. properties for oral bioavailability.  One of the key parameters used therein is log P, which is a useful descriptor, but one that fails to take into account variation in the lipophilicity of a drug with respect to the ionic states present at key biol. pH values.  Given that the majority of com. pharmaceuticals contain an ionizable moiety, we propose that log D is a better descriptor for lipophilicity in the context of the Rule of 5.  It gives more physiol. relevant results, thereby reducing the no. of potential false-negatives incorrectly eliminated in screening.  Using a series of com. compd. libraries, this study showed that the adapted Rule of 5 using log D instead of log P provides notable improvement in pass rate for compds. that have the desired lipophilicity at a relevant physiol. pH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDjia9TQd8orVg90H21EOLACvtfcHk0li5lnrltV_5yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1Oru78%253D&md5=d1bff6170cce36dc690a1afdd4839d70</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fmp0700209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp0700209%26sid%3Dliteratum%253Aachs%26aulast%3DBhal%26aufirst%3DS.%2BK.%26aulast%3DKassam%26aufirst%3DK.%26aulast%3DPeirson%26aufirst%3DI.%2BG.%26aulast%3DPearl%26aufirst%3DG.%2BM.%26atitle%3DThe%2520Rule%2520of%2520Five%2520Revisited%253A%2520Applying%2520log%2520D%2520in%2520Place%2520of%2520log%2520P%2520in%2520Drug-Likeness%2520Filters%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2007%26volume%3D4%26issue%3D4%26spage%3D556%26epage%3D560%26doi%3D10.1021%2Fmp0700209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2736</span>– <span class="NLM_lpage">2745</span>, <span class="refDoi"> DOI: 10.1021/jm5000529</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5000529" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2736-2745&issue=6&author=Z.+Y.+Jiangauthor=M.+C.+Luauthor=L.+L.+Xuauthor=T.+T.+Yangauthor=M.+Y.+Xiauthor=X.+L.+Xuauthor=X.+K.+Guoauthor=X.+J.+Zhangauthor=Q.+D.+Youauthor=H.+P.+Sun&title=Discovery+of+Potent+Keap1-Nrf2+Protein-Protein+Interaction+Inhibitor+Based+on+Molecular+Binding+Determinants+Analysis&doi=10.1021%2Fjm5000529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis</span></div><div class="casAuthors">Jiang, Zheng-Yu; Lu, Meng-Chen; Xu, Li-Li; Yang, Ting-Ting; Xi, Mei-Yang; Xu, Xiao-Li; Guo, Xiao-Ke; Zhang, Xiao-Jin; You, Qi-Dong; Sun, Hao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2736-2745</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Keap1 is known to mediate the ubiquitination of Nrf2, a master regulator of the antioxidant response.  Directly interrupting the Keap1-Nrf2 interaction has been emerged as a promising strategy to develop novel class of antioxidant, antiinflammatory, and anticancer agents.  On the basis of the mol. binding determinants anal. of Keap1, we successfully designed and characterized the most potent protein-protein interaction (PPI) inhibitor of Keap1-Nrf2, compd. 2, with KD value of 3.59 nM binding to Keap1 for the first time to single-digit nanomolar.  Compd. 2 can effectively disrupt the Nrf2-Keap1 interaction with an EC50 of 28.6 nM in the fluorescence polarization assay.  It can also activate the Nrf2 transcription activity in the cell-based ARE-luciferase reporter assay in a dose-dependent manner.  The qRT-PCR results of Nrf2 transcription targets gave the consistent results.  These results confirm direct and highly efficient interruption of the Keap1-Nrf2 PPI can be fully achieved by small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRS8nWHc40ZrVg90H21EOLACvtfcHk0li5lnrltV_5yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKmtro%253D&md5=b5d43ac3973478ecc54e26c74435f2c4</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm5000529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5000529%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DXu%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DT.%2BT.%26aulast%3DXi%26aufirst%3DM.%2BY.%26aulast%3DXu%26aufirst%3DX.%2BL.%26aulast%3DGuo%26aufirst%3DX.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DSun%26aufirst%3DH.%2BP.%26atitle%3DDiscovery%2520of%2520Potent%2520Keap1-Nrf2%2520Protein-Protein%2520Interaction%2520Inhibitor%2520Based%2520on%2520Molecular%2520Binding%2520Determinants%2520Analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D6%26spage%3D2736%26epage%3D2745%26doi%3D10.1021%2Fjm5000529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, S. S.</span></span> <span> </span><span class="NLM_article-title">Cu-Catalyzed Aerobic Oxidative Three-Component Coupling Route to N-Sulfonyl Amidines via an Ynamine Intermediate</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">2448</span>– <span class="NLM_lpage">2454</span>, <span class="refDoi"> DOI: 10.1021/jo5029198</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo5029198" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVCitLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2015&pages=2448-2454&issue=4&author=J.+Kimauthor=S.+S.+Stahl&title=Cu-Catalyzed+Aerobic+Oxidative+Three-Component+Coupling+Route+to+N-Sulfonyl+Amidines+via+an+Ynamine+Intermediate&doi=10.1021%2Fjo5029198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Cu-Catalyzed Aerobic Oxidative Three-Component Coupling Route to N-Sulfonyl Amidines via an Ynamine Intermediate</span></div><div class="casAuthors">Kim, Jinho; Stahl, Shannon S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2448-2454</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cu-catalyzed aerobic oxidative three-component coupling of a terminal alkyne, secondary amine, and sulfonamide enables efficient synthesis of amidines.  The use of Cu(OTf)2 (5 mol %) produces amidines selectively without Glaser-Hay alkyne homocoupling products.  Preliminary studies suggest that the reaction pathway involves initial oxidative coupling of the terminal alkyne with the secondary amine, followed by hydroamidation of the ynamine intermediate with the sulfonamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3MrVncuZRqbVg90H21EOLACvtfcHk0liHFxo19_iaxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVCitLc%253D&md5=f9cf7cbe14b03ed6291ecc003a80a1c1</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjo5029198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo5029198%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DStahl%26aufirst%3DS.%2BS.%26atitle%3DCu-Catalyzed%2520Aerobic%2520Oxidative%2520Three-Component%2520Coupling%2520Route%2520to%2520N-Sulfonyl%2520Amidines%2520via%2520an%2520Ynamine%2520Intermediate%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2015%26volume%3D80%26issue%3D4%26spage%3D2448%26epage%3D2454%26doi%3D10.1021%2Fjo5029198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daelemans, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannecouque, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel DAPY-IAS Hybrid Derivatives as Potential HIV-1 Inhibitors Using Molecular Hybridization Based on Crystallographic Overlays</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">4397</span>– <span class="NLM_lpage">4406</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.06.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.bmc.2017.06.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=28659246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVOjt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=4397-4406&issue=16&author=B.+Huangauthor=X.+Wangauthor=X.+Liuauthor=Z.+Chenauthor=W.+Liauthor=S.+Sunauthor=H.+Liuauthor=D.+Daelemansauthor=E.+De+Clercqauthor=C.+Pannecouqueauthor=P.+Zhanauthor=X.+Liu&title=Discovery+of+Novel+DAPY-IAS+Hybrid+Derivatives+as+Potential+HIV-1+Inhibitors+Using+Molecular+Hybridization+Based+on+Crystallographic+Overlays&doi=10.1016%2Fj.bmc.2017.06.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel DAPY-IAS hybrid derivatives as potential HIV-1 inhibitors using molecular hybridization based on crystallographic overlays</span></div><div class="casAuthors">Huang, Boshi; Wang, Xueshun; Liu, Xinhao; Chen, Zihui; Li, Wanzhuo; Sun, Songkai; Liu, Huiqing; Daelemans, Dirk; De Clercq, Erik; Pannecouque, Christophe; Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4397-4406</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Crystallog. overlap studies and pharmacophoric anal. indicated that diarylpyrimidine (DAPY)-based HIV-1 NNRTIs showed a similar binding mode and pharmacophoric features as indolylarylsulfones (IASs), another class of potent NNRTIs.  Thus, a novel series of DAPY-IAS hybrid derivs. were identified as newer NNRTIs using structure-based mol. hybridization.  Some target compds. exhibited moderate activities against HIV-1 IIIB strain, among which the two most potent inhibitors possessed EC50 values of 1.48 μM and 1.61 μM, resp.  They were much potent than the ref. drug ddI (EC50 = 76.0 μM) and comparable to 3TC (EC50 = 2.54 μM).  Compd. 7a also exhibited the favorable selectivity index (SI = 80).  Preliminary structure-activity relationships (SARs), structure-cytotoxicity relationships, mol. modeling studies, and in silico calcn. of physicochem. properties of these new inhibitors were also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmCF96b9U2RLVg90H21EOLACvtfcHk0ljP8yDkf4gC_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVOjt77F&md5=a6c95a11786296ab7d7c98f99e30248b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.06.022%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DDaelemans%26aufirst%3DD.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520Novel%2520DAPY-IAS%2520Hybrid%2520Derivatives%2520as%2520Potential%2520HIV-1%2520Inhibitors%2520Using%2520Molecular%2520Hybridization%2520Based%2520on%2520Crystallographic%2520Overlays%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26issue%3D16%26spage%3D4397%26epage%3D4406%26doi%3D10.1016%2Fj.bmc.2017.06.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoevels, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nar, H.</span></span> <span> </span><span class="NLM_article-title">Crystal-Contact Engineering to Obtain a Crystal Form of the Kelch Domain of Human Keap1 Suitable for Ligand-Soaking Experiments</span>. <i>Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">592</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1107/S174430911301124X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1107%2FS174430911301124X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=23722832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A280%3ADC%252BC3snotlOhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=592-596&author=S.+Horerauthor=D.+Reinertauthor=K.+Ostmannauthor=Y.+Hoevelsauthor=H.+Nar&title=Crystal-Contact+Engineering+to+Obtain+a+Crystal+Form+of+the+Kelch+Domain+of+Human+Keap1+Suitable+for+Ligand-Soaking+Experiments&doi=10.1107%2FS174430911301124X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal-contact engineering to obtain a crystal form of the Kelch domain of human Keap1 suitable for ligand-soaking experiments</span></div><div class="casAuthors">Horer Stefan; Reinert Dirk; Ostmann Katja; Hoevels Yvette; Nar Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section F, Structural biology and crystallization communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">Pt 6</span>),
    <span class="NLM_cas:pages">592-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Keap1 is a substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex and plays an important role in the cellular response to oxidative stress.  It binds Nrf2 with its Kelch domain and thus triggers the ubiquitinylation and degradation of Nrf2.  Oxidative stress prevents the degradation of Nrf2 and leads to the activation of cytoprotective genes.  Therefore, Keap1 is an attractive drug target in inflammatory diseases.  The support of a medicinal chemistry effort by structural research requires a robust crystallization system in which the crystals are preferably suited for performing soaking experiments.  This facilitates the generation of protein-ligand complexes in a routine and high-throughput manner.  The structure of human Keap1 has been described previously.  In this crystal form, however, the binding site for Nrf2 was blocked by a crystal contact.  This interaction was analysed and mutations were introduced to disrupt this crystal contact.  One double mutation (E540A/E542A) crystallized in a new crystal form in which the binding site for Nrf2 was not blocked and was accessible to small-molecule ligands.  The crystal structures of the apo form of the mutated Keap1 Kelch domain (1.98 ÅA resolution) and of the complex with an Nrf2-derived peptide obtained by soaking (2.20 ÅA resolution) are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkA18dqept1NLIORRPd5lbfW6udTcc2eaQbVmYljq8gbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snotlOhtw%253D%253D&md5=10cef0b161c5ea120f8577508b55e0a9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1107%2FS174430911301124X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS174430911301124X%26sid%3Dliteratum%253Aachs%26aulast%3DHorer%26aufirst%3DS.%26aulast%3DReinert%26aufirst%3DD.%26aulast%3DOstmann%26aufirst%3DK.%26aulast%3DHoevels%26aufirst%3DY.%26aulast%3DNar%26aufirst%3DH.%26atitle%3DCrystal-Contact%2520Engineering%2520to%2520Obtain%2520a%2520Crystal%2520Form%2520of%2520the%2520Kelch%2520Domain%2520of%2520Human%2520Keap1%2520Suitable%2520for%2520Ligand-Soaking%2520Experiments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2013%26volume%3D69%26spage%3D592%26epage%3D596%26doi%3D10.1107%2FS174430911301124X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Studier, F. W.</span></span> <span> </span><span class="NLM_article-title">Protein Production by Auto-Induction in High-Density Shaking Cultures</span>. <i>Protein Expression Purif.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/j.pep.2005.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.pep.2005.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=15915565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFCktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=207-234&issue=1&author=F.+W.+Studier&title=Protein+Production+by+Auto-Induction+in+High-Density+Shaking+Cultures&doi=10.1016%2Fj.pep.2005.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Protein production by auto-induction in high-density shaking cultures</span></div><div class="casAuthors">Studier, F. William</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">207-234</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Inducible expression systems in which T7 RNA polymerase transcribes coding sequences cloned under control of a T7lac promoter efficiently produce a wide variety of proteins in Escherichia coli.  Investigation of factors that affect stability, growth, and induction of T7 expression strains in shaking vessels led to the recognition that sporadic, unintended induction of expression in complex media, previously reported by others, is almost certainly caused by small amts. of lactose.  Glucose prevents induction by lactose by well-studied mechanisms.  Amino acids also inhibit induction by lactose during log-phase growth, and high rates of aeration inhibit induction at low lactose concns.  These observations, and metabolic balancing of pH, allowed development of reliable non-inducing and auto-inducing media in which batch cultures grow to high densities.  Expression strains grown to satn. in non-inducing media retain plasmid and remain fully viable for weeks in the refrigerator, making it easy to prep. many freezer stocks in parallel and use working stocks for an extended period.  Auto-induction allows efficient screening of many clones in parallel for expression and soly., as cultures have only to be inoculated and grown to satn., and yields of target protein are typically several-fold higher than obtained by conventional IPTG induction.  Auto-inducing media have been developed for labeling proteins with selenomethionine, 15N or 13C, and for prodn. of target proteins by arabinose induction of T7 RNA polymerase from the pBAD promoter in BL21-AI.  Selenomethionine labeling was equally efficient in the commonly used methionine auxotroph B834(DE3)(found to be metE) or the prototroph BL21(DE3).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYNqgn15xP_bVg90H21EOLACvtfcHk0ljP8yDkf4gC_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFCktLw%253D&md5=d31b76747c808ce6fbb27c7a1192b6b8</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2005.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2005.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DStudier%26aufirst%3DF.%2BW.%26atitle%3DProtein%2520Production%2520by%2520Auto-Induction%2520in%2520High-Density%2520Shaking%2520Cultures%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2005%26volume%3D41%26issue%3D1%26spage%3D207%26epage%3D234%26doi%3D10.1016%2Fj.pep.2005.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">XDS</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lir0HpslwKqAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teplyakov, A.</span></span> <span> </span><span class="NLM_article-title">Molecular Replacement with MOLREP</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1107/S0907444909042589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1107%2FS0907444909042589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=20057045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Kktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=22-25&author=A.+Vaginauthor=A.+Teplyakov&title=Molecular+Replacement+with+MOLREP&doi=10.1107%2FS0907444909042589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular replacement with MOLREP</span></div><div class="casAuthors">Vagin, Alexei; Teplyakov, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-25</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">MOLREP is an automated program for mol. replacement that utilizes a no. of original approaches to rotational and translational search and data prepn.  Since the first publication describing the program, MOLREP has acquired a variety of features that include weighting of the X-ray data and search models, multi-copy search, fitting the model into electron d., structural superposition of two models and rigid-body refinement.  The program can run in a fully automatic mode using optimized parameters calcd. from the input data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzj5SzYvyu_7Vg90H21EOLACvtfcHk0lir0HpslwKqAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Kktw%253D%253D&md5=820d114719aca209994ffb0403e3b20d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0907444909042589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909042589%26sid%3Dliteratum%253Aachs%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DTeplyakov%26aufirst%3DA.%26atitle%3DMolecular%2520Replacement%2520with%2520MOLREP%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D22%26epage%3D25%26doi%3D10.1107%2FS0907444909042589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turkenburg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E.</span></span> <span> </span><span class="NLM_article-title">A Graphical User Interface to the CCP4 Program Suite</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1131</span>– <span class="NLM_lpage">1137</span>, <span class="refDoi"> DOI: 10.1107/S0907444903008126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1107%2FS0907444903008126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=12832755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFSksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=1131-1137&author=E.+Pottertonauthor=P.+Briggsauthor=M.+Turkenburgauthor=E.+Dodson&title=A+Graphical+User+Interface+to+the+CCP4+Program+Suite&doi=10.1107%2FS0907444903008126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A graphical user interface to the CCP4 program suite</span></div><div class="casAuthors">Potterton, Elizabeth; Briggs, Peter; Turkenburg, Maria; Dodson, Eleanor</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">D59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1131-1137</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4i is a graphical user interface that makes running programs from the CCP4 suite simpler and quicker.  It is particularly directed at inexperienced users and tightly linked to introductory and scientific documentation.  It also provides a simple project-management system and visualization tools.  The system is readily extensible and not specific to CCP4 software.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDH-BQSvi5qbVg90H21EOLACvtfcHk0lir0HpslwKqAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFSksLs%253D&md5=25a0168dd7ea9f930036453a829e1e3d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0907444903008126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444903008126%26sid%3Dliteratum%253Aachs%26aulast%3DPotterton%26aufirst%3DE.%26aulast%3DBriggs%26aufirst%3DP.%26aulast%3DTurkenburg%26aufirst%3DM.%26aulast%3DDodson%26aufirst%3DE.%26atitle%3DA%2520Graphical%2520User%2520Interface%2520to%2520the%2520CCP4%2520Program%2520Suite%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2003%26volume%3D59%26spage%3D1131%26epage%3D1137%26doi%3D10.1107%2FS0907444903008126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span> <span> </span><span class="NLM_article-title">Refinement of Macromolecular Structures by the Maximum-Likelihood Method</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-55&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+Macromolecular+Structures+by+the+Maximum-Likelihood+Method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lir0HpslwKqAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520Macromolecular%2520Structures%2520by%2520the%2520Maximum-Likelihood%2520Method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D55%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and Development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljWNLuVndapFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Sepideh Hayatgheybi, Hormoz Khosravi, Hossein Zahedian Tejeneki, Frank Rominger, Hamid Reza Bijanzadeh, <span class="NLM_string-name hlFld-ContribAuthor">Saeed Balalaie</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of N-(Isoquinolin-1-yl)sulfonamides via Ag2O-Catalyzed Tandem Reaction of ortho-Alkynylbenzaldoximes with Benchtop Stabilized Ketenimines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (9)
                                     , 3524-3529. <a href="https://doi.org/10.1021/acs.orglett.1c00937" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00937</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00937%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252BN-%252528Isoquinolin-1-yl%252529sulfonamides%252Bvia%252BAg2O-Catalyzed%252BTandem%252BReaction%252Bof%252Bortho-Alkynylbenzaldoximes%252Bwith%252BBenchtop%252BStabilized%252BKetenimines%26aulast%3DHayatgheybi%26aufirst%3DSepideh%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19032021%26date%3D14042021%26volume%3D23%26issue%3D9%26spage%3D3524%26epage%3D3529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jakob S. Pallesen, Dilip Narayanan, Kim T. Tran, Sara M. Ø. Solbak, Giuseppe Marseglia, Louis M. E. Sørensen, Lars J. Høj, Federico Munafò, Rosa M. C. Carmona, Anthony D. Garcia, Haritha L. Desu, Roberta Brambilla, Tommy N. Johansen, Grzegorz M. Popowicz, Michael Sattler, Michael Gajhede, <span class="NLM_string-name hlFld-ContribAuthor">Anders Bach</span>. </span><span class="cited-content_cbyCitation_article-title">Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4623-4661. <a href="https://doi.org/10.1021/acs.jmedchem.0c02094" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02094%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDeconstructing%252BNoncovalent%252BKelch-like%252BECH-Associated%252BProtein%252B1%252B%252528Keap1%252529%252BInhibitors%252Binto%252BFragments%252Bto%252BReconstruct%252BNew%252BPotent%252BCompounds%26aulast%3DPallesen%26aufirst%3DJakob%2BS.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D03122020%26date%3D05042021%26volume%3D64%26issue%3D8%26spage%3D4623%26epage%3D4661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaoping Hu, Xin Xie, Yi Gan, Gaonan Wang, <span class="NLM_string-name hlFld-ContribAuthor">Yuanhong Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Nickel-Catalyzed β-Regioselective Amination/Cyclization of Ynamide-Nitriles with Amines: Synthesis of Functionalized 3-Aminoindoles and 4-Aminoisoquinolines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (4)
                                     , 1296-1301. <a href="https://doi.org/10.1021/acs.orglett.0c04278" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c04278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c04278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c04278%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DNickel-Catalyzed%252B%2525CE%2525B2-Regioselective%252BAmination%25252FCyclization%252Bof%252BYnamide-Nitriles%252Bwith%252BAmines%25253A%252BSynthesis%252Bof%252BFunctionalized%252B3-Aminoindoles%252Band%252B4-Aminoisoquinolines%26aulast%3DHu%26aufirst%3DXiaoping%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D28122020%26date%3D03022021%26volume%3D23%26issue%3D4%26spage%3D1296%26epage%3D1301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hai-Shan Zhou, Lv-Bin Hu, Han Zhang, Wen-Xin Shan, Yan Wang, Xue Li, Tian Liu, Jing Zhao, Qi-Dong You, <span class="NLM_string-name hlFld-ContribAuthor">Zheng-Yu Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Structure–Activity Relationships of Indoline-Based Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-Like 2 (Keap1-Nrf2) Protein–Protein Interaction Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 11149-11168. <a href="https://doi.org/10.1021/acs.jmedchem.0c01116" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01116%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BIndoline-Based%252BKelch-like%252BECH-Associated%252BProtein%252B1-Nuclear%252BFactor%252B%252528Erythroid-Derived%252B2%252529-Like%252B2%252B%252528Keap1-Nrf2%252529%252BProtein%2525E2%252580%252593Protein%252BInteraction%252BInhibitors%26aulast%3DZhou%26aufirst%3DHai-Shan%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29062020%26date%3D18092020%26date%3D09092020%26volume%3D63%26issue%3D19%26spage%3D11149%26epage%3D11168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yong Zhang, Zeyu Shi, Yujun Zhou, Qiong Xiao, Hongyue Wang, <span class="NLM_string-name hlFld-ContribAuthor">Ying Peng</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Protein–Protein Interaction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 7986-8002. <a href="https://doi.org/10.1021/acs.jmedchem.9b01865" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01865</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01865%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEmerging%252BSubstrate%252BProteins%252Bof%252BKelch-like%252BECH%252BAssociated%252BProtein%252B1%252B%252528Keap1%252529%252Band%252BPotential%252BChallenges%252Bfor%252Bthe%252BDevelopment%252Bof%252BSmall-Molecule%252BInhibitors%252Bof%252Bthe%252BKeap1-Nuclear%252BFactor%252BErythroid%252B2-Related%252BFactor%252B2%252B%252528Nrf2%252529%252BProtein%2525E2%252580%252593Protein%252BInteraction%26aulast%3DZhang%26aufirst%3DYong%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D11112019%26date%3D08042020%26date%3D01042020%26volume%3D63%26issue%3D15%26spage%3D7986%26epage%3D8002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Phillip R. Lazzara, Atul D. Jain, Amanda C. Maldonado, Benjamin Richardson, Kornelia J. Skowron, Brian P. David, Zamia Siddiqui, Kiira M. Ratia, <span class="NLM_string-name hlFld-ContribAuthor">Terry W. Moore</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Noncovalent Naphthalene-Based KEAP1-NRF2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (4)
                                     , 521-527. <a href="https://doi.org/10.1021/acsmedchemlett.9b00631" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00631%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BNoncovalent%252BNaphthalene-Based%252BKEAP1-NRF2%252BInhibitors%26aulast%3DLazzara%26aufirst%3DPhillip%2BR.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D19122019%26date%3D19022020%26date%3D24022020%26date%3D19022020%26volume%3D11%26issue%3D4%26spage%3D521%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuta  Horie</span>, <span class="hlFld-ContribAuthor ">Takafumi  Suzuki</span>, <span class="hlFld-ContribAuthor ">Jin  Inoue</span>, <span class="hlFld-ContribAuthor ">Tatsuro  Iso</span>, <span class="hlFld-ContribAuthor ">Geoffrey  Wells</span>, <span class="hlFld-ContribAuthor ">Terry W.  Moore</span>, <span class="hlFld-ContribAuthor ">Tsunehiro  Mizushima</span>, <span class="hlFld-ContribAuthor ">Albena T.  Dinkova-Kostova</span>, <span class="hlFld-ContribAuthor ">Takuma  Kasai</span>, <span class="hlFld-ContribAuthor ">Takashi  Kamei</span>, <span class="hlFld-ContribAuthor ">Seizo  Koshiba</span>, <span class="hlFld-ContribAuthor ">Masayuki  Yamamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular basis for the disruption of Keap1–Nrf2 interaction via Hinge & Latch mechanism. </span><span class="cited-content_cbyCitation_journal-name">Communications Biology</span><span> <strong>2021,</strong> <em>4 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s42003-021-02100-6" title="DOI URL">https://doi.org/10.1038/s42003-021-02100-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s42003-021-02100-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs42003-021-02100-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCommunications%2520Biology%26atitle%3DMolecular%252Bbasis%252Bfor%252Bthe%252Bdisruption%252Bof%252BKeap1%2525E2%252580%252593Nrf2%252Binteraction%252Bvia%252BHinge%252B%252526%252BLatch%252Bmechanism%26aulast%3DHorie%26aufirst%3DYuta%26date%3D2021%26date%3D2021%26volume%3D4%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aiten M.  Soliman</span>, <span class="hlFld-ContribAuthor ">Mai H.  Mekkawy</span>, <span class="hlFld-ContribAuthor ">Heba M.  Karam</span>, <span class="hlFld-ContribAuthor ">Maureen  Higgins</span>, <span class="hlFld-ContribAuthor ">Albena T.  Dinkova-Kostova</span>, <span class="hlFld-ContribAuthor ">Mostafa M.  Ghorab</span>. </span><span class="cited-content_cbyCitation_article-title">Novel iodinated quinazolinones bearing sulfonamide as new scaffold targeting radiation induced oxidative stress. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>42 </em>, 128002. <a href="https://doi.org/10.1016/j.bmcl.2021.128002" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128002%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Biodinated%252Bquinazolinones%252Bbearing%252Bsulfonamide%252Bas%252Bnew%252Bscaffold%252Btargeting%252Bradiation%252Binduced%252Boxidative%252Bstress%26aulast%3DSoliman%26aufirst%3DAiten%2BM.%26date%3D2021%26volume%3D42%26spage%3D128002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keiko  Taguchi</span>, <span class="hlFld-ContribAuthor ">Masayuki  Yamamoto</span>. </span><span class="cited-content_cbyCitation_article-title">The KEAP1–NRF2 System as a Molecular Target of Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (1)
                                     , 46. <a href="https://doi.org/10.3390/cancers13010046" title="DOI URL">https://doi.org/10.3390/cancers13010046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13010046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13010046%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BKEAP1%2525E2%252580%252593NRF2%252BSystem%252Bas%252Ba%252BMolecular%252BTarget%252Bof%252BCancer%252BTreatment%26aulast%3DTaguchi%26aufirst%3DKeiko%26date%3D2021%26date%3D2020%26volume%3D13%26issue%3D1%26spage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takafumi  Suzuki</span>, <span class="hlFld-ContribAuthor ">Takanori  Hidaka</span>, <span class="hlFld-ContribAuthor ">Yoshito  Kumagai</span>, <span class="hlFld-ContribAuthor ">Masayuki  Yamamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Environmental pollutants and the immune response. </span><span class="cited-content_cbyCitation_journal-name">Nature Immunology</span><span> <strong>2020,</strong> <em>21 </em>
                                    (12)
                                     , 1486-1495. <a href="https://doi.org/10.1038/s41590-020-0802-6" title="DOI URL">https://doi.org/10.1038/s41590-020-0802-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41590-020-0802-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41590-020-0802-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Immunology%26atitle%3DEnvironmental%252Bpollutants%252Band%252Bthe%252Bimmune%252Bresponse%26aulast%3DSuzuki%26aufirst%3DTakafumi%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D12%26spage%3D1486%26epage%3D1495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dionysios V.  Chartoumpekis</span>, <span class="hlFld-ContribAuthor ">Chun-Yan  Fu</span>, <span class="hlFld-ContribAuthor ">Panos G.  Ziros</span>, <span class="hlFld-ContribAuthor ">Gerasimos P.  Sykiotis</span>. </span><span class="cited-content_cbyCitation_article-title">Patent Review (2017–2020) of the Keap1/Nrf2 Pathway Using PatSeer Pro: Focus on Autoimmune Diseases. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2020,</strong> <em>9 </em>
                                    (11)
                                     , 1138. <a href="https://doi.org/10.3390/antiox9111138" title="DOI URL">https://doi.org/10.3390/antiox9111138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox9111138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox9111138%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DPatent%252BReview%252B%2525282017%2525E2%252580%2525932020%252529%252Bof%252Bthe%252BKeap1%25252FNrf2%252BPathway%252BUsing%252BPatSeer%252BPro%25253A%252BFocus%252Bon%252BAutoimmune%252BDiseases%26aulast%3DChartoumpekis%26aufirst%3DDionysios%2BV.%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D11%26spage%3D1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio  Cuadrado</span>, <span class="hlFld-ContribAuthor ">Marta  Pajares</span>, <span class="hlFld-ContribAuthor ">Cristina  Benito</span>, <span class="hlFld-ContribAuthor ">José  Jiménez-Villegas</span>, <span class="hlFld-ContribAuthor ">Maribel  Escoll</span>, <span class="hlFld-ContribAuthor ">Raquel  Fernández-Ginés</span>, <span class="hlFld-ContribAuthor ">Angel J.  Garcia Yagüe</span>, <span class="hlFld-ContribAuthor ">Diego  Lastra</span>, <span class="hlFld-ContribAuthor ">Gina  Manda</span>, <span class="hlFld-ContribAuthor ">Ana I.  Rojo</span>, <span class="hlFld-ContribAuthor ">Albena T.  Dinkova-Kostova</span>. </span><span class="cited-content_cbyCitation_article-title">Can Activation of NRF2 Be a Strategy against COVID-19?. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2020,</strong> <em>41 </em>
                                    (9)
                                     , 598-610. <a href="https://doi.org/10.1016/j.tips.2020.07.003" title="DOI URL">https://doi.org/10.1016/j.tips.2020.07.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2020.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2020.07.003%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DCan%252BActivation%252Bof%252BNRF2%252BBe%252Ba%252BStrategy%252Bagainst%252BCOVID-19%25253F%26aulast%3DCuadrado%26aufirst%3DAntonio%26date%3D2020%26volume%3D41%26issue%3D9%26spage%3D598%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liam  Baird</span>, <span class="hlFld-ContribAuthor ">Masayuki  Yamamoto</span>. </span><span class="cited-content_cbyCitation_article-title">The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Biology</span><span> <strong>2020,</strong> <em>40 </em>
                                    (13)
                                     <a href="https://doi.org/10.1128/MCB.00099-20" title="DOI URL">https://doi.org/10.1128/MCB.00099-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/MCB.00099-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FMCB.00099-20%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Biology%26atitle%3DThe%252BMolecular%252BMechanisms%252BRegulating%252Bthe%252BKEAP1-NRF2%252BPathway%26aulast%3DBaird%26aufirst%3DLiam%26date%3D2020%26volume%3D40%26issue%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/medium/jm9b01074_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01074&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/medium/jm9b01074_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Under basal conditions, NRF2 is bound to KEAP1, ubiquitinated by CUL3, and degraded by the proteasome (top). In the presence of an electrophile (middle) or a noncovalent inhibitor (bottom), NRF2 translocates to the nucleus and transcribes cytoprotective genes, like NADPH quinone oxidoreductase 1 (NQO1), heme oxygenase-1 (HO-1), and glutathione <i>S</i>-transferase (GST).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01074&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/medium/jm9b01074_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Electrophilic Activators of NRF2<a onclick="showRef(event, 'ref9 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref9 ref15 ref16 ref17">(9,15−17)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01074&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/medium/jm9b01074_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Non-electrophilic Inhibitors of KEAP1<a onclick="showRef(event, 'ref19 ref21 ref22 ref28'); return false;" href="javascript:void(0);" class="ref ref19 ref21 ref22 ref28">(19,21,22,28)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01074&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/medium/jm9b01074_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 1,4-Substituted Isoquinolines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01074&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) 4-methoxybenzenesulfonyl chloride, pyridine, rt, 1 h; (b) Boc<sub>2</sub>O, <i>N</i>,<i>N</i>-dimethylaminopyridine, MeCN, rt, 2 h; (c) <i>m</i>CPBA, CHCl<sub>3</sub>, rt, 24 h; (d) 4-methoxybenzenesulfonamide or 4-fluorobenzenesulfonamide, PPh<sub>3</sub>, PhI(OAc)<sub>2</sub>, MeCN, 80 °C, 1 h; (e) CF<sub>3</sub>CO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 2 h; (f) BrCH<sub>2</sub>CO<sub>2</sub>Et, K<sub>2</sub>CO<sub>3</sub>, Me<sub>2</sub>NCHO, rt, 48 h; (g) 15% NaOH, MeOH, rt, 4 h; (h) alkyl-X or alkyl-OTf, K<sub>2</sub>CO<sub>3</sub>, Me<sub>2</sub>NCHO or MeCN, rt, 18–48 h.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/medium/jm9b01074_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UF0">6UF0</a>) of compound <b>13a</b> bound to human Keap1 Kelch domain. (A, B) Interactions of <b>13a</b> (orange) with the NRF-2 binding site of Keap1 (cyan ribbon). Polar interactions within 3 Å are denoted by dashed lines in panel A. An <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density omit map, with <b>13a</b> removed from map calculations, is shown as blue mesh and contoured at 2.7σ in panel B. (C) Superposition of Keap1 structures bound to <b>13a</b> (cyan) and compound <b>7</b> from pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FNU">5FNU</a> (wheat).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01074&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/medium/jm9b01074_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) HaCaT cells were treated with vehicle control DMSO, 10 μM compound (<b>5e</b>, <b>12</b>, <b>5a</b>, <b>11b</b>, <b>11c</b>, <b>13a</b>), or positive control <b>3</b> (1 μM) for 16 h. Cell lysates were prepared, equal amounts of protein were probed with antibodies specific for NRF2 or NQO1. Actin was used as a reference. Image was cropped at the dotted line to remove an unrelated compound. See the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01074/suppl_file/jm9b01074_si_001.pdf" class="ext-link">Supporting Information</a> for the uncropped images. NRF2 and NQO1 band intensities were quantified using NIH ImageJ software and were normalized to that of the respective actin band intensity. The normalized values of NRF2 and NQO1 of DMSO-treated samples were taken as one unit. The fold increase in NRF2 and NQO1 expression of two independent sets is presented relative to DMSO controls independently or combined. (B) HaCaT cells were treated with DMSO, 0.1, 1, or 10 μM <b>13a</b>, or 250 nM <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01074/20200618/images/large/jm9b01074_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01074&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30887" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30887" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 45 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S. M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Signaling Pathway: Pivotal Roles in Inflammation</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1863</i></span>,  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">597</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2016.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.bbadis.2016.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=27825853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVahtLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2017&pages=585-597&author=S.+M.+U.+Ahmedauthor=L.+Luoauthor=A.+Namaniauthor=X.+J.+Wangauthor=X.+Tang&title=Nrf2+Signaling+Pathway%3A+Pivotal+Roles+in+Inflammation&doi=10.1016%2Fj.bbadis.2016.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 signaling pathway: Pivotal roles in inflammation</span></div><div class="casAuthors">Ahmed, Syed Minhaj Uddin; Luo, Lin; Namani, Akhileshwar; Wang, Xiu Jun; Tang, Xiuwen</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">585-597</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Inflammation is the most common feature of many chronic diseases and complications, while playing crit. roles in carcinogenesis.  Several studies have demonstrated that Nrf2 contributes to the anti-inflammatory process by orchestrating the recruitment of inflammatory cells and regulating gene expression through the antioxidant response element (ARE).  The Keap1 (Kelch-like ECH-assocd. protein)/Nrf2 (NF-E2 p45-related factor 2)/ARE signaling pathway mainly regulates anti-inflammatory gene expression and inhibits the progression of inflammation.  Therefore, the identification of new Nrf2-dependent anti-inflammatory phytochems. has become a key point in drug discovery.  In this review, the authors discuss the members of the Keap1/Nrf2/ARE signal pathway and its downstream genes, the effects of this pathway on animal models of inflammatory diseases, and crosstalk with the NF-κB pathway.  In addn. the authors also discuss about the regulation of NLRP3 inflammasome by Nrf2.  Besides this, the authors summarize the current scenario of the development of anti-inflammatory phytochems. and others that mediate the Nrf2/ARE signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmDI6VHTdR9bVg90H21EOLACvtfcHk0lgFOnoVNx58wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVahtLrE&md5=ddd05f60f85531bcee5892695c133433</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2016.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2016.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%2BM.%2BU.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DNamani%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DTang%26aufirst%3DX.%26atitle%3DNrf2%2520Signaling%2520Pathway%253A%2520Pivotal%2520Roles%2520in%2520Inflammation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2017%26volume%3D1863%26spage%3D585%26epage%3D597%26doi%3D10.1016%2Fj.bbadis.2016.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">7130</span>– <span class="NLM_lpage">7139</span>, <span class="refDoi"> DOI: 10.1128/MCB.24.16.7130-7139.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1128%2FMCB.24.16.7130-7139.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=15282312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlOjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=7130-7139&author=A.+Kobayashiauthor=M.-I.+Kangauthor=H.+Okawaauthor=M.+Ohtsujiauthor=Y.+Zenkeauthor=T.+Chibaauthor=K.+Igarashiauthor=M.+Yamamoto&title=Oxidative+Stress+Sensor+Keap1+Functions+as+an+Adaptor+for+Cul3-Based+E3+Ligase+To+Regulate+Proteasomal+Degradation+of+Nrf2&doi=10.1128%2FMCB.24.16.7130-7139.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2</span></div><div class="casAuthors">Kobayashi, Akira; Kang, Moon-Il; Okawa, Hiromi; Ohtsuji, Makiko; Zenke, Yukari; Chiba, Tomoki; Igarashi, Kazuhiko; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7130-7139</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Transcription factor Nrf2 is a major regulator of genes encoding phase 2 detoxifying enzymes and antioxidant stress proteins in response to electrophilic agents and oxidative stress.  In the absence of such stimuli, Nrf2 is inactive owing to its cytoplasmic retention by Keap1 and rapid degrdn. through the proteasome system.  We examd. the contribution of Keap1 to the rapid turnover of Nrf2 (half-life of less than 20 min) and found that a direct assocn. between Keap1 and Nrf2 is required for Nrf2 degrdn.  In a series of domain function analyses of Keap1, we found that both the BTB and intervening-region (IVR) domains are crucial for Nrf2 degrdn., implying that these two domains act to recruit ubiquitin-proteasome factors.  Indeed, Cullin 3 (Cul3), a subunit of the E3 ligase complex, was found to interact specifically with Keap1 in vivo.  Keap1 assocs. with the N-terminal region of Cul3 through the IVR domain and promotes the ubiquitination of Nrf2 in cooperation with the Cul3-Roc1 complex.  These results thus provide solid evidence that Keap1 functions as an adaptor of Cul3-based E3 ligase.  To our knowledge, Nrf2 and Keap1 are the first reported mammalian substrate and adaptor, resp., of the Cul3-based E3 ligase system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrut4YvhAuZKrVg90H21EOLACvtfcHk0lgFOnoVNx58wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlOjt7w%253D&md5=3d6e356865cd6f33c800bf9124d7c8da</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.16.7130-7139.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.16.7130-7139.2004%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DM.-I.%26aulast%3DOkawa%26aufirst%3DH.%26aulast%3DOhtsuji%26aufirst%3DM.%26aulast%3DZenke%26aufirst%3DY.%26aulast%3DChiba%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DOxidative%2520Stress%2520Sensor%2520Keap1%2520Functions%2520as%2520an%2520Adaptor%2520for%2520Cul3-Based%2520E3%2520Ligase%2520To%2520Regulate%2520Proteasomal%2520Degradation%2520of%2520Nrf2%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D7130%26epage%3D7139%26doi%3D10.1128%2FMCB.24.16.7130-7139.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cullinan, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordan, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, J. A.</span></span> <span> </span><span class="NLM_article-title">The Keap1-BTB Protein is an Adaptor That Bridges Nrf2 to a Cul3-Based E3 Ligase: Oxidative Stress Sensing by a Cul3-Keap1 Ligase</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">8477</span>– <span class="NLM_lpage">8486</span>, <span class="refDoi"> DOI: 10.1128/MCB.24.19.8477-8486.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1128%2FMCB.24.19.8477-8486.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=15367669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVakt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=8477-8486&author=S.+B.+Cullinanauthor=J.+D.+Gordanauthor=J.+Jinauthor=J.+W.+Harperauthor=J.+A.+Diehl&title=The+Keap1-BTB+Protein+is+an+Adaptor+That+Bridges+Nrf2+to+a+Cul3-Based+E3+Ligase%3A+Oxidative+Stress+Sensing+by+a+Cul3-Keap1+Ligase&doi=10.1128%2FMCB.24.19.8477-8486.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: Oxidative stress sensing by a Cul3-Keap1 ligase</span></div><div class="casAuthors">Cullinan, Sara B.; Gordan, John D.; Jin, Jianping; Harper, J. Wade; Diehl, J. Alan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8477-8486</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The Nrf2 transcription factor promotes survival following cellular insults that trigger oxidative damage.  Nrf2 activity is opposed by the BTB/POZ domain protein Keap1.  Keap1 is proposed to regulate Nrf2 activity strictly through its capacity to inhibit Nrf2 nuclear import.  Recent work suggests that inhibition of Nrf2 may also depend upon ubiquitin-mediated proteolysis.  To address the contribution of Keap1-dependent sequestration vs. Nrf2 proteolysis, we identified the E3 ligase that regulates Nrf2 ubiquitination.  We demonstrate that Keap1 is not solely a cytosolic anchor; rather, Keap1 is an adaptor that bridges Nrf2 to Cul3.  We demonstrate that Cul3-Keap1 complexes regulate Nrf2 polyubiquitination both in vitro and in vivo.  Inhibition of either Keap1 or Cul3 increases Nrf2 nuclear accumulation, leading to promiscuous activation of Nrf2-dependent gene expression.  Our data demonstrate that Keap1 restrains Nrf2 activity via its capacity to target Nrf2 to a cytoplasmic Cul3-based E3 ligase and suggest a model in which Keap1 coordinately regulates both Nrf2 accumulation and access to target genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokzxnJWH6ecbVg90H21EOLACvtfcHk0lgFOnoVNx58wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVakt7k%253D&md5=4a51087f90e5eb8f1f1cace9278941ad</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.19.8477-8486.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.19.8477-8486.2004%26sid%3Dliteratum%253Aachs%26aulast%3DCullinan%26aufirst%3DS.%2BB.%26aulast%3DGordan%26aufirst%3DJ.%2BD.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DDiehl%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520Keap1-BTB%2520Protein%2520is%2520an%2520Adaptor%2520That%2520Bridges%2520Nrf2%2520to%2520a%2520Cul3-Based%2520E3%2520Ligase%253A%2520Oxidative%2520Stress%2520Sensing%2520by%2520a%2520Cul3-Keap1%2520Ligase%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D8477%26epage%3D8486%26doi%3D10.1128%2FMCB.24.19.8477-8486.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salinas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallardo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz De
Galarreta, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span> <span> </span><span class="NLM_article-title">Regulation of Heme Oxygenase-1 Expression through the Phosphatidylinositol 3-Kinase/Akt Pathway and the Nrf2 Transcription Factor in Response to the Antioxidant Phytochemical Carnosol</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">8919</span>– <span class="NLM_lpage">8929</span>, <span class="refDoi"> DOI: 10.1074/jbc.M309660200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1074%2Fjbc.M309660200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=14688281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1Onurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=8919-8929&author=D.+Martinauthor=A.+I.+Rojoauthor=M.+Salinasauthor=R.+Diazauthor=G.+Gallardoauthor=J.+Alamauthor=C.+M.+Ruiz+De%0AGalarretaauthor=A.+Cuadrado&title=Regulation+of+Heme+Oxygenase-1+Expression+through+the+Phosphatidylinositol+3-Kinase%2FAkt+Pathway+and+the+Nrf2+Transcription+Factor+in+Response+to+the+Antioxidant+Phytochemical+Carnosol&doi=10.1074%2Fjbc.M309660200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Heme Oxygenase-1 Expression through the Phosphatidylinositol 3-Kinase/Akt Pathway and the Nrf2 Transcription Factor in Response to the Antioxidant Phytochemical Carnosol</span></div><div class="casAuthors">Martin, Daniel; Rojo, Ana I.; Salinas, Marta; Diaz, Raquel; Gallardo, German; Alam, Jawed; Ruiz de Galarreta, Carlos M.; Cuadrado, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">8919-8929</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt pathway elicits a survival signal against multiple apoptotic insults.  In addn., phase II enzymes such as heme oxygenase-1 (HO-1) protect cells against diverse toxins and oxidative stress.  In this work, we describe a link between these defense systems at the level of transcriptional regulation of the antioxidant enzyme HO-1.  The herb-derived phenol carnosol induced HO-1 expression at both mRNA and protein levels.  Luciferase reporter assays indicated that carnosol targeted the mouse ho1 promoter at two enhancer regions comprising the antioxidant response elements (AREs).  Moreover, carnosol increased the nuclear levels of Nrf2, a transcription factor governing AREs.  Electrophoretic mobility shift assays and luciferase reporter assays with a dominant-neg. Nrf2 mutant indicated that carnosol increased the binding of Nrf2 to ARE and induced Nrf2-dependent activation of the ho1 promoter.  While investigating the signaling pathways responsible for HO-1 induction, we obsd. that carnosol activated the ERK, p38, and JNK pathways as well as the survival pathway driven by PI3K.  Inhibition of PI3K reduced the increase in Nrf2 protein levels and activation of the ho1 promoter.  Expression of active PI3K-CAAX (where A is aliph. amino acid) was sufficient to activate AREs.  The use of dominant-neg. mutants of protein kinase Cζ and Akt1, two kinases downstream from PI3K, demonstrated a requirement for active Akt1, but not protein kinase Cζ.  Moreover, the long-term antioxidant effect of carnosol was partially blocked by PI3K or HO-1 inhibitors, further demonstrating that carnosol attenuates oxidative stress through a pathway that involves PI3K and HO-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW9UH0hJnHCbVg90H21EOLACvtfcHk0lgwxPwGi0wYrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1Onurs%253D&md5=e44ad1bec1c702807726d26641c6d8db</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M309660200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M309660200%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DD.%26aulast%3DRojo%26aufirst%3DA.%2BI.%26aulast%3DSalinas%26aufirst%3DM.%26aulast%3DDiaz%26aufirst%3DR.%26aulast%3DGallardo%26aufirst%3DG.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DRuiz%2BDe%2BGalarreta%26aufirst%3DC.%2BM.%26aulast%3DCuadrado%26aufirst%3DA.%26atitle%3DRegulation%2520of%2520Heme%2520Oxygenase-1%2520Expression%2520through%2520the%2520Phosphatidylinositol%25203-Kinase%252FAkt%2520Pathway%2520and%2520the%2520Nrf2%2520Transcription%2520Factor%2520in%2520Response%2520to%2520the%2520Antioxidant%2520Phytochemical%2520Carnosol%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D8919%26epage%3D8929%26doi%3D10.1074%2Fjbc.M309660200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyake, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatayama, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabeshima, Y.-i.</span></span> <span> </span><span class="NLM_article-title">An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>236</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">322</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1997.6943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1006%2Fbbrc.1997.6943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=9240432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADyaK2sXkvVWns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=1997&pages=313-322&author=K.+Itohauthor=T.+Chibaauthor=S.+Takahashiauthor=T.+Oyakeauthor=T.+Ishiiauthor=M.+Yamamotoauthor=Y.+Katohauthor=N.+Hayashiauthor=K.+Satohauthor=K.+Igarashiauthor=I.+Hatayamaauthor=Y.-i.+Nabeshima&title=An+Nrf2%2FSmall+Maf+Heterodimer+Mediates+the+Induction+of+Phase+II+Detoxifying+Enzyme+Genes+through+Antioxidant+Response+Elements&doi=10.1006%2Fbbrc.1997.6943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements</span></div><div class="casAuthors">Itoh, Ken; Chiba, Tomoki; Takahashi, Satoru; Ishii, Tetsuro; Igarashi, Kazuhiko; Katoh, Yasutake; Oyake, Tatsuya; Hayashi, Norio; Satoh, Kimihiko; Hatayama, Ichiro; Yamamoto, Masayuki; Nabeshima, Yo-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">236</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">313-322</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">The induction of phase II detoxifying enzymes in an important defense mechanism against intake of xenobiotics.  While this group of enzymes is believed to be under the transcriptional control of antioxidant response elements (AREs), this contention is exptl. unconfirmed.  Since the ARE resembles the binding sequence of erythroid transcription factor NF-E2, the authors investigated the possibility that the phase II enzyme genes might be regulated by transcription factors that also bind to the NF-E2 sequence.  The expression profiles of a no. of transcription factor suggest that an Nrf2/small Maf heterodimer is the most likely candidate to fulfill this role in vivo.  To directly test these questions, the authors disrupted the murine nrf2 gene in vivo.  While the expression of phase II enzymes (e.g., glutathione S-transferase and NAD(P)H: quinone oxidoreductase) was markedly induced by a phenolic antioxidant in vivo in both wild type and heterozygous mutant mice, the induction was largely eliminated in the liver and intestine of homozygous nrf2-mutant mice.  Nrf2 was found to bind to the ARE with high affinity only as a heterodimer with a small Maf protein, suggesting that Nrf2/small Maf activates gene expression directly through the ARE.  These results demonstrate that Nrf2 is essential for the transcriptional induction of phase II enzymes and the presence of a coordinate transcriptional regulatory mechanism for phase II enzyme genes.  The nrf2-deficient mice may prove to be a very useful model for the in vivo anal. of chem. carcinogenesis and resistance to anti-cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwOKWP1JSQT7Vg90H21EOLACvtfcHk0lgwxPwGi0wYrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvVWns78%253D&md5=c3daaa556967bc2aaaa55834e99605c3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1997.6943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1997.6943%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DChiba%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DOyake%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DN.%26aulast%3DSatoh%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DK.%26aulast%3DHatayama%26aufirst%3DI.%26aulast%3DNabeshima%26aufirst%3DY.-i.%26atitle%3DAn%2520Nrf2%252FSmall%2520Maf%2520Heterodimer%2520Mediates%2520the%2520Induction%2520of%2520Phase%2520II%2520Detoxifying%2520Enzyme%2520Genes%2520through%2520Antioxidant%2520Response%2520Elements%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1997%26volume%3D236%26spage%3D313%26epage%3D322%26doi%3D10.1006%2Fbbrc.1997.6943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cousin, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumsey, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attucks, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levonen, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Targeting of the NRF2 and KEAP1 Partnership in Chronic Diseases</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1038/s41573-018-0008-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1038%2Fs41573-018-0008-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=30610225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlslKlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=295-317&author=A.+Cuadradoauthor=A.+I.+Rojoauthor=G.+Wellsauthor=J.+D.+Hayesauthor=S.+P.+Cousinauthor=W.+L.+Rumseyauthor=O.+C.+Attucksauthor=S.+Franklinauthor=A.+L.+Levonenauthor=T.+W.+Kenslerauthor=A.+T.+Dinkova-Kostova&title=Therapeutic+Targeting+of+the+NRF2+and+KEAP1+Partnership+in+Chronic+Diseases&doi=10.1038%2Fs41573-018-0008-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases</span></div><div class="casAuthors">Cuadrado, Antonio; Rojo, Ana I.; Wells, Geoffrey; Hayes, John D.; Cousin, Sharon P.; Rumsey, William L.; Attucks, Otis C.; Franklin, Stephen; Levonen, Anna-Liisa; Kensler, Thomas W.; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  The transcription factor NF-E2 p45-related factor 2 (NRF2; encoded by NFE2L2) and its principal neg. regulator, the E3 ligase adaptor Kelch-like ECH-assocd. protein 1 (KEAP1), are crit. in the maintenance of redox, metabolic and protein homeostasis, as well as the regulation of inflammation.  Thus, NRF2 activation provides cytoprotection against numerous pathologies including chronic diseases of the lung and liver; autoimmune, neurodegenerative and metabolic disorders; and cancer initiation.  One NRF2 activator has received clin. approval and several electrophilic modifiers of the cysteine-based sensor KEAP1 and inhibitors of its interaction with NRF2 are now in clin. development.  However, challenges regarding target specificity, pharmacodynamic properties, efficacy and safety remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW9hICH7_1WbVg90H21EOLACvtfcHk0lgwxPwGi0wYrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlslKlsr0%253D&md5=ce3b8d39cd759418444f6e375ee1a38c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fs41573-018-0008-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41573-018-0008-x%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DRojo%26aufirst%3DA.%2BI.%26aulast%3DWells%26aufirst%3DG.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DCousin%26aufirst%3DS.%2BP.%26aulast%3DRumsey%26aufirst%3DW.%2BL.%26aulast%3DAttucks%26aufirst%3DO.%2BC.%26aulast%3DFranklin%26aufirst%3DS.%26aulast%3DLevonen%26aufirst%3DA.%2BL.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DTherapeutic%2520Targeting%2520of%2520the%2520NRF2%2520and%2520KEAP1%2520Partnership%2520in%2520Chronic%2520Diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2019%26volume%3D18%26spage%3D295%26epage%3D317%26doi%3D10.1038%2Fs41573-018-0008-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrándiz, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacher-Juan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaraz, M. J.</span></span> <span> </span><span class="NLM_article-title">Nrf2 as a Therapeutic Target for Rheumatic Diseases</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2018.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.bcp.2018.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=29660314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnslOiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2018&pages=338-346&author=M.+L.+Ferr%C3%A1ndizauthor=J.+Nacher-Juanauthor=M.+J.+Alcaraz&title=Nrf2+as+a+Therapeutic+Target+for+Rheumatic+Diseases&doi=10.1016%2Fj.bcp.2018.04.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 as a therapeutic target for rheumatic diseases</span></div><div class="casAuthors">Ferrandiz, Maria Luisa; Nacher-Juan, Josep; Alcaraz, Maria Jose</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">338-346</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a master regulator of cellular protective processes.  Rheumatic diseases are chronic conditions characterized by inflammation, pain, tissue damage and limitations in function.  Main examples are rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis and osteoporosis.  Their high prevalence constitutes a major health problem with an important social and economic impact.  A wide range of evidence indicates that Nrf2 may control different mechanisms involved in the physiopathol. of rheumatic conditions.  Therefore, the appropriate expression and balance of Nrf2 is necessary for regulation of oxidative stress, inflammation, immune responses, and cartilage and bone metab.  Numerous studies have demonstrated that Nrf2 deficiency aggravates the disease in exptl. models while Nrf2 activation results in immunoregulatory and anti-inflammatory effects.  These reports reinforce the increasing interest in the pharmacol. regulation of Nrf2 and its potential applications.  Nevertheless, a majority of Nrf2 inducers are electrophilic mols. which may present off-target effects.  In recent years, novel strategies have been sought to modulate the Nrf2 pathway which has emerged as a therapeutic target in rheumatic conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Kqw0GQrgYrVg90H21EOLACvtfcHk0lhp5v2kgtwWyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnslOiuro%253D&md5=c1810bf46725cf0110662a5e13c705a3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2018.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2018.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DFerr%25C3%25A1ndiz%26aufirst%3DM.%2BL.%26aulast%3DNacher-Juan%26aufirst%3DJ.%26aulast%3DAlcaraz%26aufirst%3DM.%2BJ.%26atitle%3DNrf2%2520as%2520a%2520Therapeutic%2520Target%2520for%2520Rheumatic%2520Diseases%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D152%26spage%3D338%26epage%3D346%26doi%3D10.1016%2Fj.bcp.2018.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nezu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saigusa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Transcription Factor Nrf2 Hyperactivation In Early-Phase Renal Ischemia-Reperfusion Injury Prevents Tubular Damage Progression</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1016/j.kint.2016.08.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.kint.2016.08.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=27789056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCku7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2017&pages=387-401&author=M.+Nezuauthor=T.+Soumaauthor=L.+Yuauthor=T.+Suzukiauthor=D.+Saigusaauthor=S.+Itoauthor=N.+Suzukiauthor=M.+Yamamoto&title=Transcription+Factor+Nrf2+Hyperactivation+In+Early-Phase+Renal+Ischemia-Reperfusion+Injury+Prevents+Tubular+Damage+Progression&doi=10.1016%2Fj.kint.2016.08.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression</span></div><div class="casAuthors">Nezu, Masahiro; Souma, Tomokazu; Yu, Lei; Suzuki, Takafumi; Saigusa, Daisuke; Ito, Sadayoshi; Suzuki, Norio; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">387-401</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Acute kidney injury is a devastating disease with high morbidity in hospitalized patients and contributes to the pathogenesis of chronic kidney disease.  An underlying mechanism of acute kidney injury involves ischemia-reperfusion injury which, in turn, induces oxidative stress and provokes organ damage.  Nrf2 is a master transcription factor that regulates the cellular response to oxidative stress.  Here, we examd. the role of Nrf2 in the progression of ischemia-reperfusion injury-induced kidney damage in mice using genetic and pharmacol. approaches.  Both global and tubular-specific Nrf2 activation enhanced gene expression of antioxidant and NADPH synthesis enzymes, including glucose-6-phosphate dehydrogenase, and ameliorated both the initiation of injury in the outer medulla and the progression of tubular damage in the cortex.  Myeloid-specific Nrf2 activation was ineffective.  Short-term administration of the Nrf2 inducer CDDO during the initial phase of injury ameliorated the late phase of tubular damage.  This inducer effectively protected the human proximal tubular cell line HK-2 from oxidative stress-mediated cell death while glucose-6-phosphate dehydrogenase knockdown increased intracellular reactive oxygen species.  These findings demonstrate that tubular hyperactivation of Nrf2 in the initial phase of injury prevents the progression of reactive oxygen species-mediated tubular damage by inducing antioxidant enzymes and NADPH synthesis.  Thus, Nrf2 may be a promising therapeutic target for preventing acute kidney injury to chronic kidney disease transition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0cKCFdEBWR7Vg90H21EOLACvtfcHk0lhp5v2kgtwWyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCku7jP&md5=7a1cacbf340881a9b50a4c4aa74c9509</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.kint.2016.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.kint.2016.08.023%26sid%3Dliteratum%253Aachs%26aulast%3DNezu%26aufirst%3DM.%26aulast%3DSouma%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DSaigusa%26aufirst%3DD.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DTranscription%2520Factor%2520Nrf2%2520Hyperactivation%2520In%2520Early-Phase%2520Renal%2520Ischemia-Reperfusion%2520Injury%2520Prevents%2520Tubular%2520Damage%2520Progression%26jtitle%3DKidney%2520Int.%26date%3D2017%26volume%3D91%26spage%3D387%26epage%3D401%26doi%3D10.1016%2Fj.kint.2016.08.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gopal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikulskis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaravadi, L.</span></span> <span> </span><span class="NLM_article-title">Evidence of Activation of the Nrf2 Pathway in Multiple Sclerosis Patients Treated with Delayed-Release Dimethyl Fumarate in the Phase 3 DEFINE and CONFIRM Studies</span>. <i>Multiple Sclerosis Journal</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1875</span>– <span class="NLM_lpage">1883</span>, <span class="refDoi"> DOI: 10.1177/1352458517690617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1177%2F1352458517690617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=28156185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFKmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=1875-1883&author=S.+Gopalauthor=A.+Mikulskisauthor=R.+Goldauthor=R.+J.+Foxauthor=K.+T.+Dawsonauthor=L.+Amaravadi&title=Evidence+of+Activation+of+the+Nrf2+Pathway+in+Multiple+Sclerosis+Patients+Treated+with+Delayed-Release+Dimethyl+Fumarate+in+the+Phase+3+DEFINE+and+CONFIRM+Studies&doi=10.1177%2F1352458517690617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies</span></div><div class="casAuthors">Gopal, Sreeja; Mikulskis, Alvydas; Gold, Ralf; Fox, Robert J.; Dawson, Katherine T.; Amaravadi, Lakshmi</div><div class="citationInfo"><span class="NLM_cas:title">Multiple Sclerosis Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1875-1883</span>CODEN:
                <span class="NLM_cas:coden">MSJUAP</span>;
        ISSN:<span class="NLM_cas:issn">1477-0970</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Delayed-release di-Me fumarate (DMF) is an approved oral treatment for relapsing forms of multiple sclerosis (MS).  Preclin. studies demonstrated that DMF activated the nuclear factor E2-related factor 2 (Nrf2) pathway.  DMF and its primary metabolite monomethyl fumarate (MMF) were also shown to promote cytoprotection of cultured central nervous system (CNS) cells via the Nrf2 pathway.  To investigate the activation of Nrf2 pathway following ex vivo stimulation of human peripheral blood mononuclear cells (PBMCs) with DMF or MMF, and in DMF-treated patients from two Phase 3 relapsing MS studies DEFINE and CONFIRM.  Transcription of Nrf2 target genes NADPH:quinone oxidoreductase-1 (NQO1) and heme-oxygenase-1 (HO1) was measured using Taqman assays.  RNA samples were isolated from ex vivo-stimulated PBMCs and from whole blood samples of 200 patients each from placebo, twice daily (BID) and three times daily (TID) treatments.  DMF and MMF induced NQO1 and HO1 gene expression in ex vivo-stimulated PBMCs, DMF being the more potent inducer.  Induction of NQO1 occurred at lower DMF concns. compared to that of HO1.  In DMF-treated patients, a statistically significant induction of NQO1 was obsd. relative to baseline and compared to placebo.  No statistical significance was reached for HO1 induction.  These data provide the first evidence of Nrf2 pathway activation from two large pivotal Phase 3 studies of DMF-treated MS patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ8WOKcGfF07Vg90H21EOLACvtfcHk0lhp5v2kgtwWyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFKmurg%253D&md5=9d7f5974a822bc8d3090b351b9ebbef9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1177%2F1352458517690617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1352458517690617%26sid%3Dliteratum%253Aachs%26aulast%3DGopal%26aufirst%3DS.%26aulast%3DMikulskis%26aufirst%3DA.%26aulast%3DGold%26aufirst%3DR.%26aulast%3DFox%26aufirst%3DR.%2BJ.%26aulast%3DDawson%26aufirst%3DK.%2BT.%26aulast%3DAmaravadi%26aufirst%3DL.%26atitle%3DEvidence%2520of%2520Activation%2520of%2520the%2520Nrf2%2520Pathway%2520in%2520Multiple%2520Sclerosis%2520Patients%2520Treated%2520with%2520Delayed-Release%2520Dimethyl%2520Fumarate%2520in%2520the%2520Phase%25203%2520DEFINE%2520and%2520CONFIRM%2520Studies%26jtitle%3DMultiple%2520Sclerosis%2520Journal%26date%3D2017%26volume%3D23%26spage%3D1875%26epage%3D1883%26doi%3D10.1177%2F1352458517690617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabbani, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waqas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sultan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Viso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceradini, D. J.</span></span> <span> </span><span class="NLM_article-title">Targeted Nrf2 Activation Therapy with RTA 408 Enhances Regenerative Capacity of Diabetic Wounds</span>. <i>Diabetes Res. Clin. Pract.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.diabres.2018.02.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.diabres.2018.02.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=29476889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsF2ntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2018&pages=11-23&author=P.+S.+Rabbaniauthor=T.+Ellisonauthor=B.+Waqasauthor=D.+Sultanauthor=S.+Abdouauthor=J.+A.+Davidauthor=J.+M.+Cohenauthor=A.+Gomez-Visoauthor=G.+Lamauthor=C.+Kimauthor=J.+Thomsonauthor=D.+J.+Ceradini&title=Targeted+Nrf2+Activation+Therapy+with+RTA+408+Enhances+Regenerative+Capacity+of+Diabetic+Wounds&doi=10.1016%2Fj.diabres.2018.02.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Nrf2 activation therapy with RTA 408 enhances regenerative capacity of diabetic wounds</span></div><div class="casAuthors">Rabbani, Piul S.; Ellison, Trevor; Waqas, Bukhtawar; Sultan, Darren; Abdou, Salma; David, Joshua A.; Cohen, Joshua M.; Gomez-Viso, Alejandro; Lam, Gretl; Kim, Camille; Thomson, Jennifer; Ceradini, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes Research and Clinical Practice</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-23</span>CODEN:
                <span class="NLM_cas:coden">DRCPE9</span>;
        ISSN:<span class="NLM_cas:issn">0168-8227</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Though unmitigated oxidative stress in diabetic chronic non-healing wounds poses a major therapeutic challenge, currently, there are no effective pharmacol. agents.  We targeted the cytoprotective Nrf2/Keap1 pathway, which is dysfunctional in diabetic skin and the regenerative environment in the diabetic wound.  We assessed the efficacy of a potent Nrf2-activator, RTA 408, a semi-synthetic oleanane triterpenoid, on accelerating diabetic wound healing.Using Leprdb/dbmice, we made 10 mm-diam. excisional humanized wounds in dorsal skin.  We administered RTA 408 formulations daily, and used ANOVA for comparison of time to closure, in vivo real-time ROS, histol., mol. changes.We found that RTA 408, specifically a 0.1% formulation, significantly reduced wound healing time and increased wound closure rate.  While either systemic or topical administration of RTA 408 is effective, wound closure time with the latter was far superior.  RTA 408-treated diabetic wounds upregulated Nrf2 and downstream antioxidant genes, and exhibited well-vascularized granulation tissue that aided in re-epithelialization.  Reintroduction of redox mechanisms via RTA 408-induced Nrf2 resulted in redn. of the oxidative status of wounds, to coordinate successful wound closure.This preclin. study shows that promoting Nrf2-mediated antioxidant activity in the localized regenerative milieu of a diabetic wound markedly improves the mol. and cellular compn. of diabetic wound beds.  RTA 408 treats and corrects the irregularity in redox balance mechanisms involving Nrf2, in an avenue not explored previously for treatment of diabetic wounds and tissue regeneration.  Our study supports development of RTA 408 as a therapeutic modality for chronic diabetic wounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokOe8iphSixLVg90H21EOLACvtfcHk0lhQ5cmhb9ArJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsF2ntbY%253D&md5=51a6357b0334d10f0daaf20d7895908f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.diabres.2018.02.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.diabres.2018.02.021%26sid%3Dliteratum%253Aachs%26aulast%3DRabbani%26aufirst%3DP.%2BS.%26aulast%3DEllison%26aufirst%3DT.%26aulast%3DWaqas%26aufirst%3DB.%26aulast%3DSultan%26aufirst%3DD.%26aulast%3DAbdou%26aufirst%3DS.%26aulast%3DDavid%26aufirst%3DJ.%2BA.%26aulast%3DCohen%26aufirst%3DJ.%2BM.%26aulast%3DGomez-Viso%26aufirst%3DA.%26aulast%3DLam%26aufirst%3DG.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DThomson%26aufirst%3DJ.%26aulast%3DCeradini%26aufirst%3DD.%2BJ.%26atitle%3DTargeted%2520Nrf2%2520Activation%2520Therapy%2520with%2520RTA%2520408%2520Enhances%2520Regenerative%2520Capacity%2520of%2520Diabetic%2520Wounds%26jtitle%3DDiabetes%2520Res.%2520Clin.%2520Pract.%26date%3D2018%26volume%3D139%26spage%3D11%26epage%3D23%26doi%3D10.1016%2Fj.diabres.2018.02.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo de la Vega, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wondrak, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">An Essential Role of NRF2 in Diabetic Wound Healing</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">780</span>– <span class="NLM_lpage">793</span>, <span class="refDoi"> DOI: 10.2337/db15-0564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.2337%2Fdb15-0564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=26718502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKltLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=780-793&issue=3&author=M.+Longauthor=M.+Rojo+de+la+Vegaauthor=Q.+Wenauthor=M.+Bhararaauthor=T.+Jiangauthor=R.+Zhangauthor=S.+Zhouauthor=P.+K.+Wongauthor=G.+T.+Wondrakauthor=H.+Zhengauthor=D.+D.+Zhang&title=An+Essential+Role+of+NRF2+in+Diabetic+Wound+Healing&doi=10.2337%2Fdb15-0564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">An essential role of NRF2 in diabetic wound healing</span></div><div class="casAuthors">Long, Min; Rojo de la Vega, Montserrat; Wen, Qing; Bharara, Manish; Jiang, Tao; Zhang, Rui; Zhou, Shiwen; Wong, Pak K.; Wondrak, Georg T.; Zheng, Hongting; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">780-793</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">The high mortality and disability of diabetic nonhealing skin ulcers create an urgent need for the development of more efficacious strategies targeting diabetic wound healing.  In the current study, using human clin. specimens, we show that perilesional skin tissues from patients with diabetes are under more severe oxidative stress and display higher activation of the nuclear factor-E2-related factor 2 (NRF2)-mediated antioxidant response than perilesional skin tissues from normoglycemic patients.  In a streptozotocin-induced diabetes mouse model, Nrf2-/- mice have delayed wound closure rates compared with Nrf2+/+mice, which is, at least partially, due to greater oxidative DNA damage, low transforming growth factor-β1 (TGF-β1) and high matrix metalloproteinase 9 (MMP9) expression, and increased apoptosis.  More importantly, pharmacol. activation of the NRF2 pathway significantly improves diabetic wound healing.  In vitro expts. in human immortalized keratinocyte cells confirm that NRF2 contributes to wound healing by alleviating oxidative stress, increasing proliferation and migration, decreasing apoptosis, and increasing the expression of TGF-β1 and lowering MMP9 under high-glucose conditions.  This study indicates an essential role for NRF2 in diabetic wound healing and the therapeutic benefits of activating NRF2 in this disease, laying the foundation for future clin. trials using NRF2 activators in treating diabetic skin ulcers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqldj1KoAeHQbVg90H21EOLACvtfcHk0lhQ5cmhb9ArJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKltLbM&md5=af5090db91645197a35e867fb350f711</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2337%2Fdb15-0564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb15-0564%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DM.%26aulast%3DRojo%2Bde%2Bla%2BVega%26aufirst%3DM.%26aulast%3DWen%26aufirst%3DQ.%26aulast%3DBharara%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DP.%2BK.%26aulast%3DWondrak%26aufirst%3DG.%2BT.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DAn%2520Essential%2520Role%2520of%2520NRF2%2520in%2520Diabetic%2520Wound%2520Healing%26jtitle%3DDiabetes%26date%3D2016%26volume%3D65%26issue%3D3%26spage%3D780%26epage%3D793%26doi%3D10.2337%2Fdb15-0564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Molecular Basis of the Keap1-Nrf2 System</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.freeradbiomed.2015.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=26117331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Cku7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=93-100&author=T.+Suzukiauthor=M.+Yamamoto&title=Molecular+Basis+of+the+Keap1-Nrf2+System&doi=10.1016%2Fj.freeradbiomed.2015.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of the Keap1-Nrf2 system</span></div><div class="casAuthors">Suzuki, Takafumi; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">93-100</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nrf2 (NF-E2-related factor 2) is a master regulator of cellular responses against environmental stresses.  Nrf2 induces the expression of detoxification and antioxidant enzymes, and Keap1 (Kelch-like ECH-assocd. protein 1), an adaptor subunit of Cullin 3-based E3 ubiquitin ligase, regulates Nrf2 activity.  Keap1 also acts as a sensor for oxidative and electrophilic stresses.  Keap1 retains multiple sensor cysteine residues that detect various stress stimuli.  Increasing attention has been paid to the roles that Nrf2 plays in the protection of our bodies against drug toxicity and stress-induced diseases.  On the other hand, Nrf2 is found to promote both oncogenesis and cancer cell resistance against chemotherapeutic drugs.  Thus, although Nrf2 acts to protect our body from deleterious stresses, cancer cells hijack the Nrf2 activity to support their malignant growth.  Nrf2 has emerged as a new therapeutic target, and both inducers and inhibitors of Nrf2 are awaited.  Studies challenging the mol. basis of the Keap1-Nrf2 system functions are now critically important to improve translational studies of the system.  Indeed, recent studies identified cross talk between Nrf2 and other signaling pathways, which provides new insights into the mechanisms by which the Keap1-Nrf2 system serves as a potent regulator of our health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3SXIMvWYgU7Vg90H21EOLACvtfcHk0lhQ5cmhb9ArJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Cku7bL&md5=893e5dbf9b3cfe85fd30590a4a93b49c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DMolecular%2520Basis%2520of%2520the%2520Keap1-Nrf2%2520System%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D88%26spage%3D93%26epage%3D100%26doi%3D10.1016%2Fj.freeradbiomed.2015.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boobis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldring, C. E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenna, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laverty, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naisbitt, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoll-Griffith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routledge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweedie, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermeulen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span> <span> </span><span class="NLM_article-title">Managing the Challenge of Chemically Reactive Metabolites in Drug Development</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">292</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1038/nrd3408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1038%2Fnrd3408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=21455238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=292-306&author=B.+K.+Parkauthor=A.+Boobisauthor=S.+Clarkeauthor=C.+E.+P.+Goldringauthor=D.+Jonesauthor=J.+G.+Kennaauthor=C.+Lambertauthor=H.+G.+Lavertyauthor=D.+J.+Naisbittauthor=S.+Nelsonauthor=D.+A.+Nicoll-Griffithauthor=R.+S.+Obachauthor=P.+Routledgeauthor=D.+A.+Smithauthor=D.+J.+Tweedieauthor=N.+Vermeulenauthor=D.+P.+Williamsauthor=I.+D.+Wilsonauthor=T.+A.+Baillie&title=Managing+the+Challenge+of+Chemically+Reactive+Metabolites+in+Drug+Development&doi=10.1038%2Fnrd3408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Managing the challenge of chemically reactive metabolites in drug development</span></div><div class="casAuthors">Park, B. Kevin; Boobis, Alan; Clarke, Stephen; Goldring, Chris E. P.; Jones, David; Kenna, J. Gerry; Lambert, Craig; Laverty, Hugh G.; Naisbitt, Dean J.; Nelson, Sidney; Nicoll-Griffith, Deborah A.; Obach, R. Scott; Routledge, Philip; Smith, Dennis A.; Tweedie, Donald J.; Vermeulen, Nico; Williams, Dominic P.; Wilson, Ian D.; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">292-306</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The normal metab. of drugs can generate metabolites that have intrinsic chem. reactivity towards cellular mols., and therefore have the potential to alter biol. function and initiate serious adverse drug reactions.  Here, we present an assessment of the current approaches used for the evaluation of chem. reactive metabolites.  We also describe how these approaches are being used within the pharmaceutical industry to assess and minimize the potential of drug candidates to cause toxicity.  At early stages of drug discovery, iteration between medicinal chem. and drug metab. can eliminate perceived reactive metabolite-mediated chem. liabilities without compromising pharmacol. activity or the need for extensive safety evaluation beyond std. practices.  In the future, reactive metabolite evaluation may also be useful during clin. development for improving clin. risk assessment and risk management.  Currently, there remains a huge gap in our understanding of the basic mechanisms that underlie chem. stress-mediated adverse reactions in humans.  This Review summarizes our views on this complex topic, and includes insights into practices considered by the pharmaceutical industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBv41vr7ZlNLVg90H21EOLACvtfcHk0lgRgQzXKJ7JYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGnu78%253D&md5=8f6865f17bbe50b51aa4282379e82a08</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd3408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3408%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DB.%2BK.%26aulast%3DBoobis%26aufirst%3DA.%26aulast%3DClarke%26aufirst%3DS.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%2BP.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26aulast%3DLambert%26aufirst%3DC.%26aulast%3DLaverty%26aufirst%3DH.%2BG.%26aulast%3DNaisbitt%26aufirst%3DD.%2BJ.%26aulast%3DNelson%26aufirst%3DS.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DRoutledge%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DTweedie%26aufirst%3DD.%2BJ.%26aulast%3DVermeulen%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26aulast%3DWilson%26aufirst%3DI.%2BD.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DManaging%2520the%2520Challenge%2520of%2520Chemically%2520Reactive%2520Metabolites%2520in%2520Drug%2520Development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D292%26epage%3D306%26doi%3D10.1038%2Fnrd3408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">To, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shilton, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Guglielmo, G. M.</span></span> <span> </span><span class="NLM_article-title">Synthetic Triterpenoids Target the Arp2/3 Complex and Inhibit Branched Actin Polymerization</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">27944</span>– <span class="NLM_lpage">27957</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.103036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1074%2Fjbc.M110.103036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=20566646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVOnsLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=27944-27957&author=C.+Toauthor=B.+H.+Shiltonauthor=G.+M.+Di+Guglielmo&title=Synthetic+Triterpenoids+Target+the+Arp2%2F3+Complex+and+Inhibit+Branched+Actin+Polymerization&doi=10.1074%2Fjbc.M110.103036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Triterpenoids Target the Arp2/3 Complex and Inhibit Branched Actin Polymerization</span></div><div class="casAuthors">To, Ciric; Shilton, Brian H.; Di Guglielmo, Gianni M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">27944-27957</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Synthetic triterpenoids are anti-tumor agents that affect numerous cellular functions including apoptosis and growth inhibition.  Here, we used mass spectrometric and protein array approaches and uncovered that triterpenoids assoc. with proteins of the actin cytoskeleton, including actin-related protein 3 (Arp3).  Arp3, a subunit of the Arp2/3 complex, is involved in branched actin polymn. and the formation of lamellipodia.  2-Cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO)-Im and CDDO-Me were obsd. to (1) inhibit the localization of Arp3 and actin at the leading edge of cells, (2) abrogate cell polarity, and (3) inhibit Arp2/3-dependent branched actin polymn.  We confirmed our drug effects with siRNA targeting of Arp3 and obsd. a decrease in Rat2 cell migration.  Taken together, our data suggest that synthetic triterpenoids target Arp3 and branched actin polymn. to inhibit cell migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0cef7euFKLrVg90H21EOLACvtfcHk0lgRgQzXKJ7JYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVOnsLrP&md5=b3205f082ce74377971c4f54b6bcda71</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.103036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.103036%26sid%3Dliteratum%253Aachs%26aulast%3DTo%26aufirst%3DC.%26aulast%3DShilton%26aufirst%3DB.%2BH.%26aulast%3DDi%2BGuglielmo%26aufirst%3DG.%2BM.%26atitle%3DSynthetic%2520Triterpenoids%2520Target%2520the%2520Arp2%252F3%2520Complex%2520and%2520Inhibit%2520Branched%2520Actin%2520Polymerization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D27944%26epage%3D27957%26doi%3D10.1074%2Fjbc.M110.103036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prigge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Z.</span></span> <span> </span><span class="NLM_article-title">Chemoprevention of Oxidative Stress-Associated Oral Carcinogenesis by Sulforaphane Depends on NRF2 and the Isothiocyanate Moiety</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">53502</span>– <span class="NLM_lpage">53514</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.10609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.18632%2Foncotarget.10609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=27447968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A280%3ADC%252BC2s3jt1Sguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=53502-53514&author=A.+Lanauthor=W.+Liauthor=Y.+Liuauthor=X.+Zhangauthor=S.+Zhouauthor=O.+Palkoauthor=H.+Chenauthor=M.+Kapitaauthor=J.+Priggeauthor=E.+Schmidtauthor=X.+Chenauthor=Z.+Sunauthor=X.+L.+Chenauthor=Z.+Xiong&title=Chemoprevention+of+Oxidative+Stress-Associated+Oral+Carcinogenesis+by+Sulforaphane+Depends+on+NRF2+and+the+Isothiocyanate+Moiety&doi=10.18632%2Foncotarget.10609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoprevention of oxidative stress-associated oral carcinogenesis by sulforaphane depends on NRF2 and the isothiocyanate moiety</span></div><div class="casAuthors">Lan Aixian; Li Wenjun; Liu Yao; Zhang Xinyan; Sun Zheng; Xiong Zhaohui; Palko Olesya; Chen Hao; Kapita Mayanga; Chen Xiaoxin Luke; Zhou Shanshan; Chen Xin; Prigge Justin R; Schmidt Edward E</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">53502-53514</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxidative stress is known to play an important role in oral cancer development.  In this study we aimed to examine whether a chemical activator of NRF2, sulforaphane (SFN), may have chemopreventive effects on oxidative stress-associated oral carcinogenesis.  We first showed that Nrf2 activation and oxidative damage were commonly seen in human samples of oral leukoplakia.  With gene microarray and immunostaining, we found 4-nitroquinoline 1-oxide (4NQO) in drink activated the Nrf2 pathway and produced oxidative damage in mouse tongue.  Meanwhile whole exome sequencing of mouse tongue identified mutations consistent with 4NQO's mutagenic profile.  Using cultured human oral keratinocytes and 4NQO-treated mouse tongue, we found that SFN pre-treatment activated the NRF2 pathway and inhibited oxidative damage both in vitro and in vivo.  On the contrary, a structural analogue of SFN without the isothiocyanate moiety did not have such effects.  In a long-term chemoprevention study using wild-type and Nrf2-/- mice, we showed that topical application of SFN activated the NRF2 pathway, inhibited oxidative damage, and prevented 4NQO-induced oral carcinogenesis in an Nrf2-dependent manner.  Our data clearly demonstrate that SFN has chemopreventive effects on oxidative stress-associated oral carcinogenesis, and such effects depend on Nrf2 and the isothiocyanate moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSPWXwNzPqwq7qxQ2mb9Pu8fW6udTcc2eZb9fJxQcwu2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3jt1Sguw%253D%253D&md5=4457a77e4fd52f2e2457ac993c075412</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.10609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.10609%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DPalko%26aufirst%3DO.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DKapita%26aufirst%3DM.%26aulast%3DPrigge%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%2BL.%26aulast%3DXiong%26aufirst%3DZ.%26atitle%3DChemoprevention%2520of%2520Oxidative%2520Stress-Associated%2520Oral%2520Carcinogenesis%2520by%2520Sulforaphane%2520Depends%2520on%2520NRF2%2520and%2520the%2520Isothiocyanate%2520Moiety%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D53502%26epage%3D53514%26doi%3D10.18632%2Foncotarget.10609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCullough, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, S.</span></span> <span> </span><span class="NLM_article-title">Cardiac and Renal Function in Patients with Type 2 Diabetes Who have Chronic Kidney Disease: Potential Effects of Bardoxolone Methyl</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S26714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.2147%2FDDDT.S26714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=22787387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVWmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&pages=141-149&author=P.+A.+McCulloughauthor=S.+Ali&title=Cardiac+and+Renal+Function+in+Patients+with+Type+2+Diabetes+Who+have+Chronic+Kidney+Disease%3A+Potential+Effects+of+Bardoxolone+Methyl&doi=10.2147%2FDDDT.S26714"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac and renal function in patients with type 2 diabetes who have chronic kidney disease: potential effects of bardoxolone methyl</span></div><div class="casAuthors">McCullough, Peter A.; Ali, Sajid</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141-149</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The intracellular and tissue balance of oxidant and antioxidant forces is a potential therapeutic target for a variety of agents in the treatment of complications due to chronic disease including diabetes mellitus and hypertension.  There are a myriad of processes controlled at the level of genes, transcription factors, and protein messages that work to control the normal use of oxidative reactions within cells.  Loss of control of these processes may lead to reversible dysfunction in many cell lines including the podocyte, renal tubular cells, and cardiac myocytes.  Bardoxolone Me is a novel nuclear regulator factor (Nrf-2) activator which works to tip the balance of effects towards antioxidn. and as an observation made serendipitously, improves renal filtration function in humans after approx. 12 wk of therapy.  The improvement in estd. glomerular filtration can be up to 30% in those with stage 3 and 4 chronic kidney disease.  However, exptl. evidence suggests there may be a consequence of relative hyperfiltration in diseased kidneys as well as potential adverse effects on skeletal and cardiac myocytes.  Only large, prospective randomized trials with carefully collected and adjudicated clin. outcomes will inform the research community on the therapeutic risks and benefits of this important new agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLVpv2PudfnrVg90H21EOLACvtfcHk0lhCRe-SZeUn9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVWmtL8%253D&md5=25a039b43a061dc0911065e23f9b4662</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S26714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S26714%26sid%3Dliteratum%253Aachs%26aulast%3DMcCullough%26aufirst%3DP.%2BA.%26aulast%3DAli%26aufirst%3DS.%26atitle%3DCardiac%2520and%2520Renal%2520Function%2520in%2520Patients%2520with%2520Type%25202%2520Diabetes%2520Who%2520have%2520Chronic%2520Kidney%2520Disease%253A%2520Potential%2520Effects%2520of%2520Bardoxolone%2520Methyl%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2012%26volume%3D6%26spage%3D141%26epage%3D149%26doi%3D10.2147%2FDDDT.S26714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Zeeuw, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audhya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakris, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ-Schmidt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsberry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambers Heerspink, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurray, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parving, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remuzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toto, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaziri, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrolstad, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chertow, G. M.</span></span> <span> </span><span class="NLM_article-title">Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>369</i></span>,  <span class="NLM_fpage">2492</span>– <span class="NLM_lpage">2503</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1306033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1056%2FNEJMoa1306033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=24206459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=2492-2503&author=D.+de%0AZeeuwauthor=T.+Akizawaauthor=P.+Audhyaauthor=G.+L.+Bakrisauthor=M.+Chinauthor=H.+Christ-Schmidtauthor=A.+Goldsberryauthor=M.+Houserauthor=M.+Krauthauthor=H.+J.+Lambers+Heerspinkauthor=J.+J.+McMurrayauthor=C.+J.+Meyerauthor=H.-H.+Parvingauthor=G.+Remuzziauthor=R.+D.+Totoauthor=N.+D.+Vaziriauthor=C.+Wannerauthor=J.+Wittesauthor=D.+Wrolstadauthor=G.+M.+Chertow&title=Bardoxolone+Methyl+in+Type+2+Diabetes+and+Stage+4+Chronic+Kidney+Disease&doi=10.1056%2FNEJMoa1306033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease</span></div><div class="casAuthors">de Zeeuw, Dick; Akizawa, Tadao; Audhya, Paul; Bakris, George L.; Chin, Melanie; Christ-Schmidt, Heidi; Goldsberry, Angie; Houser, Mark; Krauth, Melissa; Lambers Heerspink, Hiddo J.; McMurray, John J.; Meyer, Colin J.; Parving, Hans-Henrik; Remuzzi, Giuseppe; Toto, Robert D.; Vaziri, Nosratola D.; Wanner, Christoph; Wittes, Janet; Wrolstad, Danielle; Chertow, Glenn M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2492-2503</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Although inhibitors of the renin-angiotensin-aldosterone system can slow the progression of diabetic kidney disease, the residual risk is high.  Whether nuclear I factor (erythroid-derived 2)-related factor 2 activators further reduce this risk is unknown.  METHODS: We randomly assigned 2185 patients with type 2 diabetes mellitus and stage 4 chronic kidney disease (estd. glomerular filtration rate [GFR], 15 to <30 mL per min per 1.73 m2 of body-surface area) to bardoxolone Me, at a daily dose of 20 mg, or placebo.  The primary composite outcome was end-stage renal disease (ESRD) or death from cardiovascular causes.  RESULTS: The sponsor and the steering committee terminated the trial on the recommendation of the independent data and safety monitoring committee; the median follow-up was 9 mo.  A total of 69 of 1088 patients (6%) randomly assigned to bardoxolone Me and 69 of 1097 (6%) randomly assigned to placebo had a primary composite outcome (hazard ratio in the bardoxolone Me group vs. the placebo group, 0.98; 95% confidence interval [CI], 0.70 to 1.37; P = 0.92).  In the bardoxolone Me group, ESRD developed in 43 patients, and 27 patients died from cardiovascular causes; in the placebo group, ESRD developed In 51 patients, and 19 patients died from cardiovascular causes.  A total of 96 patients in the bardoxolone Me group were hospitalized for heart failure or died from heart failure, as compared with 55 in the placebo group (hazard ratio, 1.83; 95% CI, 1.32 to 2.55; P < 0.001).  Estd. GFR, blood pressure, and the urinary albumin-to-creatinine ratio increased significantly and body wt. decreased significantly in the bardoxolone Me group, as compared with the placebo group.  CONCLUSIONS: Among patients with type 2 diabetes mellitus and stage 4 chronic kidney disease, bardoxolone Me did not reduce the risk of ESRD or death from cardiovascular causes.  A higher rate of cardiovascular events with bardoxolone Me than with placebo prompted termination of the trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomI6Z9q4C0LLVg90H21EOLACvtfcHk0lhCRe-SZeUn9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKqs74%253D&md5=1bcc997b57ba700423e0549a617231b5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1306033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1306033%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BZeeuw%26aufirst%3DD.%26aulast%3DAkizawa%26aufirst%3DT.%26aulast%3DAudhya%26aufirst%3DP.%26aulast%3DBakris%26aufirst%3DG.%2BL.%26aulast%3DChin%26aufirst%3DM.%26aulast%3DChrist-Schmidt%26aufirst%3DH.%26aulast%3DGoldsberry%26aufirst%3DA.%26aulast%3DHouser%26aufirst%3DM.%26aulast%3DKrauth%26aufirst%3DM.%26aulast%3DLambers%2BHeerspink%26aufirst%3DH.%2BJ.%26aulast%3DMcMurray%26aufirst%3DJ.%2BJ.%26aulast%3DMeyer%26aufirst%3DC.%2BJ.%26aulast%3DParving%26aufirst%3DH.-H.%26aulast%3DRemuzzi%26aufirst%3DG.%26aulast%3DToto%26aufirst%3DR.%2BD.%26aulast%3DVaziri%26aufirst%3DN.%2BD.%26aulast%3DWanner%26aufirst%3DC.%26aulast%3DWittes%26aufirst%3DJ.%26aulast%3DWrolstad%26aufirst%3DD.%26aulast%3DChertow%26aufirst%3DG.%2BM.%26atitle%3DBardoxolone%2520Methyl%2520in%2520Type%25202%2520Diabetes%2520and%2520Stage%25204%2520Chronic%2520Kidney%2520Disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D2492%26epage%3D2503%26doi%3D10.1056%2FNEJMoa1306033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallesen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solbak, S. M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguayo-Orozco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmona, R. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span> <span> </span><span class="NLM_article-title">A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">8028</span>– <span class="NLM_lpage">8052</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00723</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00723" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFOqt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8028-8052&issue=17&author=K.+T.+Tranauthor=J.+S.+Pallesenauthor=S.+M.+O.+Solbakauthor=D.+Narayananauthor=A.+Baigauthor=J.+Zangauthor=A.+Aguayo-Orozcoauthor=R.+M.+C.+Carmonaauthor=A.+D.+Garciaauthor=A.+Bach&title=A+Comparative+Assessment+Study+of+Known+Small-Molecule+Keap1-Nrf2+Protein-Protein+Interaction+Inhibitors%3A+Chemical+Synthesis%2C+Binding+Properties%2C+and+Cellular+Activity&doi=10.1021%2Facs.jmedchem.9b00723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity</span></div><div class="casAuthors">Tran, Kim T.; Pallesen, Jakob S.; Solbak, Sara M. Oe.; Narayanan, Dilip; Baig, Amina; Zang, Jie; Aguayo-Orozco, Alejandro; Carmona, Rosa M. C.; Garcia, Anthony D.; Bach, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8028-8052</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibiting the protein-protein interaction (PPI) between the transcription factor Nrf2 and its repressor protein Keap1 has emerged as a promising strategy to target oxidative stress in diseases, including central nervous system (CNS) disorders.  Numerous non-covalent small-mol. Keap1-Nrf2 PPI inhibitors have been reported to date, but many feature suboptimal physicochem. properties for permeating the blood-brain barrier, while others contain problematic structural moieties.  Here, we present the first side-by-side assessment of all reported Keap1-Nrf2 PPI inhibitor classes using fluorescence polarization, thermal shift assay, and surface plasmon resonance-and further evaluate the compds. in an NQO1 induction cell assay and in counter tests for nonspecific activities.  Surprisingly, half of the compds. were inactive or deviated substantially from reported activities, while we confirm the cross-assay activities for others.  Through this study, we have identified the most promising Keap1-Nrf2 inhibitors that can serve as pharmacol. probes or starting points for developing CNS-active Keap1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX8UEx5LbA87Vg90H21EOLACvtfcHk0ljbS9DXW9iLrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFOqt73P&md5=a80925ac602d3b3e4cae05bf5454ff34</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00723%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DPallesen%26aufirst%3DJ.%2BS.%26aulast%3DSolbak%26aufirst%3DS.%2BM.%2BO.%26aulast%3DNarayanan%26aufirst%3DD.%26aulast%3DBaig%26aufirst%3DA.%26aulast%3DZang%26aufirst%3DJ.%26aulast%3DAguayo-Orozco%26aufirst%3DA.%26aulast%3DCarmona%26aufirst%3DR.%2BM.%2BC.%26aulast%3DGarcia%26aufirst%3DA.%2BD.%26aulast%3DBach%26aufirst%3DA.%26atitle%3DA%2520Comparative%2520Assessment%2520Study%2520of%2520Known%2520Small-Molecule%2520Keap1-Nrf2%2520Protein-Protein%2520Interaction%2520Inhibitors%253A%2520Chemical%2520Synthesis%252C%2520Binding%2520Properties%252C%2520and%2520Cellular%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D17%26spage%3D8028%26epage%3D8052%26doi%3D10.1021%2Facs.jmedchem.9b00723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2736</span>– <span class="NLM_lpage">2745</span>, <span class="refDoi"> DOI: 10.1021/jm5000529</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5000529" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2736-2745&author=Z.+Y.+Jiangauthor=M.+C.+Luauthor=L.+L.+Xuauthor=T.+T.+Yangauthor=M.+Y.+Xiauthor=X.+L.+Xuauthor=X.+K.+Guoauthor=X.+J.+Zhangauthor=Q.+D.+Youauthor=H.+P.+Sun&title=Discovery+of+Potent+Keap1-Nrf2+Protein-Protein+Interaction+Inhibitor+Based+on+Molecular+Binding+Determinants+Analysis&doi=10.1021%2Fjm5000529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis</span></div><div class="casAuthors">Jiang, Zheng-Yu; Lu, Meng-Chen; Xu, Li-Li; Yang, Ting-Ting; Xi, Mei-Yang; Xu, Xiao-Li; Guo, Xiao-Ke; Zhang, Xiao-Jin; You, Qi-Dong; Sun, Hao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2736-2745</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Keap1 is known to mediate the ubiquitination of Nrf2, a master regulator of the antioxidant response.  Directly interrupting the Keap1-Nrf2 interaction has been emerged as a promising strategy to develop novel class of antioxidant, antiinflammatory, and anticancer agents.  On the basis of the mol. binding determinants anal. of Keap1, we successfully designed and characterized the most potent protein-protein interaction (PPI) inhibitor of Keap1-Nrf2, compd. 2, with KD value of 3.59 nM binding to Keap1 for the first time to single-digit nanomolar.  Compd. 2 can effectively disrupt the Nrf2-Keap1 interaction with an EC50 of 28.6 nM in the fluorescence polarization assay.  It can also activate the Nrf2 transcription activity in the cell-based ARE-luciferase reporter assay in a dose-dependent manner.  The qRT-PCR results of Nrf2 transcription targets gave the consistent results.  These results confirm direct and highly efficient interruption of the Keap1-Nrf2 PPI can be fully achieved by small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRS8nWHc40ZrVg90H21EOLACvtfcHk0ljbS9DXW9iLrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKmtro%253D&md5=b5d43ac3973478ecc54e26c74435f2c4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm5000529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5000529%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DXu%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DT.%2BT.%26aulast%3DXi%26aufirst%3DM.%2BY.%26aulast%3DXu%26aufirst%3DX.%2BL.%26aulast%3DGuo%26aufirst%3DX.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DSun%26aufirst%3DH.%2BP.%26atitle%3DDiscovery%2520of%2520Potent%2520Keap1-Nrf2%2520Protein-Protein%2520Interaction%2520Inhibitor%2520Based%2520on%2520Molecular%2520Binding%2520Determinants%2520Analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2736%26epage%3D2745%26doi%3D10.1021%2Fjm5000529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potteti, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kingsley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciano, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryuzoji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krunic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesecar, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span> <span> </span><span class="NLM_article-title">Probing the Structural Requirements of Non-Electrophilic Naphthalene-Based Nrf2 Activators</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.08.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.ejmech.2015.08.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=26363505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2nsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2015&pages=252-268&author=A.+D.+Jainauthor=H.+Pottetiauthor=B.+G.+Richardsonauthor=L.+Kingsleyauthor=J.+P.+Lucianoauthor=A.+F.+Ryuzojiauthor=H.+Leeauthor=A.+Krunicauthor=A.+D.+Mesecarauthor=S.+P.+Reddyauthor=T.+W.+Moore&title=Probing+the+Structural+Requirements+of+Non-Electrophilic+Naphthalene-Based+Nrf2+Activators&doi=10.1016%2Fj.ejmech.2015.08.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators</span></div><div class="casAuthors">Jain, Atul D.; Potteti, Haranatha; Richardson, Benjamin G.; Kingsley, Laura; Luciano, Julia P.; Ryuzoji, Aya F.; Lee, Hyun; Krunic, Aleksej; Mesecar, Andrew D.; Reddy, Sekhar P.; Moore, Terry W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">252-268</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Activation of the transcription factor Nrf2 has been posited to be a promising therapeutic strategy in a no. of inflammatory and oxidative stress diseases due to its regulation of detoxifying enzymes.  In this work, the authors have developed a comprehensive structure-activity relationship around a known, naphthalene-based nonelectrophilic activator of Nrf2, and the authors report highly potent nonelectrophilic activators of Nrf2.  Computational docking anal. of a subset of the compd. series demonstrates the importance of water mol. displacement for affinity, and the x-ray structure of di-amide I supports the computational anal.  One of the best compds., acid II, has an IC50 of 61 nM in a fluorescence anisotropy assay and a Kd of 120 nM in a surface plasmon resonance assay.  Addnl., the authors demonstrate that the Et ester of II is an efficacious inducer of Nrf2 target genes, exhibiting ex vivo efficacy similar to the well-known electrophilic activator, sulforaphane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzcvlMBGU0C7Vg90H21EOLACvtfcHk0ljviqSthFRGMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2nsrzJ&md5=750fd3ca47f1a122618942312390891b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.08.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.08.049%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DA.%2BD.%26aulast%3DPotteti%26aufirst%3DH.%26aulast%3DRichardson%26aufirst%3DB.%2BG.%26aulast%3DKingsley%26aufirst%3DL.%26aulast%3DLuciano%26aufirst%3DJ.%2BP.%26aulast%3DRyuzoji%26aufirst%3DA.%2BF.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKrunic%26aufirst%3DA.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26aulast%3DReddy%26aufirst%3DS.%2BP.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26atitle%3DProbing%2520the%2520Structural%2520Requirements%2520of%2520Non-Electrophilic%2520Naphthalene-Based%2520Nrf2%2520Activators%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D103%26spage%3D252%26epage%3D268%26doi%3D10.1016%2Fj.ejmech.2015.08.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winkel, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margerie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szillat, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glombik, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Güssregen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herling, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Knethen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmoll, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">28446</span>– <span class="NLM_lpage">28455</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.678136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1074%2Fjbc.M115.678136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=26459563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOlsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=28446-28455&author=A.+F.+Winkelauthor=C.+K.+Engelauthor=D.+Margerieauthor=A.+Kanntauthor=H.+Szillatauthor=H.+Glombikauthor=C.+Kallusauthor=S.+Rufauthor=S.+G%C3%BCssregenauthor=J.+Riedelauthor=A.+W.+Herlingauthor=A.+Von+Knethenauthor=A.+Weigertauthor=B.+Br%C3%BCneauthor=D.+Schmoll&title=Characterization+of+RA839%2C+a+Noncovalent+Small+Molecule+Binder+to+Keap1+and+Selective+Activator+of+Nrf2+Signaling&doi=10.1074%2Fjbc.M115.678136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling</span></div><div class="casAuthors">Winkel, Angelika F.; Engel, Christian K.; Margerie, Daniel; Kannt, Aimo; Szillat, Hauke; Glombik, Heiner; Kallus, Christopher; Ruf, Sven; Guessregen, Stefan; Riedel, Jens; Herling, Andreas W.; von Knethen, Andreas; Weigert, Andreas; Bruene, Bernhard; Schmoll, Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">28446-28455</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The activation of the transcription factor NF-E2-related factor 2 (Nrf2) maintains cellular homeostasis in response to oxidative stress by the regulation of multiple cytoprotective genes.  Without stressors, the activity of Nrf2 is inhibited by its interaction with the Keap1 (kelch-like ECH-assocd. protein 1).  Here, we describe (3S)-1-[4-[(2,3,5,6-tetramethylphenyl) sulfonylamino]-1-naphthyl]pyrrolidine-3-carboxylic acid (RA839), a small mol. that binds noncovalently to the Nrf2-interacting kelch domain of Keap1 with a Kd of ∼6 μm, as demonstrated by x-ray co-crystn. and isothermal titrn. calorimetry.  Whole genome DNA arrays showed that at 10 μm RA839 significantly regulated 105 probe sets in bone marrow-derived macrophages.  Canonical pathway mapping of these probe sets revealed an activation of pathways linked with Nrf2 signaling.  These pathways were also activated after the activation of Nrf2 by the silencing of Keap1 expression.  RA839 regulated only two genes in Nrf2 knock-out macrophages.  Similar to the activation of Nrf2 by either silencing of Keap1 expression or by the reactive compd. 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid Me ester (CDDO-Me), RA839 prevented the induction of both inducible nitric-oxide synthase expression and nitric oxide release in response to lipopolysaccharides in macrophages.  In mice, RA839 acutely induced Nrf2 target gene expression in liver.  RA839 is a selective inhibitor of the Keap1/Nrf2 interaction and a useful tool compd. to study the biol. of Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqu4FlVebzcbVg90H21EOLACvtfcHk0ljviqSthFRGMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOlsrjF&md5=082998a0e4685dc8622662270fbba223</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.678136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.678136%26sid%3Dliteratum%253Aachs%26aulast%3DWinkel%26aufirst%3DA.%2BF.%26aulast%3DEngel%26aufirst%3DC.%2BK.%26aulast%3DMargerie%26aufirst%3DD.%26aulast%3DKannt%26aufirst%3DA.%26aulast%3DSzillat%26aufirst%3DH.%26aulast%3DGlombik%26aufirst%3DH.%26aulast%3DKallus%26aufirst%3DC.%26aulast%3DRuf%26aufirst%3DS.%26aulast%3DG%25C3%25BCssregen%26aufirst%3DS.%26aulast%3DRiedel%26aufirst%3DJ.%26aulast%3DHerling%26aufirst%3DA.%2BW.%26aulast%3DVon%2BKnethen%26aufirst%3DA.%26aulast%3DWeigert%26aufirst%3DA.%26aulast%3DBr%25C3%25BCne%26aufirst%3DB.%26aulast%3DSchmoll%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520RA839%252C%2520a%2520Noncovalent%2520Small%2520Molecule%2520Binder%2520to%2520Keap1%2520and%2520Selective%2520Activator%2520of%2520Nrf2%2520Signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D28446%26epage%3D28455%26doi%3D10.1074%2Fjbc.M115.678136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wixted, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths-Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMenamin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, H. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottom, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kou, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonchuk, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldser, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognese, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podolin, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, J. K.</span></span> <span> </span><span class="NLM_article-title">Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3991</span>– <span class="NLM_lpage">4006</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00228</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00228" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1Gjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3991-4006&author=T.+G.+Daviesauthor=W.+E.+Wixtedauthor=J.+E.+Coyleauthor=C.+Griffiths-Jonesauthor=K.+Hearnauthor=R.+McMenaminauthor=D.+Nortonauthor=S.+J.+Richauthor=C.+Richardsonauthor=G.+Saxtyauthor=H.+M.+G.+Willemsauthor=A.+J.+A.+Woolfordauthor=J.+E.+Cottomauthor=J.+P.+Kouauthor=J.+G.+Yonchukauthor=H.+G.+Feldserauthor=Y.+Sanchezauthor=J.+P.+Foleyauthor=B.+J.+Bologneseauthor=G.+Loganauthor=P.+L.+Podolinauthor=H.+Yanauthor=J.+F.+Callahanauthor=T.+D.+Heightmanauthor=J.+K.+Kerns&title=Monoacidic+Inhibitors+of+the+Kelch-like+ECH-Associated+Protein+1%3A+Nuclear+Factor+Erythroid+2-Related+Factor+2+%28KEAP1%3ANRF2%29+Protein-Protein+Interaction+with+High+Cell+Potency+Identified+by+Fragment-Based+Discovery&doi=10.1021%2Facs.jmedchem.6b00228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery</span></div><div class="casAuthors">Davies, Thomas G.; Wixted, William E.; Coyle, Joseph E.; Griffiths-Jones, Charlotte; Hearn, Keisha; McMenamin, Rachel; Norton, David; Rich, Sharna J.; Richardson, Caroline; Saxty, Gordon; Willems, Henriette M. G.; Woolford, Alison J.-A.; Cottom, Joshua E.; Kou, Jen-Pyng; Yonchuk, John G.; Feldser, Heidi G.; Sanchez, Yolanda; Foley, Joseph P.; Bolognese, Brian J.; Logan, Gregory; Podolin, Patricia L.; Yan, Hongxing; Callahan, James F.; Heightman, Tom D.; Kerns, Jeffrey K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3991-4006</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">KEAP1 is the key regulator of the NRF2-mediated cytoprotective response, and increasingly recognized as a target for diseases involving oxidative stress.  Pharmacol. intervention has focused on mols. that decrease NRF2-ubiquitination through covalent modification of KEAP1 cysteine residues, but such electrophilic compds. lack selectivity and may be assocd. with off-target toxicity.  We report here the first use of a fragment-based approach to directly target the KEAP1 Kelch-NRF2 interaction.  X-ray crystallog. screening identified three distinct "hot-spots" for fragment binding within the NRF2 binding pocket of KEAP1, allowing progression of a weak fragment hit to mols. with nanomolar affinity for KEAP1 while maintaining drug-like properties.  This work resulted in a promising lead compd. (I) which exhibits tight and selective binding to KEAP1, and activates the NRF2 antioxidant response in cellular and in vivo models, thereby providing a high quality chem. probe to explore the therapeutic potential of disrupting the KEAP1-NRF2 interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq-gfBTuYreLVg90H21EOLACvtfcHk0lgIzIdUbci1lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Gjtr0%253D&md5=ae42cc9f06d14b340cb3a8f5d6c157a7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00228%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DWixted%26aufirst%3DW.%2BE.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DGriffiths-Jones%26aufirst%3DC.%26aulast%3DHearn%26aufirst%3DK.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DNorton%26aufirst%3DD.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DWillems%26aufirst%3DH.%2BM.%2BG.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%2BA.%26aulast%3DCottom%26aufirst%3DJ.%2BE.%26aulast%3DKou%26aufirst%3DJ.%2BP.%26aulast%3DYonchuk%26aufirst%3DJ.%2BG.%26aulast%3DFeldser%26aufirst%3DH.%2BG.%26aulast%3DSanchez%26aufirst%3DY.%26aulast%3DFoley%26aufirst%3DJ.%2BP.%26aulast%3DBolognese%26aufirst%3DB.%2BJ.%26aulast%3DLogan%26aufirst%3DG.%26aulast%3DPodolin%26aufirst%3DP.%2BL.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DKerns%26aufirst%3DJ.%2BK.%26atitle%3DMonoacidic%2520Inhibitors%2520of%2520the%2520Kelch-like%2520ECH-Associated%2520Protein%25201%253A%2520Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528KEAP1%253ANRF2%2529%2520Protein-Protein%2520Interaction%2520with%2520High%2520Cell%2520Potency%2520Identified%2520by%2520Fragment-Based%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3991%26epage%3D4006%26doi%3D10.1021%2Facs.jmedchem.6b00228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarparin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths-Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakdawala, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMenamin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortenson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumsey, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, H. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, T. G.</span></span> <span> </span><span class="NLM_article-title">Structure–Activity and Structure–Conformation Relationships of Aryl Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1/Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1/NRF2) Protein–Protein Interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4683</span>– <span class="NLM_lpage">4702</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00279</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00279" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntlegs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4683-4702&author=T.+D.+Heightmanauthor=J.+F.+Callahanauthor=E.+Chiarparinauthor=J.+E.+Coyleauthor=C.+Griffiths-Jonesauthor=A.+S.+Lakdawalaauthor=R.+McMenaminauthor=P.+N.+Mortensonauthor=D.+Nortonauthor=T.+M.+Peakmanauthor=S.+J.+Richauthor=C.+Richardsonauthor=W.+L.+Rumseyauthor=Y.+Sanchezauthor=G.+Saxtyauthor=H.+M.+G.+Willemsauthor=L.+Wolfeauthor=A.+J.-A.+Woolfordauthor=Z.+Wuauthor=H.+Yanauthor=J.+K.+Kernsauthor=T.+G.+Davies&title=Structure%E2%80%93Activity+and+Structure%E2%80%93Conformation+Relationships+of+Aryl+Propionic+Acid+Inhibitors+of+the+Kelch-like+ECH-Associated+Protein+1%2FNuclear+Factor+Erythroid+2-Related+Factor+2+%28KEAP1%2FNRF2%29+Protein%E2%80%93Protein+Interaction&doi=10.1021%2Facs.jmedchem.9b00279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity and Structure-Conformation Relationships of Aryl Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1/Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1/NRF2) Protein-Protein Interaction</span></div><div class="casAuthors">Heightman, Tom D.; Callahan, James F.; Chiarparin, Elisabetta; Coyle, Joseph E.; Griffiths-Jones, Charlotte; Lakdawala, Ami S.; McMenamin, Rachel; Mortenson, Paul N.; Norton, David; Peakman, Torren M.; Rich, Sharna J.; Richardson, Caroline; Rumsey, William L.; Sanchez, Yolanda; Saxty, Gordon; Willems, Henriette M. G.; Wolfe, Lawrence; Woolford, Alison J.-A.; Wu, Zining; Yan, Hongxing; Kerns, Jeffrey K.; Davies, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4683-4702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The KEAP1-NRF2-mediated cytoprotective response plays a key role in cellular homoeostasis.  Insufficient NRF2 signaling during chronic oxidative stress may be assocd. with the pathophysiol. of several diseases with an inflammatory component, and pathway activation through direct modulation of the KEAP1-NRF2 protein-protein interaction is being increasingly explored as a potential therapeutic strategy.  Nevertheless, the physicochem. nature of the KEAP1-NRF2 interface suggests that achieving high affinity for a cell-penetrant druglike inhibitor might be challenging.  We recently reported the discovery of a highly potent tool compd. which was used to probe the biol. assocd. with directly disrupting the interaction of NRF2 with the KEAP1 Kelch domain.  We now present a detailed account of the medicinal chem. campaign leading to this mol., which included exploration and optimization of protein-ligand interactions in three energetic "hot spots" identified by fragment screening.  In particular, we also discuss how consideration of ligand conformational stabilization was important to its development and present evidence for preorganization of the lead compd. which may contribute to its high affinity and cellular activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraCUAFq5SVmLVg90H21EOLACvtfcHk0lgIzIdUbci1lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntlegs7c%253D&md5=b946f7b770bc2c4e020e7e796483a753</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00279%26sid%3Dliteratum%253Aachs%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DChiarparin%26aufirst%3DE.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DGriffiths-Jones%26aufirst%3DC.%26aulast%3DLakdawala%26aufirst%3DA.%2BS.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DNorton%26aufirst%3DD.%26aulast%3DPeakman%26aufirst%3DT.%2BM.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DRumsey%26aufirst%3DW.%2BL.%26aulast%3DSanchez%26aufirst%3DY.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DWillems%26aufirst%3DH.%2BM.%2BG.%26aulast%3DWolfe%26aufirst%3DL.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.-A.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DKerns%26aufirst%3DJ.%2BK.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26atitle%3DStructure%25E2%2580%2593Activity%2520and%2520Structure%25E2%2580%2593Conformation%2520Relationships%2520of%2520Aryl%2520Propionic%2520Acid%2520Inhibitors%2520of%2520the%2520Kelch-like%2520ECH-Associated%2520Protein%25201%252FNuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528KEAP1%252FNRF2%2529%2520Protein%25E2%2580%2593Protein%2520Interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4683%26epage%3D4702%26doi%3D10.1021%2Facs.jmedchem.9b00279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pallesen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span> <span> </span><span class="NLM_article-title">Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8088</span>– <span class="NLM_lpage">8103</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00358</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00358" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt12hsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8088-8103&author=J.+S.+Pallesenauthor=K.+T.+Tranauthor=A.+Bach&title=Non-covalent+Small-Molecule+Kelch-like+ECH-Associated+Protein+1-Nuclear+Factor+Erythroid+2-Related+Factor+2+%28Keap1-Nrf2%29+Inhibitors+and+Their+Potential+for+Targeting+Central+Nervous+System+Diseases&doi=10.1021%2Facs.jmedchem.8b00358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases</span></div><div class="casAuthors">Pallesen, Jakob S.; Tran, Kim T.; Bach, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8088-8103</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) has a protective effect against oxidative stress and plays a major role in inflammation and central nervous system (CNS) diseases.  Inhibition of the protein-protein interaction (PPI) between Nrf2 and its repressor protein, Kelch-like ECH-assocd. protein 1 (Keap1), leads to translocation of Nrf2 from the cytosol to the nucleus and expression of detoxifying antioxidant enzymes.  To date, several non-covalent small-mol. Keap1-Nrf2 inhibitors have been identified; however, many of them contain carboxylic acids and are rather large in size, which likely prevents or decreases CNS permeability.  This Perspective describes current small-mol. Keap1-Nrf2 inhibitors with exptl. evidence for the ability to inhibit the Keap1-Nrf2 interaction by binding to Keap1 in a non-covalent manner.  Binding data, biostructural studies, and biol. activity are summarized for the inhibitors, and their potential as CNS tool compds. is discussed by analyzing physicochem. properties, including CNS multiparameter optimization (MPO) scoring algorithms.  Finally, several strategies for identifying CNS-targeting Keap1 inhibitors are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAnObBnG8ca7Vg90H21EOLACvtfcHk0lgIzIdUbci1lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt12hsb8%253D&md5=0492259af2532169001a1d4ef532fdbb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00358%26sid%3Dliteratum%253Aachs%26aulast%3DPallesen%26aufirst%3DJ.%2BS.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DBach%26aufirst%3DA.%26atitle%3DNon-covalent%2520Small-Molecule%2520Kelch-like%2520ECH-Associated%2520Protein%25201-Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528Keap1-Nrf2%2529%2520Inhibitors%2520and%2520Their%2520Potential%2520for%2520Targeting%2520Central%2520Nervous%2520System%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8088%26epage%3D8103%26doi%3D10.1021%2Facs.jmedchem.8b00358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speltz, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span> <span> </span><span class="NLM_article-title">Non-electrophilic Modulators of the Canonical Keap1/Nrf2 Pathway</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2261</span>– <span class="NLM_lpage">2268</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.bmcl.2015.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=25937010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslehs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2261-2268&issue=11&author=B.+G.+Richardsonauthor=A.+D.+Jainauthor=T.+E.+Speltzauthor=T.+W.+Moore&title=Non-electrophilic+Modulators+of+the+Canonical+Keap1%2FNrf2+Pathway&doi=10.1016%2Fj.bmcl.2015.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway</span></div><div class="casAuthors">Richardson, B. G.; Jain, A. D.; Speltz, T. E.; Moore, T. W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2261-2268</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nrf2 is the major transcription factor that regulates many of the cytoprotective enzymes involved in the adaptive stress response.  Modulation of Nrf2 could be therapeutically useful in a no. of disease states.  Activation can occur through either an electrophilic or non-electrophilic mechanism.  To date, most of the research has focused on electrophilic Nrf2 activators, but there is increasing interest in non-electrophilic modulators of Nrf2.  This Digest examines the current selection of small mols. that modulate Nrf2 through non-electrophilic mechanisms, and it highlights new opportunities for this important therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojMkBabiNYC7Vg90H21EOLACvtfcHk0lgaV-XaPy9g8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslehs7c%253D&md5=2e5ec64ce19ef7805892ea70a240c7df</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DB.%2BG.%26aulast%3DJain%26aufirst%3DA.%2BD.%26aulast%3DSpeltz%26aufirst%3DT.%2BE.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26atitle%3DNon-electrophilic%2520Modulators%2520of%2520the%2520Canonical%2520Keap1%252FNrf2%2520Pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D11%26spage%3D2261%26epage%3D2268%26doi%3D10.1016%2Fj.bmcl.2015.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span> <span> </span><span class="NLM_article-title">The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">924</span>– <span class="NLM_lpage">963</span>, <span class="refDoi"> DOI: 10.1002/med.21396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1002%2Fmed.21396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=27192495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSms7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=924-963&issue=5&author=M.+C.+Luauthor=J.+A.+Jiauthor=Z.+Y.+Jiangauthor=Q.+D.+You&title=The+Keap1-Nrf2-ARE+Pathway+As+a+Potential+Preventive+and+Therapeutic+Target%3A+An+Update&doi=10.1002%2Fmed.21396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update</span></div><div class="casAuthors">Lu, Meng-Chen; Ji, Jian-Ai; Jiang, Zheng-Yu; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">924-963</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Keap1-Nrf2-ARE ((Kelch-like ECH-Assocg. protein 1) nuclear factor erythroid 2 related factor 2-antioxidant response element) pathway is one of the most important defense mechanisms against oxidative and/or electrophilic stresses, and it is closely assocd. with inflammatory diseases, including cancer, neurodegenerative diseases, cardiovascular diseases, and aging.  In recent years, progress has been made in strategies aimed at modulating the Keap1-Nrf2-ARE pathway.  The Nrf2 activator DMF (Dimethylfumarates) has been approved by the FDA as a new first-line oral drug to treat patients with relapsing forms of multiple sclerosis, while a phase 3 study of another promising candidate, CDDO-Me, was terminated for safety reasons.  Directly inhibiting Keap1-Nrf2 protein-protein interactions as a novel Nrf2-modulating strategy has many advantages over using electrophilic Nrf2 activators.  The development of Keap1-Nrf2 protein-protein interaction inhibitors has become a topic of intense research, and potent inhibitors of this target have been identified.  In addn., inhibiting Nrf2 activity has attracted an increasing amt. of attention because it may provide an alternative cancer therapy.  This review summarizes the mol. mechanisms and biol. functions of the Keap1-Nrf2-ARE system.  The main focus of this review is on recent progress in studies of agents that target the Keap1-Nrf2-ARE pathway and the therapeutic applications of such agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFT_JWBNP5w7Vg90H21EOLACvtfcHk0lgaV-XaPy9g8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSms7bL&md5=b5514acfaaa6ecb31efe0d75387dd56e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fmed.21396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21396%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DJi%26aufirst%3DJ.%2BA.%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26atitle%3DThe%2520Keap1-Nrf2-ARE%2520Pathway%2520As%2520a%2520Potential%2520Preventive%2520and%2520Therapeutic%2520Target%253A%2520An%2520Update%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2016%26volume%3D36%26issue%3D5%26spage%3D924%26epage%3D963%26doi%3D10.1002%2Fmed.21396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span> <span> </span><span class="NLM_article-title">Peptide and Small Molecule Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">674</span>– <span class="NLM_lpage">679</span>, <span class="refDoi"> DOI: 10.1042/BST20150051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1042%2FBST20150051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=26551711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=674-679&issue=4&author=G.+Wells&title=Peptide+and+Small+Molecule+Inhibitors+of+the+Keap1-Nrf2+Protein-Protein+Interaction&doi=10.1042%2FBST20150051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction</span></div><div class="casAuthors">Wells, Geoff</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">674-679</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The transcription factor nuclear factor erythroid-2-related factor 2 (Nrf2) up-regulates the expression of a range of cytoprotective enzymes with antioxidant response elements in their promoter regions and thus can protect cells against oxidative damage.  Increasing Nrf2 activity has been proposed as a therapeutic intervention in a range of chronic neurodegenerative conditions and cancer chemoprevention.  One of the main mechanisms by which Nrf2 is neg. regulated involves an interaction with the ubiquitination facilitator protein, Kelch-like ECH-assocd. protein 1 (Keap1) that facilitates degrdn. of Nrf2.  Inhibition of this process underlies the mode of action of a broad group of compds. that increase Nrf2 activity.  A no. of natural products, including the isothiocyanate sulforaphane, up-regulate Nrf2 by interacting with Keap1 in a covalent manner to stall its activity.  Recently, a no. of peptide and small mol. inhibitors of the protein-protein interaction (PPI) between Keap1 and Nrf2 have been described.  These classes of compd. have contrasting modes of action at the mol. level and there is emerging evidence that their biol. activities have similarities and differences.  This review describes the various classes of PPI inhibitor that have been described in the literature and the biol. evaluations that have been performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjQzcvZNfjrLVg90H21EOLACvtfcHk0lgaV-XaPy9g8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsb3E&md5=2cb4acbd2a04ecdf29424638894c81e3</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1042%2FBST20150051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20150051%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DG.%26atitle%3DPeptide%2520and%2520Small%2520Molecule%2520Inhibitors%2520of%2520the%2520Keap1-Nrf2%2520Protein-Protein%2520Interaction%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2015%26volume%3D43%26issue%3D4%26spage%3D674%26epage%3D679%26doi%3D10.1042%2FBST20150051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potteti, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzara, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamatam, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choma, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skowron, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dye, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krunic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span> <span> </span><span class="NLM_article-title">Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8029</span>– <span class="NLM_lpage">8047</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01133</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01133" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFertbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8029-8047&author=B.+G.+Richardsonauthor=A.+D.+Jainauthor=H.+R.+Pottetiauthor=P.+R.+Lazzaraauthor=B.+P.+Davidauthor=C.+R.+Tamatamauthor=E.+Chomaauthor=K.+Skowronauthor=K.+Dyeauthor=Z.+Siddiquiauthor=Y.+T.+Wangauthor=A.+Krunicauthor=S.+P.+Reddyauthor=T.+W.+Moore&title=Replacement+of+a+Naphthalene+Scaffold+in+Kelch-like+ECH-Associated+Protein+1+%28KEAP1%29%2FNuclear+Factor+%28Erythroid-derived+2%29-like+2+%28NRF2%29+Inhibitors&doi=10.1021%2Facs.jmedchem.8b01133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) Inhibitors</span></div><div class="casAuthors">Richardson, Benjamin G.; Jain, Atul D.; Potteti, Haranatha R.; Lazzara, Phillip R.; David, Brian P.; Tamatam, Chandra R.; Choma, Ewelina; Skowron, Kornelia; Dye, Katherine; Siddiqui, Zamia; Wang, Yue-Ting; Krunic, Aleksej; Reddy, Sekhar P.; Moore, Terry W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8029-8047</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activators of nuclear factor-erythroid 2-related factor 2 (NRF2) could lead to promising therapeutics for prevention and treatment of oxidative stress and inflammatory disorders.  Ubiquitination and subsequent degrdn. of the transcription factor NRF2 is mediated by Kelch-like ECH-assocd. protein-1 (KEAP1).  Inhibition of the KEAP1/NRF2 interaction with small mols. leads to NRF2 activation.  Previously, we and others described naphthalene-based NRF2 activators, but the 1,4-diaminonaphthalene scaffold may not represent a drug-like scaffold.  Paying particular attention to aq. soly., metabolic stability, potency, and mutagenicity, we modified a previously known, naphthalene-based nonelectrophilic NRF2 activator to give a series of non-naphthalene and heterocyclic scaffolds.  We found that, compared to previously reported naphthalene-based compds., a 1,4-isoquinoline scaffold provides a better mutagenic profile without sacrificing potency, stability, or soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP0I8lhXc6Q7Vg90H21EOLACvtfcHk0lgF_UfKQXExfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFertbfE&md5=69c77e7ee6f55d87ca61ef78a734c964</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01133%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DB.%2BG.%26aulast%3DJain%26aufirst%3DA.%2BD.%26aulast%3DPotteti%26aufirst%3DH.%2BR.%26aulast%3DLazzara%26aufirst%3DP.%2BR.%26aulast%3DDavid%26aufirst%3DB.%2BP.%26aulast%3DTamatam%26aufirst%3DC.%2BR.%26aulast%3DChoma%26aufirst%3DE.%26aulast%3DSkowron%26aufirst%3DK.%26aulast%3DDye%26aufirst%3DK.%26aulast%3DSiddiqui%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%2BT.%26aulast%3DKrunic%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DS.%2BP.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26atitle%3DReplacement%2520of%2520a%2520Naphthalene%2520Scaffold%2520in%2520Kelch-like%2520ECH-Associated%2520Protein%25201%2520%2528KEAP1%2529%252FNuclear%2520Factor%2520%2528Erythroid-derived%25202%2529-like%25202%2520%2528NRF2%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8029%26epage%3D8047%26doi%3D10.1021%2Facs.jmedchem.8b01133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, M.</span></span> <span> </span><span class="NLM_article-title">Intermolecular Amidation of Quinoline N-Oxides with Arylsulfonamides under Metal-Free Conditions</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6088</span>– <span class="NLM_lpage">6091</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.7b02922</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.7b02922" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslClsr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=6088-6091&author=X.+Yuauthor=S.+Yangauthor=Y.+Zhangauthor=M.+Guoauthor=Y.+Yamamotoauthor=M.+Bao&title=Intermolecular+Amidation+of+Quinoline+N-Oxides+with+Arylsulfonamides+under+Metal-Free+Conditions&doi=10.1021%2Facs.orglett.7b02922"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Intermolecular Amidation of Quinoline N-Oxides with Arylsulfonamides under Metal-Free Conditions</span></div><div class="casAuthors">Yu, Xiaoqiang; Yang, Sana; Zhang, Yue; Guo, Mingju; Yamamoto, Yoshinori; Bao, Ming</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6088-6091</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient method for the synthesis of N-(quinolin-2-yl)sulfonamides I (Ar = Ph, 4-MeC6H4, 4-BrC6H4, etc.; R = H, 4-Me, 3-Me, 6-MeO, etc.) is described.  The intermol. amidation of quinoline N-oxides with sulfonamides proceeded smoothly in the presence of PhI(OAc)2 and PPh3 to afford N-(quinolin-2-yl)sulfonamides in satisfactory to excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwrxoDCPrrcrVg90H21EOLACvtfcHk0lgF_UfKQXExfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslClsr%252FP&md5=09888cb54c4c0707f13b7cf39dc0e32e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.7b02922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.7b02922%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DBao%26aufirst%3DM.%26atitle%3DIntermolecular%2520Amidation%2520of%2520Quinoline%2520N-Oxides%2520with%2520Arylsulfonamides%2520under%2520Metal-Free%2520Conditions%26jtitle%3DOrg.%2520Lett.%26date%3D2017%26volume%3D19%26spage%3D6088%26epage%3D6091%26doi%3D10.1021%2Facs.orglett.7b02922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inoyama, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beamer, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">Optimization of Fluorescently Labeled Nrf2 Peptide Probes and the Development of a Fluorescence Polarization Assay for the Discovery of Inhibitors of Keap1-Nrf2 Interaction</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1177/1087057111430124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1177%2F1087057111430124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=22156223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlGktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=435-447&issue=4&author=D.+Inoyamaauthor=Y.+Chenauthor=X.+Huangauthor=L.+J.+Beamerauthor=A.+N.+Kongauthor=L.+Hu&title=Optimization+of+Fluorescently+Labeled+Nrf2+Peptide+Probes+and+the+Development+of+a+Fluorescence+Polarization+Assay+for+the+Discovery+of+Inhibitors+of+Keap1-Nrf2+Interaction&doi=10.1177%2F1087057111430124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of fluorescently labeled Nrf2 peptide probes and the development of a fluorescence polarization assay for the discovery of inhibitors of Keap I-Nrf2 interaction</span></div><div class="casAuthors">Inoyama, Daigo; Chen, Yu; Huang, Xinyi; Beamer, Lesa J.; Kong, Ah-Ng Tony; Hu, Longqin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">435-447</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Activation of the antioxidant response element (ARE) upregulates enzymes involved in detoxification of electrophiles and reactive oxygen species.  The induction of ARE genes is regulated by the interaction between redox sensor protein Keap1 and the transcription factor Nrf2.  Fluorescently labeled Nrf2 peptides contg. the ETGE motif were synthesized and optimized as tracers in the development of a fluorescence polarization (FP) assay to identify small-mol. inhibitors of the Keap1-Nrf2 interaction.  The tracers were optimized to increase the dynamic range of the assay and their binding affinities to the Keap1 Kelch domain.  The binding affinities of Nrf2 peptide inhibitors obtained in our FP assay using FITC-9mer Nrf2 peptide amide as the probe were in good agreement with those obtained previously by a surface plasmon resonance assay.  The FP assay exhibits considerable tolerance toward DMSO and produced a Z' factor greater than 0.6 in a 384-well format.  Further optimization of the probe led to cyanine-labeled 9mer Nrf2 peptide amide, which can be used along with the FITC-9mer Nrf2 peptide amide in a high-throughput screening assay to discover small-mol. inhibitors of Keap1-Nrf2 interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhQhh_psWArVg90H21EOLACvtfcHk0lgF_UfKQXExfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlGktL4%253D&md5=91348dd302ddbe9cb9d3d9c21a2097f6</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1177%2F1087057111430124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057111430124%26sid%3Dliteratum%253Aachs%26aulast%3DInoyama%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBeamer%26aufirst%3DL.%2BJ.%26aulast%3DKong%26aufirst%3DA.%2BN.%26aulast%3DHu%26aufirst%3DL.%26atitle%3DOptimization%2520of%2520Fluorescently%2520Labeled%2520Nrf2%2520Peptide%2520Probes%2520and%2520the%2520Development%2520of%2520a%2520Fluorescence%2520Polarization%2520Assay%2520for%2520the%2520Discovery%2520of%2520Inhibitors%2520of%2520Keap1-Nrf2%2520Interaction%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2012%26volume%3D17%26issue%3D4%26spage%3D435%26epage%3D447%26doi%3D10.1177%2F1087057111430124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinner, M. J.</span></span> <span> </span><span class="NLM_article-title">Getting Across the Cell Membrane: An Overview for Small Molecules, Peptides, and Proteins</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1266</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-2272-7_3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1007%2F978-1-4939-2272-7_3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=25560066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Siur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1266&publication_year=2015&pages=29-53&author=N.+J.+Yangauthor=M.+J.+Hinner&title=Getting+Across+the+Cell+Membrane%3A+An+Overview+for+Small+Molecules%2C+Peptides%2C+and+Proteins&doi=10.1007%2F978-1-4939-2272-7_3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Getting Across the Cell Membrane: An Overview for Small Molecules, Peptides, and Proteins</span></div><div class="casAuthors">Yang, Nicole J.; Hinner, Marlon J.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1266</span>
        (<span class="NLM_cas:issue">Site-Specific Protein Labeling</span>),
    <span class="NLM_cas:pages">29-53</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The ability to efficiently access cytosolic proteins is desired in both biol. research and medicine.  However, targeting intracellular proteins is often challenging, because to reach the cytosol, exogenous mols. must first traverse the cell membrane.  This review provides a broad overview of how certain mols. are thought to cross this barrier, and what kinds of approaches are being made to enhance the intracellular delivery of those that are impermeable.  We first discuss rules that govern the passive permeability of small mols. across the lipid membrane, and mechanisms of membrane transport that have evolved in nature for certain metabolites, peptides, and proteins.  Then, we introduce design strategies that have emerged in the development of small mols. and peptides with improved permeability.  Finally, intracellular delivery systems that have been engineered for protein payloads are surveyed.  Viewpoints from varying disciplines have been brought together to provide a cohesive overview of how the membrane barrier is being overcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptS-9wM3Z8jbVg90H21EOLACvtfcHk0ljMHs0HMWjzGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Siur4%253D&md5=4002e2e8ab2fcc86d9ea400e1aa2a29b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-2272-7_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-2272-7_3%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DN.%2BJ.%26aulast%3DHinner%26aufirst%3DM.%2BJ.%26atitle%3DGetting%2520Across%2520the%2520Cell%2520Membrane%253A%2520An%2520Overview%2520for%2520Small%2520Molecules%252C%2520Peptides%252C%2520and%2520Proteins%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2015%26volume%3D1266%26spage%3D29%26epage%3D53%26doi%3D10.1007%2F978-1-4939-2272-7_3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wenlock, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1250</span>– <span class="NLM_lpage">1256</span>, <span class="refDoi"> DOI: 10.1021/jm021053p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm021053p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1250-1256&issue=7&author=M.+C.+Wenlockauthor=R.+P.+Austinauthor=P.+Bartonauthor=A.+M.+Davisauthor=P.+D.+Leeson&title=A+Comparison+of+Physiochemical+Property+Profiles+of+Development+and+Marketed+Oral+Drugs&doi=10.1021%2Fjm021053p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs</span></div><div class="casAuthors">Wenlock, Mark C.; Austin, Rupert P.; Barton, Patrick; Davis, Andrew M.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1250-1256</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The process of drug discovery applies rigorous selection pressures.  Marketed oral drugs will generally possess favorable physiochem. properties with respect to absorption, metab., distribution, and clearance.  This paper describes a study in which the distributions of physiochem. properties of oral drugs in different phases of clin. development are compared to those already marketed.  The aim is to identify the trends in physiochem. properties that favor a drug's successful passage through clin. development and on to the market.  Two libraries were created, one of current development oral drugs and one of marketed oral drugs.  Statistical anal. of the two showed that the mean mol. wt. of orally administered drugs in development decreases on passing through each of the different clin. phases and gradually converges toward the mean mol. wt. of marketed oral drugs.  It is also clear that the most lipophilic compds. are being discontinued from development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF0PksUFJq0bVg90H21EOLACvtfcHk0ljMHs0HMWjzGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbY%253D&md5=b9809c803a61ec99a1b4171e97952452</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm021053p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm021053p%26sid%3Dliteratum%253Aachs%26aulast%3DWenlock%26aufirst%3DM.%2BC.%26aulast%3DAustin%26aufirst%3DR.%2BP.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DA%2520Comparison%2520of%2520Physiochemical%2520Property%2520Profiles%2520of%2520Development%2520and%2520Marketed%2520Oral%2520Drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D7%26spage%3D1250%26epage%3D1256%26doi%3D10.1021%2Fjm021053p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahr, A.</span></span> <span> </span><span class="NLM_article-title">Lipophilicity and its Relationship with Passive Drug Permeation</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">977</span>, <span class="refDoi"> DOI: 10.1007/s11095-010-0303-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1007%2Fs11095-010-0303-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=21052797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlOqtrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=962-977&issue=5&author=X.+Liuauthor=B.+Testaauthor=A.+Fahr&title=Lipophilicity+and+its+Relationship+with+Passive+Drug+Permeation&doi=10.1007%2Fs11095-010-0303-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity and Its Relationship with Passive Drug Permeation</span></div><div class="casAuthors">Liu, Xiangli; Testa, Bernard; Fahr, Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">962-977</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In this review, we first summarize the structure and properties of biol. membranes and the routes of passive drug transfer through physiol. barriers.  Lipophilicity is then introduced in terms of the intermol. interactions it encodes.  Finally, lipophilicity indexes from isotropic solvent systems and from anisotropic membrane-like systems are discussed for their capacity to predict passive drug permeation across biol. membranes such as the intestinal epithelium, the blood-brain barrier (BBB) or the skin.  The broad evidence presented here shows that beyond the predictive power of lipophilicity parameters, the various intermol. forces they encode allow a mechanistic interpretation of passive drug permeation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxn2Ic1yX8SbVg90H21EOLACvtfcHk0ljMHs0HMWjzGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlOqtrzK&md5=6bd2bb54a14574f31b046204f260595a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2Fs11095-010-0303-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-010-0303-7%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DFahr%26aufirst%3DA.%26atitle%3DLipophilicity%2520and%2520its%2520Relationship%2520with%2520Passive%2520Drug%2520Permeation%26jtitle%3DPharm.%2520Res.%26date%3D2011%26volume%3D28%26issue%3D5%26spage%3D962%26epage%3D977%26doi%3D10.1007%2Fs11095-010-0303-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span> <span> </span><span class="NLM_article-title">Beyond the Rule of 5: Lessons Learned from AbbVie’s Drugs and Compound Collection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2636</span>– <span class="NLM_lpage">2651</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00717</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00717" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFeitbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2636-2651&issue=7&author=D.+A.+DeGoeyauthor=H.+J.+Chenauthor=P.+B.+Coxauthor=M.+D.+Wendt&title=Beyond+the+Rule+of+5%3A+Lessons+Learned+from+AbbVie%E2%80%99s+Drugs+and+Compound+Collection&doi=10.1021%2Facs.jmedchem.7b00717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond the Rule of 5: Lessons Learned from AbbVie's Drugs and Compound Collection</span></div><div class="casAuthors">DeGoey, David A.; Chen, Hui-Ju; Cox, Philip B.; Wendt, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2636-2651</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, there has been an increasing focus on the pursuit of targets considered to be less druggable that offer potential for development of promising new therapeutic agents for the treatment of diseases with large unmet medical need, particularly in the areas of oncol. and virol.  However, conducting drug discovery campaigns in "beyond rule of 5" (bRo5) chem. space presents a significant drug design and development challenge to medicinal chemists to achieve acceptable oral pharmacokinetics.  Retrospective anal. of past successes and failures in drug discovery bRo5 may shed light on the key principles that contribute to the oral bioavailability of successful bRo5 compds. and improve the efficiency of drug design for future projects.  We present here highlights and case studies of lessons learned from discovery of bRo5 compds.  A simple multiparametric scoring function (AB-MPS) was devised that correlated preclin. PK results with cLogD, no. of rotatable bonds, and no. of arom. rings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTHuaXbtjlALVg90H21EOLACvtfcHk0li2MaHMfAS77g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFeitbjJ&md5=48984dc65410d83d4ac8ddaca030b024</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00717%26sid%3Dliteratum%253Aachs%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DChen%26aufirst%3DH.%2BJ.%26aulast%3DCox%26aufirst%3DP.%2BB.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26atitle%3DBeyond%2520the%2520Rule%2520of%25205%253A%2520Lessons%2520Learned%2520from%2520AbbVie%25E2%2580%2599s%2520Drugs%2520and%2520Compound%2520Collection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D7%26spage%3D2636%26epage%3D2651%26doi%3D10.1021%2Facs.jmedchem.7b00717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peirson, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, G. M.</span></span> <span> </span><span class="NLM_article-title">The Rule of Five Revisited: Applying log D in Place of log P in Drug-Likeness Filters</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">556</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1021/mp0700209</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp0700209" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1Oru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=556-560&issue=4&author=S.+K.+Bhalauthor=K.+Kassamauthor=I.+G.+Peirsonauthor=G.+M.+Pearl&title=The+Rule+of+Five+Revisited%3A+Applying+log+D+in+Place+of+log+P+in+Drug-Likeness+Filters&doi=10.1021%2Fmp0700209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The Rule of Five Revisited: Applying Log D in Place of Log P in Drug-Likeness Filters</span></div><div class="casAuthors">Bhal, Sanjivanjit K.; Kassam, Karim; Peirson, Ian G.; Pearl, Greg M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">556-560</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The much publicized "Rule of 5" has been widely adopted among the pharmaceutical industry.  It is used as a first step filter to perform virtual screening of compd. libraries, in an effort to quickly eliminate lead candidates that have poor physicochem. properties for oral bioavailability.  One of the key parameters used therein is log P, which is a useful descriptor, but one that fails to take into account variation in the lipophilicity of a drug with respect to the ionic states present at key biol. pH values.  Given that the majority of com. pharmaceuticals contain an ionizable moiety, we propose that log D is a better descriptor for lipophilicity in the context of the Rule of 5.  It gives more physiol. relevant results, thereby reducing the no. of potential false-negatives incorrectly eliminated in screening.  Using a series of com. compd. libraries, this study showed that the adapted Rule of 5 using log D instead of log P provides notable improvement in pass rate for compds. that have the desired lipophilicity at a relevant physiol. pH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDjia9TQd8orVg90H21EOLACvtfcHk0li2MaHMfAS77g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1Oru78%253D&md5=d1bff6170cce36dc690a1afdd4839d70</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fmp0700209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp0700209%26sid%3Dliteratum%253Aachs%26aulast%3DBhal%26aufirst%3DS.%2BK.%26aulast%3DKassam%26aufirst%3DK.%26aulast%3DPeirson%26aufirst%3DI.%2BG.%26aulast%3DPearl%26aufirst%3DG.%2BM.%26atitle%3DThe%2520Rule%2520of%2520Five%2520Revisited%253A%2520Applying%2520log%2520D%2520in%2520Place%2520of%2520log%2520P%2520in%2520Drug-Likeness%2520Filters%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2007%26volume%3D4%26issue%3D4%26spage%3D556%26epage%3D560%26doi%3D10.1021%2Fmp0700209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2736</span>– <span class="NLM_lpage">2745</span>, <span class="refDoi"> DOI: 10.1021/jm5000529</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5000529" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2736-2745&issue=6&author=Z.+Y.+Jiangauthor=M.+C.+Luauthor=L.+L.+Xuauthor=T.+T.+Yangauthor=M.+Y.+Xiauthor=X.+L.+Xuauthor=X.+K.+Guoauthor=X.+J.+Zhangauthor=Q.+D.+Youauthor=H.+P.+Sun&title=Discovery+of+Potent+Keap1-Nrf2+Protein-Protein+Interaction+Inhibitor+Based+on+Molecular+Binding+Determinants+Analysis&doi=10.1021%2Fjm5000529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis</span></div><div class="casAuthors">Jiang, Zheng-Yu; Lu, Meng-Chen; Xu, Li-Li; Yang, Ting-Ting; Xi, Mei-Yang; Xu, Xiao-Li; Guo, Xiao-Ke; Zhang, Xiao-Jin; You, Qi-Dong; Sun, Hao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2736-2745</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Keap1 is known to mediate the ubiquitination of Nrf2, a master regulator of the antioxidant response.  Directly interrupting the Keap1-Nrf2 interaction has been emerged as a promising strategy to develop novel class of antioxidant, antiinflammatory, and anticancer agents.  On the basis of the mol. binding determinants anal. of Keap1, we successfully designed and characterized the most potent protein-protein interaction (PPI) inhibitor of Keap1-Nrf2, compd. 2, with KD value of 3.59 nM binding to Keap1 for the first time to single-digit nanomolar.  Compd. 2 can effectively disrupt the Nrf2-Keap1 interaction with an EC50 of 28.6 nM in the fluorescence polarization assay.  It can also activate the Nrf2 transcription activity in the cell-based ARE-luciferase reporter assay in a dose-dependent manner.  The qRT-PCR results of Nrf2 transcription targets gave the consistent results.  These results confirm direct and highly efficient interruption of the Keap1-Nrf2 PPI can be fully achieved by small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRS8nWHc40ZrVg90H21EOLACvtfcHk0ljtND82OcMvtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKmtro%253D&md5=b5d43ac3973478ecc54e26c74435f2c4</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm5000529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5000529%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DXu%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DT.%2BT.%26aulast%3DXi%26aufirst%3DM.%2BY.%26aulast%3DXu%26aufirst%3DX.%2BL.%26aulast%3DGuo%26aufirst%3DX.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DSun%26aufirst%3DH.%2BP.%26atitle%3DDiscovery%2520of%2520Potent%2520Keap1-Nrf2%2520Protein-Protein%2520Interaction%2520Inhibitor%2520Based%2520on%2520Molecular%2520Binding%2520Determinants%2520Analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D6%26spage%3D2736%26epage%3D2745%26doi%3D10.1021%2Fjm5000529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, S. S.</span></span> <span> </span><span class="NLM_article-title">Cu-Catalyzed Aerobic Oxidative Three-Component Coupling Route to N-Sulfonyl Amidines via an Ynamine Intermediate</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">2448</span>– <span class="NLM_lpage">2454</span>, <span class="refDoi"> DOI: 10.1021/jo5029198</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo5029198" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVCitLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2015&pages=2448-2454&issue=4&author=J.+Kimauthor=S.+S.+Stahl&title=Cu-Catalyzed+Aerobic+Oxidative+Three-Component+Coupling+Route+to+N-Sulfonyl+Amidines+via+an+Ynamine+Intermediate&doi=10.1021%2Fjo5029198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Cu-Catalyzed Aerobic Oxidative Three-Component Coupling Route to N-Sulfonyl Amidines via an Ynamine Intermediate</span></div><div class="casAuthors">Kim, Jinho; Stahl, Shannon S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2448-2454</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cu-catalyzed aerobic oxidative three-component coupling of a terminal alkyne, secondary amine, and sulfonamide enables efficient synthesis of amidines.  The use of Cu(OTf)2 (5 mol %) produces amidines selectively without Glaser-Hay alkyne homocoupling products.  Preliminary studies suggest that the reaction pathway involves initial oxidative coupling of the terminal alkyne with the secondary amine, followed by hydroamidation of the ynamine intermediate with the sulfonamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3MrVncuZRqbVg90H21EOLACvtfcHk0ljtND82OcMvtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVCitLc%253D&md5=f9cf7cbe14b03ed6291ecc003a80a1c1</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjo5029198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo5029198%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DStahl%26aufirst%3DS.%2BS.%26atitle%3DCu-Catalyzed%2520Aerobic%2520Oxidative%2520Three-Component%2520Coupling%2520Route%2520to%2520N-Sulfonyl%2520Amidines%2520via%2520an%2520Ynamine%2520Intermediate%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2015%26volume%3D80%26issue%3D4%26spage%3D2448%26epage%3D2454%26doi%3D10.1021%2Fjo5029198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daelemans, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannecouque, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel DAPY-IAS Hybrid Derivatives as Potential HIV-1 Inhibitors Using Molecular Hybridization Based on Crystallographic Overlays</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">4397</span>– <span class="NLM_lpage">4406</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.06.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.bmc.2017.06.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=28659246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVOjt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=4397-4406&issue=16&author=B.+Huangauthor=X.+Wangauthor=X.+Liuauthor=Z.+Chenauthor=W.+Liauthor=S.+Sunauthor=H.+Liuauthor=D.+Daelemansauthor=E.+De+Clercqauthor=C.+Pannecouqueauthor=P.+Zhanauthor=X.+Liu&title=Discovery+of+Novel+DAPY-IAS+Hybrid+Derivatives+as+Potential+HIV-1+Inhibitors+Using+Molecular+Hybridization+Based+on+Crystallographic+Overlays&doi=10.1016%2Fj.bmc.2017.06.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel DAPY-IAS hybrid derivatives as potential HIV-1 inhibitors using molecular hybridization based on crystallographic overlays</span></div><div class="casAuthors">Huang, Boshi; Wang, Xueshun; Liu, Xinhao; Chen, Zihui; Li, Wanzhuo; Sun, Songkai; Liu, Huiqing; Daelemans, Dirk; De Clercq, Erik; Pannecouque, Christophe; Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4397-4406</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Crystallog. overlap studies and pharmacophoric anal. indicated that diarylpyrimidine (DAPY)-based HIV-1 NNRTIs showed a similar binding mode and pharmacophoric features as indolylarylsulfones (IASs), another class of potent NNRTIs.  Thus, a novel series of DAPY-IAS hybrid derivs. were identified as newer NNRTIs using structure-based mol. hybridization.  Some target compds. exhibited moderate activities against HIV-1 IIIB strain, among which the two most potent inhibitors possessed EC50 values of 1.48 μM and 1.61 μM, resp.  They were much potent than the ref. drug ddI (EC50 = 76.0 μM) and comparable to 3TC (EC50 = 2.54 μM).  Compd. 7a also exhibited the favorable selectivity index (SI = 80).  Preliminary structure-activity relationships (SARs), structure-cytotoxicity relationships, mol. modeling studies, and in silico calcn. of physicochem. properties of these new inhibitors were also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmCF96b9U2RLVg90H21EOLACvtfcHk0ljtND82OcMvtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVOjt77F&md5=a6c95a11786296ab7d7c98f99e30248b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.06.022%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DDaelemans%26aufirst%3DD.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520Novel%2520DAPY-IAS%2520Hybrid%2520Derivatives%2520as%2520Potential%2520HIV-1%2520Inhibitors%2520Using%2520Molecular%2520Hybridization%2520Based%2520on%2520Crystallographic%2520Overlays%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26issue%3D16%26spage%3D4397%26epage%3D4406%26doi%3D10.1016%2Fj.bmc.2017.06.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoevels, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nar, H.</span></span> <span> </span><span class="NLM_article-title">Crystal-Contact Engineering to Obtain a Crystal Form of the Kelch Domain of Human Keap1 Suitable for Ligand-Soaking Experiments</span>. <i>Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">592</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1107/S174430911301124X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1107%2FS174430911301124X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=23722832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A280%3ADC%252BC3snotlOhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=592-596&author=S.+Horerauthor=D.+Reinertauthor=K.+Ostmannauthor=Y.+Hoevelsauthor=H.+Nar&title=Crystal-Contact+Engineering+to+Obtain+a+Crystal+Form+of+the+Kelch+Domain+of+Human+Keap1+Suitable+for+Ligand-Soaking+Experiments&doi=10.1107%2FS174430911301124X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal-contact engineering to obtain a crystal form of the Kelch domain of human Keap1 suitable for ligand-soaking experiments</span></div><div class="casAuthors">Horer Stefan; Reinert Dirk; Ostmann Katja; Hoevels Yvette; Nar Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section F, Structural biology and crystallization communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">Pt 6</span>),
    <span class="NLM_cas:pages">592-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Keap1 is a substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex and plays an important role in the cellular response to oxidative stress.  It binds Nrf2 with its Kelch domain and thus triggers the ubiquitinylation and degradation of Nrf2.  Oxidative stress prevents the degradation of Nrf2 and leads to the activation of cytoprotective genes.  Therefore, Keap1 is an attractive drug target in inflammatory diseases.  The support of a medicinal chemistry effort by structural research requires a robust crystallization system in which the crystals are preferably suited for performing soaking experiments.  This facilitates the generation of protein-ligand complexes in a routine and high-throughput manner.  The structure of human Keap1 has been described previously.  In this crystal form, however, the binding site for Nrf2 was blocked by a crystal contact.  This interaction was analysed and mutations were introduced to disrupt this crystal contact.  One double mutation (E540A/E542A) crystallized in a new crystal form in which the binding site for Nrf2 was not blocked and was accessible to small-molecule ligands.  The crystal structures of the apo form of the mutated Keap1 Kelch domain (1.98 ÅA resolution) and of the complex with an Nrf2-derived peptide obtained by soaking (2.20 ÅA resolution) are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkA18dqept1NLIORRPd5lbfW6udTcc2eYLQYl5pMKzD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snotlOhtw%253D%253D&md5=10cef0b161c5ea120f8577508b55e0a9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1107%2FS174430911301124X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS174430911301124X%26sid%3Dliteratum%253Aachs%26aulast%3DHorer%26aufirst%3DS.%26aulast%3DReinert%26aufirst%3DD.%26aulast%3DOstmann%26aufirst%3DK.%26aulast%3DHoevels%26aufirst%3DY.%26aulast%3DNar%26aufirst%3DH.%26atitle%3DCrystal-Contact%2520Engineering%2520to%2520Obtain%2520a%2520Crystal%2520Form%2520of%2520the%2520Kelch%2520Domain%2520of%2520Human%2520Keap1%2520Suitable%2520for%2520Ligand-Soaking%2520Experiments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2013%26volume%3D69%26spage%3D592%26epage%3D596%26doi%3D10.1107%2FS174430911301124X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Studier, F. W.</span></span> <span> </span><span class="NLM_article-title">Protein Production by Auto-Induction in High-Density Shaking Cultures</span>. <i>Protein Expression Purif.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/j.pep.2005.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1016%2Fj.pep.2005.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=15915565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFCktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=207-234&issue=1&author=F.+W.+Studier&title=Protein+Production+by+Auto-Induction+in+High-Density+Shaking+Cultures&doi=10.1016%2Fj.pep.2005.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Protein production by auto-induction in high-density shaking cultures</span></div><div class="casAuthors">Studier, F. William</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">207-234</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Inducible expression systems in which T7 RNA polymerase transcribes coding sequences cloned under control of a T7lac promoter efficiently produce a wide variety of proteins in Escherichia coli.  Investigation of factors that affect stability, growth, and induction of T7 expression strains in shaking vessels led to the recognition that sporadic, unintended induction of expression in complex media, previously reported by others, is almost certainly caused by small amts. of lactose.  Glucose prevents induction by lactose by well-studied mechanisms.  Amino acids also inhibit induction by lactose during log-phase growth, and high rates of aeration inhibit induction at low lactose concns.  These observations, and metabolic balancing of pH, allowed development of reliable non-inducing and auto-inducing media in which batch cultures grow to high densities.  Expression strains grown to satn. in non-inducing media retain plasmid and remain fully viable for weeks in the refrigerator, making it easy to prep. many freezer stocks in parallel and use working stocks for an extended period.  Auto-induction allows efficient screening of many clones in parallel for expression and soly., as cultures have only to be inoculated and grown to satn., and yields of target protein are typically several-fold higher than obtained by conventional IPTG induction.  Auto-inducing media have been developed for labeling proteins with selenomethionine, 15N or 13C, and for prodn. of target proteins by arabinose induction of T7 RNA polymerase from the pBAD promoter in BL21-AI.  Selenomethionine labeling was equally efficient in the commonly used methionine auxotroph B834(DE3)(found to be metE) or the prototroph BL21(DE3).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYNqgn15xP_bVg90H21EOLACvtfcHk0lgMV2gwpl21uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFCktLw%253D&md5=d31b76747c808ce6fbb27c7a1192b6b8</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2005.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2005.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DStudier%26aufirst%3DF.%2BW.%26atitle%3DProtein%2520Production%2520by%2520Auto-Induction%2520in%2520High-Density%2520Shaking%2520Cultures%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2005%26volume%3D41%26issue%3D1%26spage%3D207%26epage%3D234%26doi%3D10.1016%2Fj.pep.2005.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">XDS</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0ljh0av-Qidebg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teplyakov, A.</span></span> <span> </span><span class="NLM_article-title">Molecular Replacement with MOLREP</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1107/S0907444909042589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1107%2FS0907444909042589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=20057045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Kktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=22-25&author=A.+Vaginauthor=A.+Teplyakov&title=Molecular+Replacement+with+MOLREP&doi=10.1107%2FS0907444909042589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular replacement with MOLREP</span></div><div class="casAuthors">Vagin, Alexei; Teplyakov, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-25</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">MOLREP is an automated program for mol. replacement that utilizes a no. of original approaches to rotational and translational search and data prepn.  Since the first publication describing the program, MOLREP has acquired a variety of features that include weighting of the X-ray data and search models, multi-copy search, fitting the model into electron d., structural superposition of two models and rigid-body refinement.  The program can run in a fully automatic mode using optimized parameters calcd. from the input data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzj5SzYvyu_7Vg90H21EOLACvtfcHk0ljh0av-Qidebg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Kktw%253D%253D&md5=820d114719aca209994ffb0403e3b20d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0907444909042589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909042589%26sid%3Dliteratum%253Aachs%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DTeplyakov%26aufirst%3DA.%26atitle%3DMolecular%2520Replacement%2520with%2520MOLREP%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D22%26epage%3D25%26doi%3D10.1107%2FS0907444909042589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turkenburg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E.</span></span> <span> </span><span class="NLM_article-title">A Graphical User Interface to the CCP4 Program Suite</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1131</span>– <span class="NLM_lpage">1137</span>, <span class="refDoi"> DOI: 10.1107/S0907444903008126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1107%2FS0907444903008126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=12832755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFSksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=1131-1137&author=E.+Pottertonauthor=P.+Briggsauthor=M.+Turkenburgauthor=E.+Dodson&title=A+Graphical+User+Interface+to+the+CCP4+Program+Suite&doi=10.1107%2FS0907444903008126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A graphical user interface to the CCP4 program suite</span></div><div class="casAuthors">Potterton, Elizabeth; Briggs, Peter; Turkenburg, Maria; Dodson, Eleanor</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">D59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1131-1137</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4i is a graphical user interface that makes running programs from the CCP4 suite simpler and quicker.  It is particularly directed at inexperienced users and tightly linked to introductory and scientific documentation.  It also provides a simple project-management system and visualization tools.  The system is readily extensible and not specific to CCP4 software.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDH-BQSvi5qbVg90H21EOLACvtfcHk0ljh0av-Qidebg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFSksLs%253D&md5=25a0168dd7ea9f930036453a829e1e3d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0907444903008126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444903008126%26sid%3Dliteratum%253Aachs%26aulast%3DPotterton%26aufirst%3DE.%26aulast%3DBriggs%26aufirst%3DP.%26aulast%3DTurkenburg%26aufirst%3DM.%26aulast%3DDodson%26aufirst%3DE.%26atitle%3DA%2520Graphical%2520User%2520Interface%2520to%2520the%2520CCP4%2520Program%2520Suite%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2003%26volume%3D59%26spage%3D1131%26epage%3D1137%26doi%3D10.1107%2FS0907444903008126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span> <span> </span><span class="NLM_article-title">Refinement of Macromolecular Structures by the Maximum-Likelihood Method</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-55&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+Macromolecular+Structures+by+the+Maximum-Likelihood+Method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lg3fiKm7zChjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520Macromolecular%2520Structures%2520by%2520the%2520Maximum-Likelihood%2520Method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D55%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and Development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lg3fiKm7zChjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UF0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UF0','PDB','6UF0'); return false;">PDB: 6UF0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FNU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FNU','PDB','5FNU'); return false;">PDB: 5FNU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1U6D" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1U6D','PDB','1U6D'); return false;">PDB: 1U6D</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i65"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01074">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_11165"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b01074">10.1021/acs.jmedchem.9b01074</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Fluorescence anisotropy assay details, LogD<sub>7.4</sub> experimental details, metabolism data tables, Western blot and cellular assay details and quantification, crystal structure parameters, and HPLC chromatogram traces for key target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01074/suppl_file/jm9b01074_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01074/suppl_file/jm9b01074_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01074/suppl_file/jm9b01074_si_001.pdf">jm9b01074_si_001.pdf (888.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01074/suppl_file/jm9b01074_si_002.csv">jm9b01074_si_002.csv (1.73 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-12%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01074%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01074" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679973f94a593ddd","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
